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Abstract 
 
Intracellular events that take place during influenza virus replication in mammalian 
cells are well understood qualitatively. However, to better understand the complex 
interaction of the virus with its host cell and to quantitatively analyze the use of 
cellular resources for virion formation or the overall dynamics of the entire infection 
cycle, a mathematical model for influenza virus replication has to be formulated. 
Developed in the present study is the first structured model for the single cell 
reproductive cycle of influenza A virus in mammalian cells that accounts for all the 
individual steps of the process, such as attachment, internalization, genome 
replication and translation, and progeny virion assembly. 
 
The model describes an average cell surrounded by a small quantity of medium and 
infected by a low number of virus particles. It makes possible to determine the basic 
laws that control the dynamics of virus replication. The model allows estimating the 
number of cellular resources consumed by virus replication and to reveal factors that 
limit the growth rate of progeny virus particles and virus release. Based on the model 
it is also possible to analyze effects of parameter changes on the dynamics of virus 
replication, and, using this knowledge, to formulate hypotheses concerning the 
optimization of vaccine production processes. 
 
The single cell model and the results of simulations based on it provide the 
prerequisite for several useful model modifications. One of such modifications is a 
population model, taking into account the populations of uninfected, infected, and 
dead cells, as well as the population of free virus particles. The population model, 
particularly, provides a possibility to investigate the dynamics of virus production by 
a cellular system at different number of seeded virions per cell. Furthermore, having 
revealed the most critical steps of virus replication, it is possible to formulate a 
reduced single cell model, which adequately reproduces the dynamics of the process. 
Possessing a simple structure, the reduced model can be used for the development of 
structured population balance models describing the interaction of infected cells. 
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The single cell model for the influenza virus life cycle and its modifications facilitate 
future studies of influenza virus replication at a cellular level. A more detailed insight 
into the interactions of viruses and host cells might help to improve the understanding 
of virus-related diseases, to develop therapies against them, and to identify possible 
targets for molecular engineering. Model equations can be easily modified to include 
new experimental results, as well as to examine different hypotheses concerning 
cellular or viral replication mechanisms. Finally, the model can be used as a starting 
point for modeling infection cycles of other viruses. 
 
  
Abbreviations  11 
Abbreviations 
 
ATP  Adenosine triphosphate 
CGN  Cis Golgi network 
cRNA  Complementary RNA 
DNA  Deoxyribonucleic acid 
ER  Endoplasmic reticulum 
h  Hour 
HA  Hemagglutinin 
HIV  Human immunodeficiency virus 
HTLV  Human T-cell leukemia virus 
IAP  Inhibitor of apoptosis (protein) 
L  Litter 
MDCK Madin Darby canine kidney 
m  Meter 
min  Minute 
MOI  Multiplicity of infection 
mRNA  Messenger RNA 
NA  Neuraminidase 
NES  Nuclear export signal 
NEP  Nuclear export protein 
NLS  Nuclear localization signal 
NP  Nucleoprotein 
ODE  Ordinary differential equation 
ORF  Open reading frame 
p.i.  Post infection 
rER  Rough ER 
RNA  Ribonucleic acid 
rRNA  Ribosomal RNA 
sER  Smooth ER 
TGN  Trans Golgi network 
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vmRNA Viral mRNA 
vRNA  Viral RNA 
vRNP  Viral ribonucleoprotein 
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Nomenclature 
 
NPa    influence of NP proteins on vmRNA production (cells/NP protein) 
NPb    influence of NP proteins on genome replication (NP proteins/cell)  
cC   number of cRNA segments (nucleotides/cell) 
cellC   number of free cellular nucleotides (nucleotides/cell) 
cytC   number of vmRNA molecules in the cytoplasm (nucleotides/cell) 
icC ,   number of i-th cRNA segments (nucleotides/cell) 
cellmC ,   number of cellular precursor mRNA molecules (nucleotides/cell) 
nuciC ,   number of vmRNA molecules encoding i-th proteins in the nucleus  
(nucleotides/cell) 
cytiC ,   number of vmRNA molecules encoding i-th proteins in the cytoplasm  
(nucleotides/cell) 
nucC   number of vmRNA molecules in the nucleus (nucleotides/cell) 
segC   average number of nucleotides in one vRNA segment  
(nucleotides/vRNA molecule) 
TC   total number of nucleotides produced per hour (nucleotides/h) 
vC   number of vRNA segments (nucleotides/cell) 
ivC ,   number of i-th vRNA segments (nucleotides/cell) 
virC   number of nucleotides in one virus particle (nucleotides/virion)  
ribd    distance between ribosomes processing a vmRNA molecule  
(nucleotides) 
E   number of cellular endosomes (endosomes/cell) 
iF   continuous nonnegative function (  or ) 
11 −− ⋅ hmL 1−h
vC
F    continuous nonnegative function  )( 1−h
nucPolC
F
,
  continuous nonnegative function 
 
)( 1−h
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cytPolP
F
,
   continuous nonnegative function  )( 1−h
H   number of nuclear pores (pores/cell) 
i   index (-) 
j   index (-) 
cvC iv
K −,,  half-saturation function (nucleotides/cell) 
vmvC iv
K −,,  half-saturation function (nucleotides/cell) 
cvP nucPol
K −,,  half-saturation function (amino acids/cell) 
vmvP nucPol
K −,,  half-saturation function (amino acids/cell) 
inapk ,   rate coefficient of the apoptosis of infected cells  )(
1−h
unapk ,   rate coefficient of the apoptosis of uninfected cells  )(
1−⋅hnL
budk   rate constant of progeny virus assembly  )(
1−h
relbudk −   rate coefficient of progeny virus release (  or ) 
11 −− ⋅ hnL 1−h
budVrelbud
k ,−  rate coefficient of progeny virus release  )(
1−h
relVrelbud
k ,−  rate coefficient of progeny virus release  )(
11 −− ⋅ hnL
budjPbud
k
,,
 rate constant of progeny virus assembly  )( 1−h
budNAPbud
k
,,
 rate constant of progeny virus assembly  )( 1−h
budunSbud
k
,,
 rate constant of progeny virus assembly  )( 1−h
budVbud
k ,  rate constant of progeny virus assembly  )(
1−h
rck deg−   rate constant of cRNA degradation  )(
1−h
vck −   rate coefficient of vRNA synthesis  )(
1−h
max,vck −  rate coefficient of vRNA synthesis, maximum value  )(
1−h
nuccytk −   rate coefficient of vRNP nuclear import  )(
1−h
dtk   rate constant of cell detachment from microcarriers  )(
1−h
cytendk −   rate constant of vRNP uncoating   )(
1−h
cytScytend
k ,−  rate constant of vRNP uncoating   )(
1−h
endVcytend
k ,−  rate constant of vRNP uncoating  )(
1−h
  
Nomenclature  15 
rendk deg−  rate constant of “inactive” virus degradation  )(
1−h
sexk −    rate coefficient of virus binding (  or ) 
1−⋅ hnL 1−h
exVsex
k ,−  rate coefficient of virus binding  )(
1−⋅hnL
sVsex
k ,−   rate coefficient of virus binding  )(
1−h
feedk   rate of virus supply (virions/(nL ⋅ h)) 
rcytik deg, −  rate constant of i-th protein degradation in the cytoplasm  )(
1−h
nuccytik −,  rate coefficient of i-th protein nuclear import  )(
1−h
rik deg,   rate constant of i-th protein degradation  )(
1−h
rnucik deg, −  rate constant of i-th protein degradation in the nucleus  )(
1−h
syntik ,   rate coefficient of i-th protein synthesis  )(
1−h
rbudjk deg, −  rate constant of j-th protein degradation at the budding site  )(
1−h
budERjk −,  rate constant of j-th protein transport to the budding site  )(
1−h
rERjk deg, −  rate constant of j-th protein degradation in the ER  )(
1−h
budMk ,2   constant factor (amino acids/h) 
rbudNAk deg, −  rate constant of NA protein degradation at the budding site  )(
1−h
ERNAk ,  constant factor (amino acids/h) 
budERNAk −,  rate constant of NA protein transport to the budding site  )(
1−h
pckk   rate constant of viral component packaging  )(
1−h
vCpck
k ,   rate constant of viral component packaging  )(
1−h
iPpck
k ,   rate constant of viral component packaging  )(
1−h
relVpck
k ,   rate constant of viral component packaging  )(
11 −− ⋅ hnL
Plk    rate of RNA strand elongation (nucleotides/h) 
Ribk    rate of polypeptide chain elongation (amino acids/h) 
endsk −    rate coefficient of endocytosis  )(
1−h
exsk −   rate constant of virus dissociation from the cellular surface  )(
1−h
exVexs
k ,−  rate constant of virus dissociation from the cellular surface  )(
1−h
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sVexs
k ,−   rate constant of virus dissociation from the cellular surface  )(
1−h
splk   rate constant of vRNP splitting  )(
1−h
vCspl
k ,   rate constant of vRNP splitting  )(
1−h
redCspl v
k ,,  rate constant of vRNP splitting  )(
1−⋅hnL
iPspl
k ,    rate constant of vRNP splitting  )(
1−h
redPspl i
k ,,   rate constant of vRNP splitting  )(
1−⋅hnL
nuciPspl
k
,,
 rate constant of vRNP splitting  )( 1−h
nucSspl
k ,   rate constant of vRNP splitting  )(
1−h
exVspl
k ,    rate constant of vRNP splitting  )(
1−h
unk   rate constant of M1-vRNP assembly  )(
1−h
vCun
k ,   rate constant of M1-vRNP assembly  )(
1−h
inunk −   rate coefficient of infection  )(
1−h
budnucunk −,  rate coefficient of M1-vRNP nuclear export  )(
1−h
nuciPun
k
,,
 rate constant of M1-vRNP assembly  )( 1−h
nucNSPun
k
,1,
 rate constant of M1-vRNP assembly  )( 1−h
nucunSun
k
,,
 rate constant of M1-vRNP assembly  )( 1−h
vdk    rate constant of virus degradation  )(
1−⋅hnL
cvk −   rate coefficient of cRNA synthesis  )(
1−h
icvk ,−   rate coefficient of i-th cRNA synthesis  )(
1−h
max,cvk −  rate coefficient of cRNA synthesis, maximum value  )(
1−h
rvk deg−   rate constant of vRNA degradation  )(
1−h
vmvk −   rate coefficient of vmRNA synthesis  )(
1−h
ivmvk ,−   rate coefficient of the synthesis of vmRNA molecules encoding i-th  
proteins  )( 1−h
max,,ivmvk −  rate coefficient of the synthesis of vmRNA molecules encoding i-th  
proteins, maximum value  )( 1−h
  
Nomenclature  17 
rcytvmk deg, −  rate constant of vmRNA degradation in the cytoplasm  )(
1−h
rcytivmk deg,, −  rate constant of the degradation of vmRNA molecules encoding i-th  
proteins in the cytoplasm  )( 1−h
cytnucivmk −,,  rate coefficient of the nuclear export of vmRNA molecules encoding 
i-th proteins  )( 1−h
rnucivmk deg,, −  rate constant of vmRNA degradation in the nucleus  )(
1−h
cytnucvmk −,  rate coefficient of vmRNA nuclear export  )(
1−h
rnucvmk deg, −  rate constant of vmRNA degradation in the nucleus  )(
1−h
ivmL ,   length of the vmRNA molecule encoding i-th proteins (nucleotides) 
ivL ,   length of the i-th vRNA segment (nucleotides) 
1MOI   value of the MOI (virions/cell) 
2MOI   value of the MOI (virions/cell) 
optMOI  optimal value of the MOI (virions/cell) 
im   number of terms in the right-hand side of the i-th equation (-) 
cellsN   number of cells (cells) 
segN   number of genome segments in one virus particle (molecules) 
ivN ,   number of i-th vRNA segments produced per hour (molecules/h) 
n   number of model equations describing the dynamics of viral  
  components (-) 
cellP   number of free cellular amino acids (amino acids/cell) 
iP   number of i-th proteins (amino acids/cell) 
infP   probability for a virus particle to be infectious (-) 
expinf,P   probability for a virus particle to be infectious, experimental value (-) 
cytiP ,   number of i-th proteins in the cytoplasm (amino acids/cell) 
nuciP ,   number of i-th proteins in the nucleus (amino acids/cell) 
segiP ,   number of i-th proteins in one M1-vRNP complex  
(amino acids/M1-vRNP complex) 
viriP ,   number of i-th proteins in one virus particle (amino acids/virion) 
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budjP ,   number of j-th proteins at the budding site (amino acids/cell) 
ERjP ,   number of j-th proteins in the ER (amino acids/cell) 
1MP   number of M1 proteins (amino acids/cell) 
nucMP ,1   number of M1 proteins in the nucleus (amino acids/cell) 
virMP ,1   number of M1 proteins in one virus particle (amino acids/cell) 
budMP ,2   number of M2 proteins at the budding site (amino acids/cell) 
budNAP ,   number of NA proteins at the budding site (amino acids/cell) 
ERNAP ,   number of NA proteins in the ER (amino acids/cell) 
nucNPP ,   number of NP proteins in the nucleus (amino acids/cell) 
nucPolP ,   number of polymerase complexes in the nucleus (amino acids/cell) 
0R   number of cellular ribosomes (ribosomes/cell) 
sfR   number of cellular receptors (receptors/cell) 
cytS   number of vRNP complexes in the cytoplasm (vRNP complexes/cell) 
nucS   number of vRNP complexes in the nucleus (vRNP complexes/cell) 
budunS ,   number of M1-vRNP complexes at the budding site  
(M1-vRNP complexes/cell) 
nucunS ,   number of M1-vRNP complexes in the nucleus  
(M1-vRNP complexes/cell) 
t   time (h) 
0t   time point of the intersection of virus growth curves corresponding to  
different values of the MOI (h) 
T   lifetime of a cell (h) 
maxT   lifetime of a cell, maximum value (h) 
rU   volume of medium containing  cells (nL)  cellsN
budV   number of  virus particles at the budding site (virions/cell) 
endV   number of virus particles in the endosome (virions/cell) 
exV   number of virus particles in the extracellular medium (virions/nL) 
0exV   number of virus particles in the extracellular medium, initial value  
  
Nomenclature  19 
(virions/nL) 
redexV ,   number of extranuclear virus particles (virions/cell) 
iV    function staying in the left-hand side of the i-th equation  
(virions/nL or virions/cell) 
relV   number of released virus particles (virions/nL) 
1,relV   number of released virus particles at MOI=MOI1 (virions/nL) 
2,relV   number of released virus particles at MOI=MOI2 (virions/nL) 
optrelV ,   number of released virus particles at MOI=MOIopt (virions/nL) 
redrelV ,   number of virus particles assembled in the cell (virions/cell) 
sV   number of surface virus particles (virions/cell) 
Z   number of cells (cells/nL) 
0Z    number of uninfected cells, initial value (cells/nL) 
dZ    number of dead cells (cells/nL) 
inZ    number of infected cells (cells/nL) 
unZ    number of uninfected cells (cells/nL) 
ivc ,−µ   synthesis rate of i-th vRNA segments (nucleotides/h) 
icv ,−µ   synthesis rate of i-th cRNA segments (nucleotides/h) 
vmv−µ   vmRNA synthesis rate (nucleotides/h) 
ivmv ,−µ   synthesis rate of vmRNA molecules encoding i-th proteins  
(nucleotides/h)  
prodvmv ,−µ  vmRNA synthesis rate corresponding to the number of viral  
components produced in the cell (nucleotides/h)  
virvmv ,−µ  vmRNA synthesis rate corresponding to the number of viral 
components delivered with incoming virus particles (nucleotides/h) 
endatt−τ   time interval between the beginning of attachment and the beginning of  
internalization (h) 
ji ,τ   time delay of the step represented by the j-th term in the right-hand  
side of the i-th equation (h) 
1Mσ   fraction of mRNA nucleotides encoding M1 proteins in the 7th genome  
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segment (-) 
2Mσ   fraction of mRNA nucleotides encoding M2 proteins in the 7th genome  
segment (-) 
1NSσ   fraction of mRNA nucleotides encoding NS1 proteins in the 8th  
genome segment (-) 
2NSσ   fraction of mRNA nucleotides encoding NS2 proteins in the 8th  
genome segment (-) 
endω    change in cell population sizes by the beginning of endocytosis (-) 
iω   fraction of nucleotides contained in mRNA molecules encoding i-th  
proteins (-) 
HAω   fraction of nucleotides contained in mRNA molecules encoding HA  
proteins (-) 
1Mω   fraction of nucleotides contained in mRNA molecules encoding M1  
proteins (-) 
2Mω   fraction of nucleotides contained in mRNA molecules encoding M2  
proteins (-) 
NAω   fraction of nucleotides contained in mRNA molecules encoding NA  
proteins (-) 
NPω   fraction of nucleotides contained in mRNA molecules encoding NP  
proteins (-) 
1NSω   fraction of nucleotides contained in mRNA molecules encoding NS1  
proteins (-) 
2NSω   fraction of nucleotides contained in mRNA molecules encoding NS2  
proteins (-) 
Plω   fraction of nucleotides contained in mRNA molecules encoding  
polymerase complex subunits (-) 
relω    change in cell population sizes by the beginning of virus release  
(population model) (-) 
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1 Introduction 
 
Viruses are small obligate intracellular parasites, which extensively use host cell 
resources for their replication. They contain either a DNA or RNA genome, 
surrounded by coat proteins, forming a nucleocapsid. In many animal viruses this 
nucleocapsid is enclosed by a membrane containing viral glycoproteins required for 
specific virus-host cell interactions. Viruses are widely used as live attenuated, killed-
virus or recombinant protein vaccines. Additionally, the development of viral vectors 
has a great potential for gene therapy. As synthesis of viral components is carried out 
by cellular systems, viruses can also serve as powerful tools for investigating cellular 
metabolism, in particular macromolecular synthesis.  
 
The growth of viruses in their host cells is a complex, highly organized process. For a 
quantitative understanding of virus replication dynamics, mathematical modeling 
plays a crucial role. Based on a mathematical model and a set of initial conditions, it 
is possible to predict the behavior of the system at any moment of time, or to identify 
possible targets for molecular engineering to improve the yield in vaccine production 
processes. Detailed insights into virus-host cell interactions might also help to 
improve the understanding of virus-mediated diseases and to develop antiviral 
strategies. Besides that, a mathematical model provides a possibility to analyze the 
sensitivity of the system with respect to variations of its parameters. The importance 
of such an analysis results from the challenge to quantify how the functional 
properties of genetic and protein components of the virus correlate with the overall 
dynamics of virus growth. For example, what happens with the rate of virus 
production if the virus is modified to express a polymerase complex operating twice 
faster than the wild-type polymerase complex? Finally, without a mathematical model 
it is practically impossible to interpret some experimental results, particularly, an 
increase of the number of virions produced by the cell with a decrease of the number 
of virions added per cell at the time of infection. While this study deals with virus 
propagation in a single cell and in cellular populations (e.g., in bioreactors), two other 
fields, in which mathematical methods for the investigation of the spread of virus 
  
Introduction  22 
infections have been widely applied, are epidemiology (Sahai and Khurshid, 1995; 
Daly et al., 2004) and immunology (Nowak and May, 2001; Wodarz et al., 1999; 
Bocharov and Romanyukha, 1994). 
 
This section considers basic principles of model classification, gives an overview of 
existing modeling approaches for the infection of bacterial, insect, and mammalian 
cells by different viruses, and formulates the main objectives of the present study. The 
rest of the section describes the major components of the biological system to be 
modeled, i.e., mammalian cells and influenza virus particles. 
 
Section 2 formulates a model that is mainly used to achieve purposes posed in this 
section (the single cell model), as well as its modifications: the reduced model, the 
model with the reinfection of the cell by progeny virions, and the model for 
continuous infection. Besides that, it describes the population model, which allows 
revealing basic laws of virus spread through the population of cells. Presented in 
section 3 are basic model assumptions and the values of parameters used for 
modeling. The results of modeling are reported in section 4. Their importance and 
compatibility with the results obtained by other research groups are, in turn, discussed 
in section 5. Finally, section 6 summarizes the major achievements of the present 
study. 
 
 
1.1 Classification of Mathematical Models of  
      Virus Dynamics 
 
According to the set of modeling assumptions and the data sources used, 
mathematical models of virus dynamics can be classified by several aspects, the most 
common of which are abstraction level and modeling principles.  
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1.1.1 Classification by Abstraction Level 
 
Complex cellular systems are quantitatively described by using different types of 
abstractions. In other words, the model takes into account only important in the 
current investigation cellular components and processes. The other, minor parts are 
not considered. Thus, it is possible to distinguish two types of modeling approaches: 
structured and unstructured (Fig. 1.1) (Bailey, 1998; Fredrickson et al., 1970). An 
unstructured model does not consider intracellular phenomena. For example, the basic 
dynamics of virus growth in bioreactors could be modeled by a system of three 
differential equations, which describe how the numbers of uninfected cells, infected 
cells and free virus particles change over time (Moehler et al., in press). In a 
structured model, different state variables are used to model virus replication in 
different cellular compartments such as membrane, endosome, cytoplasm or nucleus. 
Based on genetic and molecular mechanistic data, rate equations are expressed for 
viral transcription, translation, protein expression, and for reactions catalyzed by 
virus-encoded enzymes (Sidorenko and Reichl, 2004). An alternative way of model 
structuring consists in the individual consideration of multiple chemical components 
of cell material, e.g., DNA, RNA, proteins, etc. (Nadeau et al., 2000). 
 
unstructured
segregatedunsegregated
unstructured
structured
segregated
structured
unsegregated
consideration
of intracellular
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consideration
of intracellular
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consideration of
the heterogeniety
of individuals
consideration of
the heterogeniety
of individuals
 
Figure 1.1 Classification of mathematical models of cell population dynamics by 
abstraction level. 
 
Besides that, modeling approaches can be considered in respect to the presence of 
heterogeneous individuals in the population of cells. A model accounting for the 
heterogeneous population of cells is referred to as a segregated model, whereas an 
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unsegregated model treats the cell population as a uniform mass of “average cells”. 
Most of the models dealing with the interaction of viruses with their host cells belong 
to the unsegregated class (see sections 1.2, 1.3).  
 
 
1.1.2 Classification by Modeling Principles 
 
Complex interactions between elementary processes taking place during the virus 
replication cycle, e.g., virus entry into the host cell, transcription and replication of the 
viral genome, and the assembly of progeny virus particles, can be quantitatively 
interpreted by either a deterministic model (based usually on a system of ordinary 
differential equations (ODEs)) or a stochastic model (Srivastava et al. (2002)). 
Deterministic models can provide the ideas concerning the relationships between the 
numbers of viral components in different intracellular compartments. However, since 
a deterministic model is unsegregated, it can be applied only for the cases when the 
number of virions is higher than the number of cells to be infected; it cannot 
adequately describe the situation when the infection of the cell culture is initiated by a 
single virus particle that delivers its genome into one cell of the whole population. In 
the later case, applying of a stochastic model can provide the dynamics of viral 
components qualitatively different from that provided by a deterministic model. The 
study of Srivastava et al. (2002) deals with the comparison of deterministic and 
stochastic modeling approaches for the investigation of the intracellular kinetics of a 
generic virus. Both approaches are based on the reactions of synthesis and depletion 
of viral structural proteins and nucleic acids. Deterministic and stochastic simulations 
provide different transient kinetics and different steady state levels of viral 
components, particularly for low values of the multiplicity of infection (MOI), when 
the infection of the cell is initiated by a low number of virus particles (the exact 
definition of the MOI is given in section 4.10 below). 
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1.2 Modeling Approaches for Virus Replication  
      in the Cells of Different Types 
 
Mathematical models have been developed for virus infection cycles in bacteria, 
insect and mammalian cells. A structured mathematical model for bacterial viruses, 
considered by Endy et al. (1997), examines the replication of the bacteriophage T7 in 
Escherichia coli. The model provides a complete picture for the phage growth cycle. 
It describes individual steps of infection, including the entry of the viral genome into 
the host cell, transcription and replication of DNA, translation of mRNA, and progeny 
phage assembly. Among the unstructured approaches for the modeling of 
bacteriophage infections are the studies of Schwienhorst et al. (1996) and Beretta and 
Kuang (1998). Developed in the former work is a basic two-stage model for the 
bacteriophage infection cycle, in which the adsorption and the intracellular stages are 
taken into account, whereas the letter model accounts for the influence of a “virus 
replication factor” (the average number of virus particles released per cell) on the 
dynamics of the infection. 
 
Other research groups are working on unstructured and structured models of 
baculovirus replication in insect cells (Dee and Shuler, 1997; Jang et al., 2000; Hu 
and Bentley, 2000; Licari and Bailey, 1992; De Gooijer et al., 1992). A 
comprehensive overview of possible approaches to model baculovirus infection is 
given by Power and Nielsen (1996). 
 
Most of the structured models either deal only with initial steps of the virus infection 
cycle or omit some intermediate steps. For example, a deterministic model from Dee 
and Shuler (1997) considers virus attachment, internalization, endosomal fusion, and 
delivery of the virus genome to the nucleus. However, neither viral protein synthesis 
nor the assembly and release of progeny virus particles are taken into account. Earlier 
a similar method was applied to describe the replication of Semliki Forest virus in 
baby hamster kidney cells (Dee et al., 1995). Another structured model was proposed 
by Jang et al. (2000). It considers the whole processes of the infection cycle of 
baculovirus, but being focused mainly on recombinant protein production and the 
effect of the infection on the host cell metabolism, it does not address some other 
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steps of infection, such as endosomal sorting, endosomal fusion, and nuclear import 
of the viral genome. 
 
A study of Licari and Bailey (1992) deals with a stochastic model capable to simulate 
the dynamics of a population of baculovirus-infected insect cells, the behavior of the 
number of extracellular virions, and the virus yield. The model deals with the 
infection of a cell population with high numbers of virus particles (up to five virions 
per cell). The authors applied a Poisson distribution to approximate the probability 
that the cell is infected by more than one virus particle. As the model takes into 
account cell growth, besides the optimal for virus production value of the MOI it can 
also predict the optimal infection time (the early exponential growth phase). Another 
probabilistic approach, demonstrated by Hu and Bentley (1999), is the first study that 
takes into account the process of the formation of progeny baculovirus particles. The 
authors present a statistical population model characterizing baculovirus infection, 
protein synthesis and the assembly of virus-like particles (empty virus particles, 
containing only the outer viral proteins) in insect cells. Like in the earlier study 
(Licari and Bailey, 1992), the probability of infection is assumed to obey a Poisson 
distribution, and the function describing the population of cells depends on three 
variables: the time post infection (p.i.), the number of infecting virions, and the time-
delay parameter τ. However, in the model of Hu and Bentley (1999) the number of 
infecting viruses per host cell is not limited by five, which seems to be essential to 
describe properly the distribution of the number of virus particles per cell. Another 
essential advantage of this approach is that it makes possible to consider the virus 
yield not only as a function of the MOI, but also as a function of the infecting cell 
density (the concentration of cells to be infected). 
 
So far, virus replication in mammalian cells has mainly been modeled by unstructured 
approaches. A number of papers are focused on hepatitis virus (Marchuk et al., 1991; 
Medley et al., 2001; Zhao et al., 2000; Neumann A. et al., 2000), human 
immunodeficiency virus (HIV) (Funk et al., 2001; Habtemariam et al., 2001; 
Krogstad et al., 1999), and human T-cell leukemia virus (HTLV) in vivo dynamics 
(Eshima et al., 2001; Wodarz et al., 1999). For example, the study of Funk et al. 
(2001) is concerned with a basic model for different forms of HIV infection, which 
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enables determining the basic reproductive rate of the virus (the average number of 
cells, secondarily infected by one virus-producing cell) as a quantitative measure of 
the replication capacity of the virus. Another model, formulated by Habtemariam et 
al. (2001), examines the interaction between the population of cells (CD4) and HIV. 
Two unstructured models of influenza virus replication in vivo are demonstrated by 
Bocharov and Romanyukha (1994) and Beauchemin et al. (2005). Both studies deal 
with the immunological aspects of the infection; the former considers a deterministic 
ODE model, and the later, based on a two-dimensional cellular automaton model, 
describes the process of infection as a sequence of stochastic events. 
 
At the same time, structured modeling is not so widespread. A detailed mathematical 
description of HIV-1 infection of CD4 cells was given by Reddy and Yin (1999). All 
major steps of the virus growth cycle after its internalization to the host cell, e.g., 
reverse transcription, integration of viral DNA molecules into the genome of the host 
cell, transcription, splicing of viral mRNA (vmRNA) molecules, genome replication, 
and formation of progeny virus particles are addressed in detail. Another example of a 
structured approach is the work of Dee et al. (1995) for Semliki Forest virus 
dynamics, which mainly considers the initial steps of the infection. 
 
 
1.3 Modeling of Influenza Virus Dynamics 
 
The present study focuses on modeling of influenza virus replication in mammalian 
cell culture. Influenza virus is a lipid-enveloped RNA virus that belongs to the 
Orthomyxoviridae family. The membrane of the virion is embedded by molecules of 
hemagglutinin (HA), a glycoprotein containing the receptor binding and the 
membrane fusion activities, and neuraminidase (NA), possessing the receptor 
destroying activity. Among the three types of influenza (A, B and C), influenza A 
virus is the best characterized and represents the most significant threat. It causes 
respiratory infections that result in severe human and animal suffering and high 
economic losses. 
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Influenza virus replication was thoroughly investigated by many groups and a number 
of excellent books and reviews describe its replication in host cells (Nicholson et al., 
1998; Flint et al., 2000; Portela and Digard, 2002; Ludwig et al., 1999; Whittaker et 
al., 1996; Lamb and Choppin, 1983). However, most studies focus on qualitative 
aspects of virus attachment, endocytosis, protein expression, genome replication, 
budding and release. 
 
Structured mathematical models developed so far describe only initial steps, such as 
virus binding and endocytosis. For example, Nunes-Correia et al. (1999) developed a 
detailed mass kinetic model for the internalization of influenza virus into Madin 
Darby canine kidney (MDCK) cells, which focuses on virus attachment and 
endosomal fusion. Together with experimental data, the model enabled the authors to 
determine several rate coefficients, particularly those for virus binding to the 
membrane of the cell and virus endocytosis. 
 
Other studies, dealing with the mathematical modeling of hemagglutinin (HA)-
mediated fusion between HA-expressing cells and erythrocytes (Mittal and Bentz, 
2001; Schreiber et al., 2001), consider in detail all basic steps of the process involved 
(e.g., lateral diffusion of HA proteins and receptors, reversible formation of HA-
receptor contact, and irreversible transformation of HA-receptor contacts into stable 
bonds between HA proteins and the membrane) and can be applied to describe the 
attachment of influenza virions to their host cells. The former work is concerned with 
a deterministic model of the process, whereas the authors of the later article consider 
the formation of fusion pores as a stochastic event (a very small number of virions 
infecting a population of host cells is considered). 
 
A detailed mathematical model related to the whole infection cycle of influenza virus 
has not yet been reported. 
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1.4 Objectives of The Present Study 
 
Developed in the present study is a structured unsegregated deterministic 
mathematical model, which describes the complete life cycle of influenza A virus in 
mammalian cells. According to the work of Bailey (1998), any mathematical model is 
meaningless if it is not preceded by the explicit definition of its purpose. It must be 
particularly defined what the use of the model is, i.e., what problems the model is 
intended to solve. The objective of the model consists in the following: a) to reveal 
basic laws that control the process of virus replication (particularly, to analyze virus 
growth dynamics), b) to better understand the complex mechanisms underlying the 
interaction of virions with their host cells, and c) to use this knowledge for the 
optimization of virus yields in vaccine production processes. Moreover, the 
population model is aimed to reveal the dynamics of virus spread in the cell 
population. Evidently, for the achievement of such purposes it is necessary to describe 
individually all the steps of the infection cycle, such as virus attachment, 
internalization, transcription and replication of the viral genome, synthesis of viral 
proteins, and assembly of newly produced viral components into progeny virions. 
 
 
1.5 Biological Properties of Mammalian Cells 
 
Cells are building blocks of all living creatures. The cell represents a compartment 
filled with a watery solution of chemical substances. The simplest form of life is 
represented by solitary cells, which propagate by division into two daughter cells. In 
higher organisms, however, cells are subdivided into different groups with certain 
functions, interconnected by complex systems of communication.  
 
All living cells are subdivided into procaryotic and eucaryotic cells. Representatives 
of procaryotic cells are bacteria, the simplest organisms found in the natural 
environment, and their close relatives. In contrast to procaryotes, which possess a 
single cytoplasmic compartment, eucaryotic cells (e.g., epithelial cells, Fig. 1.2) have 
a nucleus. The nucleus of eucaryotic cells is a separate internal compartment, 
enclosed by a double layer of a membrane and containing most of the cellular DNA 
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molecules. The rest of cellular compartment, where most of the metabolic reactions 
occur, is called cytoplasm. The cytoplasm is filled with a variety of organelles, the 
most noticeable of which are mitochondria (and chloroplasts in cells, which are able 
to carry out photosynthesis). These organelles have their own double layer 
membranes chemically different from the nuclear membrane. Additionally, eucaryotic 
cells have a cytoskeleton, a system of protein filaments. Together with adjacent 
proteins, the cytoskeleton provides the cell with the mechanical strength, controls the 
shape of the cell, and guides cellular movements. 
 
Another basic feature of all eucaryotic cells is a plenty of internal membranes. 
Besides surrounding the nucleus, mitochondria, and chloroplasts, membranes form a 
twisted structure of the endoplasmic reticulum (ER), the compartment responsible for 
the synthesis of membrane lipids and proteins, as well as the materials to be excreted 
from the cell. Flattened sacs of the Golgi apparatus, which serves for the transport 
and modification of molecules synthesized in the ER, are also formed by membranes. 
Implementing intracellular digestion lysosomes are surrounded by a membrane to 
avoid the attacks of their contents to the cellular macromolecules elsewhere in the 
cell. For the similar purpose membranes surround peroxisomes, which produce and 
degrade highly reactive hydrogen peroxide during the oxidation processes occurring 
with the participation of O2. Besides that, membranes form in the cytoplasm small 
vesicles. All membrane-bounded organelles usually occupy about a half of the total 
cellular volume. The remaining compartment of the cytoplasm is referred to as 
cytosol. 
 
  
Introduction  31 
 
Figure 1.2 Epithelial cell and its major intracellular compartments. Adapted from Alberts 
et al., 2002. 
 
This section focuses on mammalian cells, which represent a constituent of the 
biological system considered in the present study. The main attention will be paid on 
the properties of cells that virus particles use for their replication. Considered will be 
the basic characteristics of cellular compartments, their functions, as well as the 
transfer of substances between different compartments. In the end of the section the 
process of apoptosis (programmed cell death) will be briefly described. 
 
 
1.5.1 Structure of Cellular Membranes 
 
Membranes play a variety of essential roles in the lifecycle of mammalian cells. For 
example, the plasma membrane defines the boundaries of the cell and maintains the 
characteristic differences between the cytosol and the extracellular environment. 
Similarly, inside the cell membranes of organelles, e.g., Golgi apparatus or 
mitochondria, are responsible for the maintenance of the difference between the 
contents of the organelle and the cytosol. Additionally, plasma membrane contains 
proteins that are called receptors and serve as sensors of external and internal signals. 
Receptors are responsible for the transfer of information across the membrane that 
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allows the cell to adjust its behavior in accordance with possible changes of 
environmental conditions. 
 
Each biological membrane represents a thin film of lipid and protein molecules (Fig. 
1.3). Lipids make up about 50% of the membrane mass, proteins constituting almost 
all the remaining (Alberts et al., 2002). Lipid molecules form a continuous double 
layer, called a lipid bilayer, with a thickness of approximately 5 nm. Among all the 
components making up a lipid bilayer phospholipids are the most numerous. Besides 
phospholipids, cholesterol and glycolipids are also contained in essential amounts. A 
lipid bilayer is the universal basis of the structure of a cellular membrane. 
Representing a two-dimensional liquid, in which the molecules possess the ability of 
lateral movement, it defines the fluid structure of the membrane. Besides that, it 
serves as a barrier for the transfer of water-soluble molecules into the intracellular 
compartment. As influenza virus particles acquire the lipid bilayer of their membrane 
from the plasma membrane of the cell, the structure and the composition of cellular 
and viral membranes resemble each other. 
 
transmembrane protein
cytosolic protein
cytosol
extracellular mediumlipid molecule
 
Figure 1.3 Structure of a cellular membrane. Transmembrane proteins extend through the 
lipid bilayer. Other membrane proteins are entirely located in one compartment, being 
associated with the corresponding monolayer of the lipid bilayer. 
 
Protein molecules inserted into the lipid bilayer perform all the other functions of a 
membrane, such as the transport of specific molecules across it or the catalysis of 
membrane-associated reactions (e.g., ATP synthesis). In the plasma membrane part of 
the proteins serves as structural links connecting the cytoskeleton to either the 
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extracellular medium or adjacent cells. The other part represents receptors responsible 
for the detection of chemical signals in the extracellular medium. For the cell to 
function and to interact with its environment a variety of membrane proteins is 
required. Consequently, it is not surprising that approximately 30% of the proteins 
encoded by the genome of a mammalian cell are membrane proteins. 
 
 
1.5.1.1 Structure and Functions of Membrane Proteins 
 
The set of membrane proteins defines the characteristic functional properties of each 
type of cellular membranes. There are several possible mechanisms for the association 
of proteins with the membrane (Fig. 1.3) (Alberts et al., 2002). For example, some 
membrane proteins, called transmembrane proteins, extend through the lipid bilayer, 
disposing parts of their mass on each side. Some transmembrane proteins, such as 
porin proteins, form large transmembrane channels. Since the main function of 
channel proteins is the transport of inorganic ions, these proteins are usually called ion 
channels. Similar to the cell, influenza virus particles possess ion channel proteins 
embedded into their membrane (M2 proteins). The transport of H+ into the interior of 
the virion, performed by these proteins is essential for the release of viral genome 
from the endosome to the cytoplasm (see section 1.6.2). There is an essential 
difference between the parts of transmembrane proteins situated on the two sides of 
the membrane. Since the vast majority of these proteins in mammalian cells are 
glycosylated (see section 1.5.2.2), the parts of proteins on the noncytosolic side of the 
membrane always possess the oligosaccharide chains (Gahmberg and Tolvanen, 
1996). 
  
Other membrane proteins are entirely located either in the cytosol or at the external 
cell surface, being associated with the corresponding monolayer of the lipid bilayer. 
Finally, many membrane proteins do not extend into the lipid bilayer at all; they are 
bound to the membrane by noncovalent interactions with other membrane proteins 
(Driscoll and Vuidepot, 1999). Most of these proteins, called peripheral membrane 
proteins, can be released from the membrane by slight changes of the environmental 
conditions that influence protein-protein interactions, e.g., by the decrease of the pH. 
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The other membrane proteins that cannot be released from the membrane by this way, 
i.e., transmembrane proteins and proteins attached to the lipid bilayer, are referred to 
as integral membrane proteins. As well as M2 ion channels, HA and NA proteins of 
influenza virus are integral membrane proteins. 
 
The functions of a membrane protein are defined by the nature of its association with 
the lipid bilayer. For example, cellular surface receptors are transmembrane proteins 
that bind signal molecules from the extracellular medium and can generate 
corresponding intracellular signals on the opposite side of the plasma membrane. 
Proteins responsible for the intracellular signaling are, in contrast, associated only 
with the cytosolic part of the plasma membrane. 
 
 
1.5.2 Compartmentalization of Mammalian Cells 
 
All eucaryotic cells are subdivided into functionally different, membrane-enclosed 
compartments (organelles), containing their own set of specialized molecules. The 
major intracellular compartments of mammalian cells are presented in Figure 1.2. The 
most essential determinants of the structural and functional properties of the organelle 
are its proteins, which catalyze chemical reactions and selectively transport small 
molecules into and out of the organelle interior (lumen). Additionally, proteins 
function as surface markers mediating the delivery of macromolecules to the 
organelle. A mammalian cell contains in average approximately 1010 molecules of 
proteins of about 104 kinds (Alberts et al., 2002). The synthesis of the most of these 
molecules starts in the cytosol, and each newly synthesized protein is then specifically 
transported to the compartment where it is required. 
 
 
1.5.2.1 Structure of Cellular Nucleus 
 
The nucleus represents the site of nucleic acid (DNA and RNA) synthesis and 
contains the major part of cellular genome. Its envelope consists of two concentric 
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membranes, the inner membrane being structurally supported by a protein network, 
called nuclear lamina. The outer membrane of the nucleus represents the continuation 
of the membrane of the ER, and the space between the inner and the outer nuclear 
membranes (the perinuclear space) is continuous with the ER lumen. The cytosolic 
surface of the outer nuclear membrane, similar to that of the ER, contains a plenty of 
membrane-bound ribosomes, which are responsible for the synthesis of proteins 
needed in the perinuclear space. 
 
There is continuous bidirectional traffic between the cytosol and the nucleus. A plenty 
of proteins functioning in the nucleus, e.g., DNA and RNA polymerases, gene 
regulatory proteins, are imported into the nucleus from the cytosol, where they are 
synthesized. On the other hand, mRNA molecules synthesized in the nuclear 
compartment are exported to the cytosol. Both nuclear import and export are selective 
processes and proceed through the nuclear pore complexes, piercing the envelope of 
the nucleus. A nuclear pore complex represents an elaborate structure made up by 
more than 100 different proteins (nucleoporins) (Allen et al., 2000). The number of 
nuclear pore complexes is thought to define the activity of the nucleus in 
transcription, more active nuclei containing higher numbers of pores. The envelope of 
mammalian cell nucleus contains in average 3000-4000 nuclear pore complexes 
(Alberts et al., 2002).  
 
Small molecules (smaller than 5000 Daltons) are able to pass through the nuclear pore 
complex by diffusion; it was shown that in respect to free diffusion a nuclear pore was 
equivalent to a water-filled cylindrical channel, about 15 nm long and 9 nm in 
diameter (Stoffler et al., 1999). At the same time, complex protein and nucleic acid 
molecules are transported into and out of the nucleus actively, by specific receptor 
proteins binding to them. For instance, the proteins to be imported into the nucleus 
carry nuclear localization signals (NLSs), recognized by nuclear import receptors 
(Goerlich and Mattaj, 1996). The system of nuclear export, in turn, relies on nuclear 
export signals (NESs), carried by exported macromolecules, and on complementary 
nuclear export receptors. During their replication cycle influenza viruses extensively 
use cellular transport machinery for the nuclear export and import of their mRNA 
molecules and proteins, as well as for the delivery of their genome into the nucleus. 
Necessary for that NLSs and NESs are carried by correspondent viral proteins (see 
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sections 1.6.2 and 1.6.7). 
 
The nucleus is surrounded by the cytoplasm, which comprises the cytosol and 
cytoplasmic organelles. The cytosol is the main site of protein synthesis and 
degradation. Most of the intermediary metabolism of the cell, e.g., the synthesis of 
building blocks for macromolecules, also takes place in the cytosol. 
 
 
1.5.2.2 Structure of the Endoplasmic Reticulum and Golgi  
            Apparatus 
 
The ER comprises about half of the total area of cellular membrane and extends from 
the nucleus throughout the entire cytosol. Its net-like labyrinth represents an 
arrangement of interconnected tubules and sacs. The membrane of the ER encloses a 
single internal space that occupies about 10% of the total cellular volume (Alberts et 
al., 2002) and is called the ER lumen. The membrane of the ER mediates the selective 
transport of molecules between the ER lumen and the cytosol.  
 
Bound to its cytosolic surface ribosomes are involved in the synthesis of membrane 
proteins. After influenza infection ER-bound ribosome also synthesize viral HA, NA, 
and M2 proteins. ER regions that are covered by ribosomes form the rough ER (rER), 
whereas the other part of the ER, lacking ribosomes, is referred to as the smooth ER 
(sER). Since the sER contains budding sites of vesicles transporting newly 
synthesized macromolecules to the Golgi apparatus, it is also called the transitional 
ER. Besides producing proteins, the ER synthesizes lipids for the rest of the cell. 
Produced in the ER are all major classes of lipids, including phospholipids and 
cholesterol, required for the production of new cellular membranes. 
 
Another essential biosynthetic function of the ER is the covalent addition of sugars to 
proteins. This process is known as protein glycosylation, and glycosylated proteins 
are, correspondingly, referred to as glycoproteins. Almost all soluble and membrane-
bound proteins made in the ER, including proteins to be transported to the Golgi 
apparatus, lysosomes, plasma membrane, and extracellular medium, are 
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glycoproteins. The majority of cytosolic proteins are, in contrast, not glycosylated. 
Protein glycosylation has an important role in the control of protein folding in the 
lumen of the ER, so that only proper folded proteins are able to leave the ER (Parodi, 
2000). However, even being glycosylated, about 80% of proteins translocated into the 
ER fail to achieve their properly folded state. Proteins that do not fold correctly are 
excreted into the cytosol, where they are degraded by proteasomes. Additionally, 
protein glycosylation seems to be important for the protein sorting in the trans Golgi 
network (TGN, see below). 
 
Many proteins and lipids synthesized in the ER are sent by COPII-coated transport 
vesicles (see section 1.5.4 below) to the Golgi apparatus (Klumperman, 2000; Glick, 
2000). The Golgi apparatus consists of organized stacks of four to six disc-like 
membrane-enclosed compartments (Golgi cisternae). In most cells it is situated close 
to the nucleus and lies on the exit rout from the ER. The major function of the Golgi 
apparatus is the synthesis of carbohydrates, an essential part of which is attached in 
glycosylation reactions to many proteins and lipids delivered from the ER as 
oligosaccharide side chains. Having acquired the appropriate oligosaccharides, 
proteins and lipids can be recognized for targeting into transport vesicles going to a 
variety of cellular cites. Thus, the Golgi apparatus serves as a sorting station for the 
products of the ER.  
 
Each Golgi stack has two faces, a cis face (entry face) and a trans face (exit face). Cis 
and trans faces are closely associated with corresponding compartments, the cis Golgi 
network (CGN) (or intermediate compartment) and the TGN, each representing the 
network of interconnected tubular and cisternal structures (cis cisternae and trans 
cisternae respectively). Proteins and lipids enter the CGN and exit from the TGN, 
where they are packaged into transport vesicles and then transported to their specific 
destinations. Both networks seem to be important for the sorting of macromolecules. 
 
 
1.5.2.3 Membrane-Bound and Free Ribosomes 
 
Ribosomes are complex catalytic machines performing protein synthesis. They are 
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made from about 50 different proteins (ribosomal proteins) and several RNA 
molecules (ribosomal RNA molecules, rRNA molecules). Besides ribosomes attached 
to the cytosolic part of the ER (or nuclear) membrane, there is a separate population 
of free cytosolic ribosomes. A typical mammalian cell contains in its cytosol about 
107 ribosomes (Alberts et al., 2002). While membrane-bound ribosomes catalyze the 
synthesis of proteins to be translocated into the ER (or into the nucleus), free 
ribosomes synthesize all other proteins encoded by the genome (during the infection 
cycle of influenza virus they also synthesize capsid and nonstructural viral proteins). 
There is no functional difference between free and membrane-bound ribosomes; the 
location of the ribosome is defined only by the protein it produces at the given 
moment of time. For example, if a protein carries an ER signal sequence, the 
ribosome is directed to the ER membrane. 
 
Usually, several ribosomes are bound to a single mRNA molecule, forming a 
polyribosome (or a polysome complex). If the mRNA molecule to be translated 
encodes a protein carrying an ER signal sequence, the polyribosome is directed to the 
ER membrane. The growing polypeptide chain is then translocated into the ER lumen 
by threading its loop across the ER membrane. When finishing the translation, 
individual ribosomes can return to the cytosol, however the mRNA molecule remains 
bound to the membrane of the ER by a changing population of ribosomes. In the case 
when the synthesized protein lacks an ER signal sequence, the polyribosome and, 
correspondingly, the mRNA molecule, are free in the cytosol. Thus, mRNA 
molecules, similar to ribosomes, can be either attached to the membrane of the ER or 
free. Individual ribosomes are suggested to move randomly between these two mRNA 
populations. 
 
 
1.5.2.4 Structure of Mitochondria, Peroxisomes and  
             Lysosomes 
 
Mitochondria represent double-membrane-enclosed organelles that are aimed to 
generate ATP, exploited by the cell to drive the reactions requiring the input of free 
energy. Used for this purpose is the energy derived from electron transport and 
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oxidative phosphorylation. Peroxisomes are small vesicular compartments that 
contain enzymes catalyzing a variety of oxidative reactions and, together with 
mitochondria, represent the major site of molecular oxygen utilization. Unlike 
mitochondria, they are surrounded by only one membrane layer.  
 
Lysosomes are membrane-enclosed compartments containing hydrolytic enzymes 
(acid hydrolases) used for the controlled intracellular digestion of needless (e.g., 
damaged) intracellular organelles, macromolecules (e.g., sugars, proteins, nucleic 
acids, and lipids), or particles taken from the extracellular medium by endocytosis. 
Contained in lysosomes are about 40 types of digestive enzymes including proteases, 
lipases, nucleases, phosphatases, etc. (Luzio et al., 2003). The lysosomal membrane 
has an ATP-driven H+ pump responsible for the maintenance of the acidic pH in the 
interior. An acid environment is required for the activity of acid hydrolases; the 
lysosomal pH is maintained at a level of about 5.0 by pumping H+ into its lumen. At 
the cytosolic pH, equal to approximately 7.2, the digestive enzymes of lysosome 
cannot cause significant damages; consequently, their possible leakage would not be 
severely harmful for the contents of the cytosol. Products of macromolecule 
degradation are further used as precursors for cellular anabolic pathways. 
 
 
1.5.3 Movement of Proteins Between Cellular  
         Compartments 
 
The fate of cellular proteins, the most of which are synthesized in the cytosol by 
ribosomes, is defined by sorting signals contained in their amino acid sequence (von 
Heijne, 1990). Sorting signals mediate the transport of proteins to their final 
destinations outside the cytosol, and proteins deprived of sorting signals remain in the 
cytosol. Additionally, sorting signals direct the delivery of proteins from the ER to 
other destinations. 
 
There are three possible mechanisms, by which proteins are transported from one 
compartment to another: gated transport, transmembrane transport, and vesicular 
transport. Gated transport relates to protein trafficking between the cytosol and the 
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nucleus. It implies that the spaces on both sides of the membrane are topologically 
equivalent. The nuclear pore complexes present an example of selective gates actively 
transporting specific macromolecules into and out of the nucleus. By transmembrane 
transport specific proteins are directly transferred across a membrane to a 
topologically distinct space. This way relates, for example, to the transport of selected 
proteins from the cytosol to the ER interior. Vesicular transport delivers proteins from 
one compartment to another by membrane-enclosed transport intermediates (Fig. 1.4). 
A transport vesicle, loaded with molecules from the lumen of the first compartment, 
pinches off from the membrane of this compartment and discharges to the second 
compartment after fusing with its membrane. An example of vesicular transport is the 
transfer of soluble proteins from the ER to the Golgi apparatus. Transported proteins 
do not cross a membrane; consequently, vesicular transport can move proteins only 
between topologically equivalent compartments. 
 
Sorting signals are recognized by complementary sorting receptors that deliver the 
protein to the appropriate target organelle. For example, for its nuclear import a 
protein must have a sorting signal (NLS) recognized by receptor proteins that guide it 
through the nuclear pore complex (see section 1.5.2.1). Similarly, sorting signals of 
proteins to be transported directly across a membrane are recognized by the 
translocator of this membrane. At last, proteins to be loaded to a vesicle must possess 
sorting signals recognized by complementary receptors in the appropriate membrane. 
 
lipid bilayer
transported proteins
donor compartment destination compartment
transport vesicle
budding fusion
 
Figure 1.4 Movement of proteins by intracellular vesicular transport. A transport vesicle 
buds from the donor compartment and fuses with the destination compartment. 
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1.5.4 Intracellular Vesicular Transport 
 
The plasma membrane of the cell permits indispensable molecules to enter and waste 
molecules to leave the cellular interior. The nature of this barrier is defined by 
existence of specific transport processes, as well as physical properties of the lipid 
bilayer, making up the membrane. Thus, a number of molecules, e.g. water and 
dissolved gases, can freely cross the membrane. On the other hand, many metabolites, 
such as nucleotides and ATP, cannot pass through the membrane in this way. Ions, 
sugars and amino acids are taken up by permeases, integral membrane proteins, 
whereas macromolecules and large particles, such as viruses and bacteria, are usually 
transported into the cell by endocytosis. 
 
In mammalian cells the consumption of specific macromolecules from the 
extracellular medium by endocytosis (endocitic pathway) and their digestion, as well 
as the regulation of the export of newly produced macromolecules by exocytosis 
(biosynthetic-secretory pathway), is performed by a complex system of internal 
membranes. The lumens of all membrane-enclosed compartments involved in 
endocytosis and exocytosis are topologically equivalent, which allows the 
communication of compartments by vesicular transport (see section 1.5.3). The traffic 
of transport vesicles occurs along highly organized directional routs. For instance, the 
endocitic pathway leads inward from the plasma membrane, while the biosynthetic 
secretory pathway leads outward from the ER to the cell surface. Most of the transport 
vesicles are formed as coated vesicles from specialized coated domains of 
membranes. The coat represents a curved lattice, and its formation allows molding the 
form of the vesicle by the corresponding deformation of the membrane. Additionally, 
the coat concentrates specific membrane proteins in a certain patch of the membrane, 
which is destined to form the membrane of the vesicle. Before the fusion of vesicular 
and target membranes the coat disintegrates to allow the direct interaction of two 
cytosolic membrane surfaces.  
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Several types of coated vesicles are distinguished with respect to their coat proteins, 
the best characterized of which are clathrin-coated, COPI-coated, and COPII-coated 
vesicles. Clathrin-coated vesicles usually carry out the transport of molecules 
(ligands) from the plasma membrane and from the Golgi apparatus, COPI-coated 
vesicles transfers ligands from endosomes and Golgi apparatus, and COPII-coated 
vesicles mediate transport from the ER.  
 
Among the three mentioned types of coated vesicles, clathrin-coated vesicles are the 
most thoroughly studied. A clathrin-coated vesicle is formed by two major protein 
components: fibrous protein called clathrin and a multisubunit complex referred to as 
adaptin (Schmid, 1997). Clathrin subunits that possess the ability of spontaneous self-
assembly into polyhedral cages are responsible for the formation of coated pits on the 
cytosolic surface of the membrane. Clathrin-coated pits are known to include up to 
2% of the surface area of a cell (Flint et al., 2000). Adaptin is, in turn, required to bind 
the clathrine coat to the membrane and to capture transmembrane receptors that bind 
the molecules to be transported. Growing clathrin-coated buds invaginate and finally 
pinch off from the membrane (Fig. 1.5). As soon as the vesicle is released, the clathrin 
coat is rapidly (in a few seconds) removed from the vesicle membrane by special 
proteins, attached to the vesicle. 
 
 
Figure 1.5 Formation and release of a clathrin-coated vesicle. 
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1.5.4.1 Uptake of Macromolecules by Receptor-Mediated  
             Endocytosis 
 
By endocytosis the cell consumes from the extracellular medium specific substances, 
macromolecules and sometimes other cells or their fragments. The particles to be 
transported into the intracellular compartment are first enclosed by a portion of the 
plasma membrane, which is then invaginates and finally pinches off, forming a 
particle-containing endocytic vesicle in the cytosol. In respect to the size of ingested 
particles, two main types of endosytosis are distinguished: phagocytosis, which relates 
to the ingestion of large particles, and pinocytosis, which, in contrast, involves the 
uptake of fluids containing suspended small particles. 
  
Phagocytosis and pinocytosis are nonspecific processes, which means that any 
particle of appropriate size can be delivered into the cell. The import of specific 
macromolecules from the extracellular medium occurs mainly by receptor-mediated 
endocytosis, the pathway performed by clathrin-coated vesicles. The ligands bind to 
complementary transmembrane receptors, form clathrin-coated pits, and enter the cell 
as ligand-receptor complexes within clathrin-coated vesicles (see section 1.5.4). 
Unlike phagocytosis and pinocytosis, receptor-mediated endocytosis represents a 
selective mechanism. In respect to the internalization of particular ligands it is 
hundredfold more effective than mentioned above nonspecific processes. About 25 
different types of receptors are known to take part in receptor-mediated endocytosis 
and the part of plasma membrane belonging to one coated pit can accommodate up to 
1000 receptors of different types (Mellman, 1996). Many receptors enter coated pits 
free of their specific ligands.  
 
Being separated from the plasma membrane and getting rid of its coat, the vesicle 
delivers its receptor-ligand complexes into the compartment of the early endosome, a 
small smooth-walled organelle, usually located near the cellular surface. Early 
endosomes are the main sorting station in the endocytic pathway. The membrane of 
the early endosome, similar to that of the lysosome, possesses a proton pump 
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implementing an energy-dependent transport of protons into the lumen of the 
endosome. The endosomal environment is, hence, acidic. At low pH most of the 
internalized receptor proteins undergo conformational changes and, as a result, 
dissociate from their ligands. Ligands free of their receptors are directed to lysosomes, 
where they are degraded. Most of the receptors are recycled back to their initial place 
in the plasma membrane by recycling endosomes. Ligands that remain bound to their 
receptors share the fate of receptors.  
 
The way from the early endosome to the lysosome starts with the delivery of 
endocytosed ligands to the late endosome. The late endosome is then converted to the 
lysosome; it fuses with the acid hydrolase-carrying transport vesicle from the TGN, 
which results in a decrease of its pH. Being delivered to late endosomes, influenza 
virus particles (except for "inactive" ones, see section 1.6.2) are not degraded in 
lysosomes. Instead, fusion activity of their HA proteins mediates the fusion of viral 
and endosomal membranes, which results in the release of viral genome to the 
cytoplasm. 
 
 
1.5.4.2 Exocytosis 
 
By exocytisis the cell carries out the transfer of newly produced macromolecules from 
the TGN to the extracellular space. Transport vesicles, budding from the TGN and 
destined for the plasma membrane, contain membrane proteins and lipids, as well as 
soluble proteins to be excreted to the extracellular medium (Keller and Simons, 1997).  
 
Most of cells in the tissue are polarized, i.e., they have two distinct domains of the 
plasma membrane (Alberts et al., 2002). For instance, the membrane of epithelial cells 
comprises an apical domain bordering with the extracellular medium and a basal 
domain covering the rest of the cell. Apical and basal domains are separated by a ring 
of tight junction preventing proteins and lipids of one domain from the diffusion to 
the other (Fig. 1.2). Directed to the two considered domains must be different sets of 
membrane proteins and lipids. This is achieved in the TGN, where the proteins and 
lipids form the ER are sorted in accordance with their destinations and packaged to 
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transport vesicles delivering them to corresponding domains of the plasma membrane 
(Traub and Kornfeld, 1997). 
 
 
1.5.5 Apoptosis 
 
Eucaryotic cells contain the seeds of their own destruction, waiting for the signal to 
destroy the cell. Apoptosis, or programmed cell death, is a thoroughly regulated 
process of the activation of the intracellular death program. The intracellular 
machinery responsible for apoptosis depends on the family of special proteolytic 
enzymes, called caspases (Potten and Wilson, 2004). Caspases exist in the cell in their 
inactive form, as procaspases. They are usually activated via the cleavage by other 
caspases, forming an amplifying caspase cascade. Activated caspases cleave key 
proteins of the cell including nuclear lamina and proteins that hold DNA-degrading 
enzymes (DNAses) in their inactive form. As a result, active DNAses start cutting up 
the DNA in the cellular nucleus. Caspase activation is strongly regulated by proteins 
from IAP (inhibitor of apoptosis) and Bcl-2 families, some of which inhibit and the 
others promote caspase activation (Eckert et al., 1999). 
 
 
1.6 Molecular Biology and Infection Cycle of  
      Influenza A Virus 
 
Influenza A virions are roughly spherical with a diameter of 70-120 nm (Fig. 1.6). 
The genome of influenza A virus consists of eight negative-stranded RNA segments 
of different size, encapsidated by nucleoproteins (NP) (approximately 20 nucleotides 
per one protein subunit). Associated with each segment are polymerase complexes 
(RNA-dependent RNA polymerases), containing 3 protein subunits: PB1, PB2 and 
PA. The PB1 subunit of the polymerase complex carries both a transcriptase, which 
catalyses nucleotide addition during the elongation of the RNA transcript, and a cap-
dependent endonuclease, which performs the cleavage of capped RNA fragments to 
generate primers for vmRNA synthesis. The PB2 subunit is, in turn, responsible for 
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the binding of the cap of cellular precursor mRNA molecules. The PA protein is 
essential for viral genome replication, however its actual role is not fully understood. 
The arrangement of a viral genomic RNA molecule (vRNA molecule), NP protein 
and three polymerase protein subunits is referred to as a viral ribonucleoprotein 
(vRNP) complex. The NP protein represents the most abundant its component (Table 
1.1). A vRNP complex represents a 10-20 nm wide panhandle structure, in which the 
vRNA segment coated by NP proteins forms a loop, and polymerase complexes bind 
to the partially complementary ends of the vRNA molecule. Eight vRNP complexes 
are surrounded by a shell of matrix proteins M1, the most abundant among all viral 
proteins (Table 1.1). This M1 protein layer, providing the rigidity of the virion, is, in 
turn, bound to the lipid membrane of the virion, derived from the host cell. Inserted 
into the viral membrane are three envelope proteins: HA, NA, and M2. Serological 
differences of HA and NA proteins provide the basis for influenza A virus 
classification. To date 15 different HA- and 9 different NA-subtypes are known. 
Finally, virus particles contain NS2 proteins, also called nuclear export proteins 
(NEPs), associated with M1 proteins. NS2 proteins represent a minor component of 
the virion. 
 
Table 1.1 Stoichiometry of Influenza A virus (A/PR/8/34) (Knipe et al., 2001). 
Segment Protein vRNA,  
nt 
vmRNA, 
nt 
Peptide, 
aa  
MW,    
Da 
Mlc/virion 
1 PB2 2341 2320 759 85700 30-60 
2 PB1 2341 2320 757 86500 30-60 
3 PA 2233 2211 716 84200 30-60 
4 HA 1778 1757 566 61468 500 
5 NP 1565 1540 498 56101 1000 
6 NA 1413 1392 454 50087 100 
7 M1 
M2 
1027 1005 
315 
252 
97 
27801 
11010 
3000 
20-60 
8 NS1 
NS2 
890 868 
395 
230 
121 
26815 
14216 
0 
130-200 
nt: Nucleotides 
aa: Amino acids 
mlc: Molecules 
MW: Molecular weight 
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Figure 1.6 Structure of influenza A virus. U. Reichl. 
 
The total coding capacity of influenza A virus genome makes up approximately 13 kb 
(Ludwig et al., 1999). Encoded by eight genome segments are ten viral proteins, nine 
of which (structural viral proteins) are incorporated into a virus particle. NS1 proteins 
(nonstructural viral proteins), particularly responsible for vmRNA splicing 
(Nicholson et al., 1998; Juan, 1998; Ortin, 1998), are not incorporated into the virion. 
Each of the first six segments of the viral genome encodes one viral protein. Thus, 
vRNA segments 1, 2, and 3 give rise to polymerase complex subunits PB1, PB2, and 
PA, respectively; hemagglutinin and neuraminidase are correspondingly derived from 
segments 4 and 6; and segment 5 encodes NP proteins. The other two segments (the 
shortest in the genome), each containing two open reading frames (ORFs), code for 
two proteins. A collinear reading frame of segment 7 encodes M1 proteins, while a 
spliced mRNA molecule of the same segment expresses M2 proteins (Lamd and 
Choppin, 1983). Similarly, segment 8 contains the coding sequences for NS1 proteins 
and for NS2 proteins. Recently discovered was a novel protein PB1-F2, which is 
encoded by an ORF within an alternative reading frame of segment 1 (encoding PB1 
proteins) (Chen et al., 2001). This 87-residue protein, localizing at the inner 
mitochondrial membrane of infected cells (Gibbs et al., 2003), seems to permeabilize 
and destabilize the mitochondrial membranes of the cell, which leads to the leakage of 
macromolecules and apoptosis (Chanturiya et al., 2004). Besides that, it functions to 
kill host immune cells responding to influenza virus infections. The PB1-F2 protein 
was shown to be non-essential for virus replication in vitro and, therefore, is not 
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considered in the model the present study deals with. 
 
Unlike influenza virus, large DNA viruses, such as poxviruses or herpes, express 
about 200 gene products (Flint et al., 2000). However, despite the relatively small 
coding capacity of its genome, influenza A viruses are able to successfully infect and 
multiply in a wide range of mammalian and avian species. They replicate in the 
epithelial cells of the upper respiratory tract of humans, horses and pigs. In vitro they 
can also infect many other cell types that possess surface glycoproteins containing 
sialic acid moieties (Julkunen et al., 2001). By multiple interactions between viral and 
cellular proteins influenza A viruses extensively use and manipulate host cell 
functions. An increasing amount of information concerning the roles of viral and 
cellular factors in transcription and replication of the viral genome, nuclear import 
and export of viral components, and assembly of the virus particle has accumulated in 
recent years. Relying on this data, the model developed in the present study 
quantitatively describes virus infections of mammalian cells, such as MDCK or Vero 
(African Green Monkey kidney) cells, used in vaccine production. It considers the 
major steps of the virus replication cycle (Fig. 1.7), which is the focus of the current 
section. 
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Figure 1.7 Replication cycle of influenza A virus. The numbers designating the steps of 
the replication cycle correspond to the numbers of subsections in section 1.6. Sidorenko and 
Reichl, 2004. 
 
 
1.6.1 Virus Entry into the Host Cell. Structure of the  
         HA Protein 
 
Influenza virus particles attach to sialic acid-containing receptors at the apical 
membrane of polarized epithelial cells (Fig. 1.2) via viral HA glycoproteins (Fig. 1.7, 
step 1) (Nicholson et al., 1998). Each monomer of the trimeric HA spike consists of 
two subunits: a globular head (HA1), which carries sialic acid-binding sites, and a 
long helical stem (HA2), by which the molecule is anchored in the membrane (Fig. 
1.8). It is a globular head of the HA protein that mediates binding of the virus to the 
receptors at the surface of the cell. At the N-terminal tip of the HA2 protein there is a 
sequence, known as a fusion peptide, which further mediates fusion of viral and 
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cellular membranes (see section 1.6.2). 
 
31 4 2
 
Figure 1.8 Schematic drawing of the HA trimer. 1 – viral membrane; 2 – globular head 
(HA1 subunit); 3 – helical stem (HA2 subunit); 4 – fusion peptide. 
 
After attachment to the surface receptors, virions penetrate into the cell mainly by 
clathrin-dependent receptor-mediated endocytosis (see sections 1.5.4.1). The clathrin-
dependent endocytic pathway of virus entry seems to be the most common, although 
several other entry pathways for influenza virus are also reported (Sieczkarski and 
Whittaker, 2002a; Sieczkarski and Whittaker, 2002b). It was particularly suggested 
that about one third of virions were internalized by clathrin-independent pathways 
(Rust et al., 2004). 
 
 
1.6.2 vRNP Uncoating and Transport into the Nucleus.  
         Roles of HA and M2 Proteins 
 
As mentioned above, the viral genome is stored in the virion in form of vRNP 
complexes. Internalization of a virus-receptor complex by the endocytic pathway is 
followed by the release of vRNP complexes from the endosome into the cytoplasm 
(Fig. 1.7, step 2). To perform this step of its replication cycle, influenza virus has 
evolved a special mechanism adapted to the acidic pH of the endosome, which 
involves two viral proteins: HA and M2 ion channel. The import of H+ into the 
interior of the virion results in the acidification of the virion first to approximately 6.0 
in the early endosome and then to approximately 5.0 in the late endosome 
(Lakadamyali et al., 2004). As a result of the second acidification, HA proteins 
undergo an acid-catalyzed conformational rearrangement (proteolytic cleavage) 
  
Introduction  51 
(Skehel and Wiley, 2000). While in the native HA the fusion peptide is deeply buried 
inside the molecule, in the low-pH HA structure it is moved to the top of the 
molecule. Exposed fusion peptides mediate fusion of viral end endosomal 
membranes, allowing the penetration of vRNP complexes into the cytoplasm.  
 
As mentioned above, influenza virus vRNP complexes interact with viral M1 
proteins, which are, in turn, in contact with the internal tails of HA and NA proteins at 
the viral envelope. Such an arrangement gives rise to two problems. On one hand, the 
release of vRNP complexes into the cytoplasm is impossible until M1-vRNP 
interactions are disrupted (Bui et al., 1996). On the other hand, influenza A viruses 
follow a nuclear replication strategy, consequently, vRNP complexes must be 
imported to the nucleus for the transcription and replication of their vRNA segments. 
As the size of the vRNP complex exceeds the size limit for passive import into the 
nucleus, nuclear import of vRNP complexes through nuclear pore complexes occurs 
actively, by NLSs, carried by NP proteins (O’Neill et al., 1995; Neumann G. et al., 
1997; Portela and Digard, 2002). However, by masking NLSs, M1 proteins inhibit the 
nuclear import of vRNP complexes (Martin and Helenius, 1991a; Martin and 
Helenius, 1991b; Bui et al., 1996). Consequently, detachment of M1 proteins from 
vRNP complexes plays a crucial role at this step: being bound with M1 proteins, a 
vRNP complex cannot enter the nucleus.  
 
The solution to both problems is provided by influenza virus M2 proteins, proteins 
with ion channel activity (Pinto et al., 1992, Nicholson et al., 1998). At the viral 
envelope there is a small number of M2 protein molecules (14 to 68), the native form 
of which is a homotetramer. The activation of the M2 ion channel is caused by the 
low pH of the endosome and precedes the fusion between the viral envelope and the 
endosomal membrane. Due to M2 ion channel activity, protons are able to enter the 
interior of the virion. The reduced pH of the virion interior is believed to mediate 
conformational changes in the M1 protein, thus disrupting M1-vRNP interactions. As 
a result, as soon as viral and endosomal membranes are fused, vRNP complexes are 
released into the cytoplasm free of M1 proteins and separated from each other (Bui et 
al., 1996), and can be then efficiently imported to the nucleus by cellular transport 
machinery. The hypothesis concerning the crucial role of M2 proteins in the delivery 
of vRNP complexes into the cytoplasm is supported by the fact, that in the presence of 
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amantadine, the anti-influenza virus drug inhibiting M2 ion channel activity, virus 
particles are still capable to enter the cellular endosomes and undergo HA-mediated 
membrane fusion, but their vRNP complexes are no longer able to escape from the 
endosomal membrane. 
 
As pointed out in section 1.5.4.1, the primary acidification of virions in early 
endosomes is accompanied by the endosomal sorting of cellular surface receptors. 
Being secondarily acidified in late endosomes, most of the virions, in turn, perform 
the release of their genomes into the cytoplasm. However, some virus particles are 
unable to accomplish this step. Such virions are, for example, those with a defective 
M2 ion channel (Flint et al., 2000). In the next step, "inactive" virus particles are 
degraded in lysosomes (Martin and Helenius, 1991a). 
 
 
1.6.3 Transcription (vmRNA Production) 
 
The genomes of all RNA viruses meet one common requirement. Within the infected 
cell they must be efficiently copied, providing both genomes for the assembly into 
progeny virus particles and mRNA molecules for the synthesis of viral proteins. To 
catalyze the synthesis of new genomes and mRNA molecules most of the RNA 
viruses encode a trimeric RNA-dependent RNA polymerase. Being an RNA virus 
with a negative stranded genome, influenza A virus must carry the RNA polymerase 
in the virion. Otherwise, the incoming vRNA molecules could be neither translated 
nor copied by the cellular machinery. Additionally, there are two essential 
requirements for the mechanisms of vRNA synthesis. First of all, during its 
replication the RNA genome must be copied from one end to the other with no loss of 
nucleotide sequences. The second requirement refers to the production of vmRNA 
molecules that must be efficiently translated by the cellular protein synthetic 
machinery. 
 
Three types of viral RNA molecules are synthesized in cellular nucleus: vmRNA 
molecules of positive polarity, viral genomic RNA molecules (vRNA molecules) of 
negative polarity, and complementary RNA molecules (cRNA molecules) of positive 
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polarity. Like the vast majority of cellular mRNA molecules, influenza virus vmRNA 
molecules contain cap structures at their 5' ends and poly(A) tails at their 3' ends. Cap 
structures are taken from cellular precursor mRNA molecules, whereas poly(A) tails 
results from the polyadenylation, reiterative copying of poly(U) stretch, contained at 
the 5' ends of the negative strand genomic vRNA molecules. 
 
Thus, the synthesis of influenza virus vmRNA molecules (Fig. 1.7, step 3) involves 
three major components: viral polymerase complexes (i.e., their PB1 and PB2 
subunits), negative genomic vRNA strands, and cellular precursor mRNA molecules. 
It comprises several steps. The process starts with the cleavage of capped RNA 
fragments from the 5' ends of cellular nuclear mRNA molecules, transcripts of 
cellular RNA polymerase II. These fragments then serve as primers for vmRNA 
synthesis; resembling the cap structures peculiar to the 5' ends of cellular mRNA 
molecules (processed by cellular translation machinery), they are needed for the 
efficient transport out of the nucleus and the translation of vmRNA molecules. The 
requirement for capped mRNA 5' ends to function as primers in vmRNA production 
most likely explains the dependency of virus replication on RNA polymerase II 
activity (Ludwig et al., 1999).  
 
All vmRNA molecules possess the characteristic sequence (AGCAAAGCAGG) near 
their 5' ends, immediately downstream of the sequence snatched from capped cellular 
mRNA molecules (Flint et al., 2000). Binding of the viral RNA polymerase to this 
sequence occurs in a specific manner, providing the safety of vmRNA molecules from 
the cleavage by the endonuclease of the viral polymerase complex. The 5' ends of host 
cell mRNA molecules are deprived of such a protection and are, therefore, efficiently 
cleaved, providing the primers for vmRNA synthesis. 
 
Two viral gene products, M2 and NS2 proteins, are encoded by spliced vmRNA 
molecules. Splicing of M and NS vmRNA molecules also occurs in the nucleus. The 
fraction of spliced to unspliced transcripts from segments 7 and 8 was shown to be 
controlled by certain virus-encoded factors (Lamb et. al., 1981). The major function in 
the regulation of this segment-specific splicing is most likely carried by viral NS1 
proteins (Nicholson et al., 1998; Juan, 1998), although the participation of cellular or 
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other viral proteins is also not excluded. 
 
Another important role of NS1 proteins in vmRNA production is the inhibition of 
cellular pre-mRNA splicing (Lamb et. al., 1981). As discussed before, the initiation of 
vmRNA strands depends on the availability of capped 5' end structures for the 
cleavage of capped fragments, and most of the cellular mRNA transcripts are retained 
in the nucleus until they are spliced (Legrain and Rosbash, 1989). Consequently, the 
inhibition of pre-mRNA splicing results in an increase of the nuclear concentration of 
capped cellular mRNA molecules that can be used by viral polymerases for the 
initiation of transcription. 
 
Newly synthesized vmRNA molecules are efficiently exported from the nucleus into 
the cytoplasm through nuclear pore complexes. 
 
 
1.6.4 Viral Genome Replication 
 
Genome replication represents the synthesis of full-length vRNA and cRNA strands 
(Fig. 1.7, step 4). Unlike vmRNA production, this process is independent of the 
presence of cellular mRNA molecules. vmRNA production and the replication of the 
viral genome are carried out by functionally different forms of the viral RNA 
polymerase. During vmRNA synthesis the PB2 cap-binding protein is required for the 
initiation of vmRNA chains by mRNA primers, derived from the host cell mRNA 
molecules, and the PA subunit does not have any function. During genome 
replication, in contrast, the PB2 protein has no role, whereas the PA protein is 
postulated to be required for the initiation of both positive and negative strands 
without a primer. Besides that, it was recently proposed that the PA protein possessed 
protease activity (Hara et al., 2003). However, the role of this activity for the process 
of infection is still not elucidated. 
 
It is generally assumed that cRNA molecules serve as templates for vRNA synthesis, 
while newly replicated vRNA molecules are used for the further production of 
vmRNA and cRNA molecules, as well as for the assembly of vRNP complexes. 
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Nevertheless, it was experimentally shown that cRNA molecules could also serve as 
templates for vmRNA synthesis (Azzeh et al., 2001). In cells infected with influenza 
A virus, there is an excess of negative vRNA strands over positive cRNA strands 
(Flint et al., 2000). The possible reason for this event is that full-length positive 
strands are synthesized for only a short period at the early stages of the infection. 
During the infection these positive cRNA molecules remain in the nucleus and serve 
as templates for genomic vRNA synthesis. The mechanism for the temporal 
regulation of cRNA synthesis is still not clearly understood. 
 
Since the production of both vmRNA molecules and exact copies of genomic vRNA 
molecules is of vital importance for their life cycle, influenza A viruses have evolved 
a mechanism for the switch from vmRNA synthesis to genome replication. This 
mechanism may be reversible. Indeed, as new virus particles are assembled, structural 
protein levels can possibly decrease. In this situation vmRNA molecules must be 
made at the expense of genomic vRNA molecules. The switch from vmRNA 
synthesis to genomic vRNA production is regulated at the polyadenylation step of 
vmRNA synthesis (Flint et al., 2000). According to experimental data, an increasing 
concentration of NP proteins that are not associated with vRNP complexes plays an 
important role in this regulation (Portela and Digard, 2002; Shapiro and Krug, 1988; 
Flint et al., 2000). NP proteins bind to some of the elongating RNA strands and block 
poly(A) addition. Besides that, they seem to define the activity of the vRNA 
polymerase. In the presence of NP proteins the PB1 subunit of the polymerase, the 
enzyme responsible for the replication, initiates the synthesis of full-length positive 
and negative strand RNA molecules de novo, i.e., without a primer, and reads all the 
way from the 3' end to the 5' end of the genomic vRNA through the polyadenylation 
and termination signals used for vmRNA production. Although the PA protein is 
assumed to be important for viral genome replication, the exact mechanism regulating 
the initiation properties of this polymerase subunit and its responsiveness to NP 
proteins is still unclear. Copying of a positive cRNA strand into a negative vRNA 
strand also occurs with the participation of NP proteins. Consequently, intracellular 
concentrations of NP proteins are an important determinant of whether vmRNA or 
genomic vRNA strands are synthesized. 
 
As discussed above, the production of vmRNA molecules and the replication of the 
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viral genome take place in the nucleus of the host cell. One possible reason for that 
could be the need to produce capped primers from cellular mRNA molecules. 
However, such mRNA molecules exist not only in the nucleus, but also in the 
cytoplasm, and other viruses, such as bunya viruses, use them in the similar process of 
cap snatching. Therefore, a more likely explanation why the nucleus is the site of 
influenza virus RNA synthesis is the necessity of nuclear RNA splicing machinery for 
the production of spliced vmRNA molecules (Cros and Palese, 2003). 
 
 
1.6.5 Capsid and Nonstructural Protein Production 
 
In the next step of the infection cycle (Fig. 1.7, step 5) viral PB1, PB2, PA, NP, NS2 
and M1 proteins (capsid proteins) as well as NS1 proteins (nonstructural proteins) are 
produced by cellular ribosomes in the cytoplasm. As influenza virus particles are 
internalized into the cell, the rate of cellular protein production drastically decreases 
(Park and Katze, 1995), accompanied by the efficient selective translation of vmRNA 
molecules. Indeed, cellular gene expression is strongly modulated by influenza virus 
on a post-transcriptional level; in approximately 3 h p.i. the synthesis of cellular 
proteins is practically ceased despite the presence of functional cellular mRNA 
molecules in the cytoplasm (Katze and Krug, 1984). At the same time, cellular 
ribosomes organized in polysome complexes effectively synthesize viral proteins. 
 
The reasons for the event described above and the factors it is affected by are not 
clearly understood. Cassetti et al. (2001) challenged the hypothesis that the translation 
machinery of infected cells efficiently processes only mRNA molecules possessing 
the viral 5' untranslated region. Nevertheless, the translation of vmRNA molecules is 
still predominant over the translation of cellular mRNA molecules. There are three 
possible mechanisms for the inhibition of cellular protein synthesis (Park and Katze, 
1995). The first involves the degradation of newly synthesized cellular mRNA 
molecules in the nucleus. Another possibility is the inhibition of the translation of 
cellular mRNA molecules at the initiation and elongation steps. Finally, cellular 
protein production can be suppressed by retarding the transport of cellular mRNA 
molecules to the cytoplasm. It was shown that the last mechanism was performed with 
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the participation of NS1 proteins, which retain cellular RNA polymerase II transcripts 
in the nucleus (Fortes et al., 1994; Nemeroff et al., 1998).  
 
Newly synthesized polymerase complexes, as well as NP proteins, matrix and 
nonstructural proteins, are transported to the nucleus, where they participate in the 
splicing of M and NS vmRNA molecules, transcription, and genome replication. 
Additionally, some of them are consumed for the production of new M1-vRNP 
complexes. 
 
 
1.6.6 Envelope Protein Production 
 
The synthesis of M2, HA and NA proteins (Fig. 1.7, step 6) is carried out by 
ribosomes bound to the membranes of the ER. Newly synthesized precursors of 
mature HA and NA proteins follow the cellular exocytotic transport pathway (see 
section 1.5.4.2) from the ER via the Golgi apparatus and the TGN, where they are 
glycosylated and acylated (Gambaryan et al., 1998; Fischer et al., 1998; Saito et al., 
1995). In polarized epithelial cells (e.g. MDCK cells), HA and NA are transported to 
the apical surface of the cell, thus defining the site of virus release. The translation of 
M2-encoding mRNA molecules is followed by the phosphorylation of M2 proteins 
(Gregoriades et al., 1990). Additionally, M2 viral proteins were shown to be acylated 
(Holsinger et al., 1995). 
 
 
1.6.7 Packaging 
 
The formation of vRNP complexes takes place in the nucleus of the cell. It represents 
the binding of newly synthesized PB1, PB2, PA, NP, M1 and NS2 proteins (capsid 
proteins) to vRNA molecules (Fig. 1.7, step 7). By the cellular transport machinery 
newly synthesized viral RNP complexes are exported to the cytoplasm. According to 
experimental data, the nuclear export of the viral genome requires the presence of M1 
proteins, which are known to be associated with vRNP complexes (Huang et al., 
2001; Martin and Helenius, 1991b; Bui et al., 1996). Besides that, for newly 
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synthesized vRNP complexes to be delivered into the cytoplasm, they must be 
associated with NS2 proteins (O'Neill et al., 1998). The arrangement of a vRNP 
complex and the two viral proteins involved is usually referred to as an M1-vRNP 
complex. Necessary for the binding with vRNP complexes M1 and NS2 proteins 
migrate to the nucleus from the cytoplasm, where they are synthesized (Watanabe et 
al., 2001). The association of some of vRNA molecules with M1 proteins results in 
the reduction of vmRNA production (Perez and Donis, 1998). Furthermore, it halts 
viral genome replication and mediates the encapsidation of vRNA molecules by NP 
proteins (Baudin et al., 2001; Huang et al., 2001). According to experimental data, NP 
proteins can be organized into a helical structure only in the presence of both vRNA 
and M1. The NS2 protein, in turn, contains a leucine-rich NES, by which it interacts 
with nuclear pore complexes (Neumann G. et al., 2000; O’Neill et al., 1998). In spite 
of these observations, the arrangement of two viral proteins, M1 and NS2, is believed 
to mediate the nuclear export of vRNP complexes associated with them.  
 
As stated above (see section 1.6.2), M1 proteins possess a property to mask NLSs, 
carried by NP proteins. In the cytoplasm they inhibit the reimport of vRNP complexes 
into the nucleus. Therefore, newly synthesized vRNP complexes, being associated 
with M1 proteins, are unable to return into the nucleus. Another possible mechanism 
of cytoplasmic retention of vRNP complexes is based on the ability of NP and M1 
viral proteins to associate with the actin cytoskeleton of the cell (Avalos et al., 1997; 
Digard et al., 1999). This association can also reflect a role of M1 proteins for the 
targeting of vRNP complexes to virus budding sites at the plasma membrane of the 
cell. 
 
 
1.6.8 Virus Budding and Release 
 
Influenza virus particles bud from the apical membrane of polarized epithelial cells 
(Fig. 1.2). The lipid bilayer of the viral membrane is derived from the plasma 
membrane of the cell. According to experimental results, sorting signals of viral 
envelope proteins (HA, NA, and M2) are not the only factor that defines the location 
of the budding site (Barman et al., 2003). Besides them, the selection of the site of 
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virus budding involves other factors, presumably, both cellular and viral. At the 
budding site M1-vRNP complexes interact with the cytoplasmic tails of M2, HA, and 
NA proteins, which leads to the formation of a bud (Fig. 1.7, step 8). The major viral 
component that drives virus budding seems to be the M1 protein (Gomez-Puertas et 
al., 2000). It was particularly shown that in the transfected culture coexpressing just 
three viral proteins, M1, HA, and NA, particles resembling true virions in both 
density and general morphology could be formed. Neither vRNP complexes, nor NS2 
proteins are needed for their assembly. Owing to the enzymatic activity of NA 
proteins to cleave sialic acid receptors on the surface of the cell (Luo et al., 1993), the 
bud separates from the membrane and a progeny virion is released to the extracellular 
medium.  
 
NA proteins of influenza virus have a tetrameric structure and appear on the surface 
of the virion as mashroom-shaped spikes. Similar to an HA molecule, each NA 
monomer comprises transmembrane and cytoplasmic domains: a thin stalk, and a 
globular head. It is the globular head of the NA protein that defines its enzymatic 
activity and antigenic property. The function of NA proteins to remove terminal sialic 
acids not only promotes virus release from the host cell, but also prevents self-
aggregation of virus particles (Rudneva et al., 2003). A series of studies emphasize 
that for efficient entry of virus particles into the cell and their release from the cell the 
cleavage activity of NA proteins must be in balance with the binding activity of HA 
proteins (Baigent and McCauley, 2001; Wagner et al., 2002; Rudneva et al., 2003). 
The disturbance of the functional balance between HA and NA proteins usually 
results in the decrease of the viral replicative ability.  
 
There are two divergent ideas concerning the mechanism of vRNP packaging: 
genome segments can be either selectively or randomly incorporated into progeny 
virus particles (see section 5.6). The model assumes that influenza virus vRNP 
complexes are packaged in a random, nonspecific manner (Bancroft and Parslow, 
2002), although the hypothesis of specific packaging has been also supported (Fujii et 
al., 2003). 
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2 Model Formulation 
 
The main part of this section describes a system of model equations underlying the 
detailed single cell model by the successive formulation of the equations relating to 
individual steps of the infection cycle (Sidorenko and Reichl, 2004). In the rest of the 
section several model modifications, i.e., a reduced model, a model with reinfection, a 
model for continuous infection, and a population model, will be presented. 
 
Considered in the detailed single cell model is an average cell, surrounded by a small 
quantity of medium and infected by a low number of virus particles (parental virions) 
(Fig. 2.1). The major properties of the cell and the virus considered are summarized in 
Table 2.1. Only one replication cycle is taken into account - the progeny virus 
particles are not supposed to infect the same cell again. Additionally, it is assumed 
that cells do not divide after infection, which is supported by the fact that growth of 
adherent MDCK cells is contact inhibited at the time of infection in large-scale 
culture, and more than 90% of the cells detach and die within 48 h p.i. (Y. Genzel, 
personal communication, see Appendix A5).  
 
The model is represented by a system of nonlinear ODEs. All the state variables and 
rate coefficients, which will be addressed below are time-dependent functions. 
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Table 2.1 Basic properties of cells and influenza A virus used for modeling. 
Parameter Value Source 
Cell 
Number of receptors (receptors/cell) 104-105 1 
Number of endosomes (endosomes/cell) 200 2 
Number of ribosomes (ribosomes/cell) 5⋅106 2 
Distance between ribosomes on mRNA (nucleotides) 80 2 
Number of nuclear pores (pores/cell) 3000-4000 3 
Dry weight of an MDCK cell (ng/cell) 0.54 4 
Number of free nucleotides (nucleotides/cell) 1.3⋅1010 2, 5 
Number of nuclear precursor mRNAs (nucleotides/cell) 2.2⋅105 2, 5 
Average number of nucleotides per mRNA (nucleotides) 6000 2, 5 
Number of free amino acids (amino acids/cell) 3.1⋅1010 2, 6 
Virus (Influenza A, A/PR/8/34) 
Number of genome segments (segments/virion) 8 7 
Full length of the genome (nucleotides/virion) 13588 7 
Average length of one genome segment (nucleotides) 1699 7 
Total number of amino acids (amino acids/virion) 2.4⋅106 7 
1: Wickham et al., 1990 
2: Alberts et al., 2002 
3: Flint et al., 2000 
4: U. Reichl, personal communication 
5: Kaufman et al., 2000 
6: Nelson et al., 2000 
7: Knipe et al., 2001 
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Figure 2.1 Scheme of the process addressed by the single cell model. Extracellular 
virions are differentiated into parental and progeny virions. The reinfection of the cell is not 
assumed. 
 
 
2.1 Virus Entry into the Host Cell 
 
(2.1.1)  sVexsexVsex
ex VkVk
dt
dV
exex ,, −− +−=  
(2.1.2)  sendssVexsexVsex
s VkVkVk
dt
dV
ss −−− −−= ,,  
(2.1.3)  endrendendVcytendsends
end VkVkVk
dt
dV
end deg, −−− −−=  
Here,  (h) is the time,  (virions/nL),  (virions/cell), and  (virions/cell) 
represent the numbers of infectious virus particles in the extracellular medium, on the 
cellular surface and in the endosome, respectively.  
t exV sV endV
 
The term  in (2.1.1) describes the binding of extracellular virions to the 
cellular surface, and the term  is the rate of the release of surface virions to 
the extracellular medium due to dissociation. Every term, presenting the transfer of 
substance (i.e., viral components) from one compartment to another is usually 
exVsex Vk ex,−
sVexs Vk ex,−
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proportional to the number of the substance in the first compartment with a certain 
rate coefficient. Accordingly, the former term is proportional to the number of 
extracellular virus particles, and the letter one to the number of virions, attached to the 
surface of the cell. The right-hand side of equation (2.1.2) contains two terms 
(  and ), similar to those from equation (2.1.1), but, naturally, with 
opposite signs and different units of the corresponding rate constants (see below). The 
model does not take into account the exact mechanism of virus entry (coated pit 
formation, see section 1.5.4.1); virus particles are supposed to be transported from the 
cellular surface directly to the endosome. Accordingly,  in (2.1.2), as well as 
the corresponding term in (2.1.3), expresses the rate of endocytosis. Finally, the two 
negative terms in (2.1.3) (  and ) describe the escape of 
vRNP complexes from the endosome, and the degradation of inactive virus particles, 
respectively. 
exVsex Vk s,− sVexs Vk s,−
sends Vk −
endVcytend Vk end,− endrend Vk deg−
 
The rate coefficient of virus binding is  ) . Under normal in vitro 
conditions, individual cells are infected with a small number of virions. Therefore, the 
number of cellular receptors, which is in the range  receptors per cell 
(Wickham et al., 1990), significantly exceeds the number of particles bound to the cell 
surface and does not represent a limiting factor for virus entry. Consequently, Monod-
type kinetics is not considered, and it is assumed that  is a constant. The rate 
constant of virus dissociation from the surface is  ) . The rate coefficients 
 )  and  )  are related to   and  , 
respectively, via 
exVsex
k ,− (
1−⋅ hmL
54 1010 −
exVsex
k ,−
exVexs
k ,− (
1−h
sVsex
k ,− (
1−h
sVexs
k ,− (
1−h
exVsex
k ,− ) )(
1−⋅ hmL
exVexs
k ,− (
1−h
exs Vsex
cells
r
Vsex kN
Uk ,, −− =  
and  
exs Vexs
cells
r
Vexs kN
Uk ,, −− = , 
where  (nL) is the volume of medium containing  cells (  cell in the 
model). The rate coefficient of endocytosis is  ) . There are approximately 
200 endosomes per cell, of which only a small fraction contains virus (Alberts et al., 
rU cellsN 1=cellsN
endsk − (
1−h
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2002). Consequently, it can be assumed that  remains constant. The uncoating of 
vRNP complexes and the degradation of inactive viruses are described by the rate 
constants  )  and  ) , respectively. 
endsk −
endVcytend
k ,− (
1−h rendk deg− (
1−h
 
 
2.2 vRNP Uncoating and Transport into the  
      Nucleus 
 
(2.2.1)  cytnuccytendScytend
cyt SkVk
dt
dS
cyt −− −= ,    
(2.2.2)  nucSsplcytnuccyt
nuc SkSk
dt
dS
nuc,
−= −     
Here,  (vRNP complexes/cell) and  (vRNP complexes/cell) are the total 
numbers of vRNP complexes in the cytoplasm and in the nucleus, respectively.  
cytS nucS
 
Similar to the corresponding term in (2.1.3),  in (2.2.1) expresses the rate 
of vRNP uncoating. The term  in (2.2.1) describes the nuclear import of 
vRNP complexes, and  in (2.2.2), proportional to the number of vRNP 
complexes in the nucleus, represents the splitting of vRNP complexes into vRNA 
molecules, NP proteins and polymerase complexes. 
endScytend Vk cyt,−
cytnuccyt Sk −
nucSspl Sk nuc,
 
The rate constants of vRNP uncoating  )  and  )  (see 
equation (2.1.3)) are related to each other by 
cytScytend
k ,− (
1−h
endVcytend
k ,− (
1−h
endcyt VcytendsegScytend
kNk ,, −− = , 
where  (molecules) is the number of genome segments (or the number of vRNP 
complexes) contained in one virus particle (in the model N
segN
seg = 8 molecules). The rate 
coefficient of the nuclear import of vRNP complexes is  ) . There are 
approximately 3000-4000 pores in a nuclear membrane (Flint et al., 2000). With a 
small number of virions entering only a low percentage of them are involved in the 
delivery of vRNP complexes to the nucleus. This also applies for the whole average 
nuccytk − (
1−h
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life span of infected cells (approximately 12 h; Roy et al., 2000; J. Schulze-Horsel, Y. 
Genzel, personal communication) including processes related to the nuclear export 
and import of viral proteins and vmRNA molecules (shown in section 4.8 below). 
Thus,  is not limited by the number of pores. The rate constant   
describes the separation of vRNP complexes into vRNA molecules, NP proteins and 
polymerase complexes. 
nuccytk − nucSsplk , )(
1−h
 
 
2.3 Transcription (vmRNA Production) 
 
(2.3.1)  nucirnucivmnucicytnucivmnucPolivmv
nuci CkCkPk
dt
dC
,deg,,,,,,,
,
−−− −−=  
(2.3.2)  cytircytivmnucicytnucivm
cyti CkCk
dt
dC
,deg,,,,,
,
−− −=  
},,2,2,1,1,,{ NAHAMNSNSMNPPoli∈  
Here, the numbers of vmRNA molecules encoding the i-th protein in the nucleus and 
in the cytoplasm are described by functions  (nucleotides/cell) and  
(nucleotides/cell), respectively. All three polymerase subunits are always considered 
as one unit, as well as the vmRNA molecules encoding them. The number of 
polymerase complexes in the nucleus is  (amino acids/cell).  
nuciC , cytiC ,
nucPolP ,
 
The term  in (2.3.1) is the rate of vmRNA synthesis. Polymerase 
complexes are assumed to operate at the same speed (  ) ), consequently this 
term is proportional to . The terms  and  are, 
correspondingly, the rates of the nuclear export and the degradation of nuclear 
vmRNA molecules. Described by  in (2.3.2) is the degradation of 
cytoplasmic vmRNA molecules. 
nucPolivmv Pk ,,−
Plk (
1−h
nucPolP , nucicytnucivm Ck ,,, − nucirnucivm Ck ,deg,, −
cytircytivm Ck ,deg,, −
 
In general, the rate coefficient of vmRNA synthesis  )  depends on  (the 
number of vRNA molecules, defined by equation 2.4.2) - vRNA molecules serve as 
templates - and on  (the number of NP molecules in the nucleus, defined by 
ivmvk ,− (
1−h vC
nucNPP ,
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equation 2.5.2). Based on dry weight and chemical composition of a typical 
mammalian cell (0.54 mg/106 cells, MDCK cells; U. Reichl, personal 
communication), it was estimated that a cell possessed a pool of approximately 
 free nucleotides (0.4% of cellular wet weight, 330 Dalton average 
weight of nucleotides) and about 3.0⋅10
10103.1 ⋅=cellC
6 nuclear precursor mRNA molecules, with an 
average length of 6000 nucleotides (see Appendix A4). As the total number of 
nucleotides is significantly higher than that required for vmRNA synthesis and 
genome replication (see section 4.8 below), the influence of the number of free 
cellular nucleotides and cellular mRNA molecules on the transcription rate of vRNA 
molecules  is neglected. It is also assumed that the rate of the process is not 
limited by  (every polymerase complex is involved in transcription and all 
polymerase complexes operate at the same speed): 
ivmvk ,−
vC
vnucPol CP <<, . 
The correctness of this assumption will be discussed in section 5.4 below. As 
mentioned above, NP proteins inhibit the production of vmRNA molecules. 
Consequently,  should be maximal when ivmvk ,− 0, =nucNPP , and tend to zero when 
. Taking into account all the assumptions, it can be assumed that  ∞→nucNPP ,
nucNPNP
ivmvivmv Pa
kk
,
max,,, 1
1
+= −− , 
where  (cells/NP protein) is a positive parameter.  represents an inverse 
concentration of NP proteins, at which  
NPa NPa
max,,, 2
1
ivmvivmv kk −− = .  
Therefore,  defines the influence of NP proteins on vmRNA production. The rate 
coefficients of vmRNA nuclear export and degradation are  )  and 
 )( , respectively. The rate constant of cytoplasmic vmRNA degradation 
is  ) . The splicing of M and NS vmRNA molecules is not considered 
in the model. 
NPa
cytnucivmk −,, (
1−h
rnucivmk deg,, −
1−h
rcytivmk deg,, − (
1−h
 
Cytoplasmic and nuclear vmRNA molecules could be considered as two pools of 
nucleotides, irrelative to the individual types of vmRNA molecules. Such an 
  
Model Formulation  67 
approach, particularly applied for the formulation of the reduced model (see section 
2.9 below), results in the reduction of the number of differential equations underlying 
the model without limiting the generality of the model. However, several studies 
revealed that vmRNA processing might depend on the type of the vmRNA to be 
processed (e.g., early and late genes were discussed: Watanabe et al., 2001; Julkunen 
et al., 2001; Whittaker et al., 1996), particularly, on signals carried by noncoding 
sequences of the vmRNA involved (Luytjes et al., 1989). Additionally, M and NS 
vmRNA molecules are known to undergo splicing in the nucleus (see section 1.6.3). 
Thus, the numbers of vmRNA molecules of different types are still described by 
different functions to keep the possibility of model modifications. 
 
 
2.4 Viral Genome Replication 
 
(2.4.1)  crcnucPolcv
c CkPk
dt
dC
deg, −− −=  
(2.4.2)  vrv
l
nuclvCunnucCsplnucPolvc
v CkPCkSkPk
dt
dC
vv deg,,,, −− −−+= ∏  
}2,1,,{ NSMNPPoll∈  
Here,  (nucleotides/cell) is the number of cRNA molecules,  (nucleotides/cell) 
is the number of vRNA molecules, and  (amino acids/cell) is the number of 
molecules of the l-th protein in the nucleus.  
cC vC
nuclP ,
 
The terms  in (2.4.1) and  in (2.4.2) describe the synthesis of 
cRNA and vRNA, respectively. The terms  in (2.4.1) and  in (2.4.2) 
express, correspondingly, the rates of degradation processes for cRNA and vRNA 
molecules. The term  in (2.4.2) is the rate of splitting of incoming vRNP 
complexes, as well as the corresponding term in (2.2.2). At last, the term 
 in (2.4.2) describes the assembly of new M1-vRNP complexes. It is 
proportional to the number of all viral components (i.e., vRNA, polymerase 
nucPolcv Pk ,− nucPolvc Pk ,−
crc Ck deg− vrv Ck deg−
nucCspl Sk v,
∏
l
nuclvCun PCk v ,,
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complexes, NP, M1, and NS2 viral proteins) to be incorporated into M1-vRNP 
complexes.  
 
The rate coefficients of cRNA and vRNA synthesis are  )  and  , 
respectively. It is assumed that all vRNA molecules are synthesized at similar rates 
(Yamanaka et al., 1988); therefore it is not necessary to describe their numbers by 
different functions. Furthermore, every polymerase complex is assumed to participate 
in either positive or negative strand synthesis. Neither  nor  limit the rate of the 
corresponding process because their number exceeds the number of polymerase 
complexes: 
cvk − (
1−h vck − )(
1−h
vC cC
vnucPol CP <<, ;  cnucPol CP <<,
(see section 5.4 below for a discussion of this assumption). Since NP proteins 
promote genome replication,  and  should have maximum values when 
, and be equal to zero when 
cvk − vck −
∞→nucNPP , 0, =nucNPP . Thus, they are described by the 
following expressions: 
nucNPNP
nucNP
cvcv Pb
P
kk
,
,
max, += −−  
and 
nucNPNP
nucNP
vcvc Pb
P
kk
,
,
max, += −− , 
where  (NP proteins/cell) is a positive parameter that defines the influence of NP 
proteins on virus genome replication. The parameter  represents the concentration 
of NP proteins, at which 
NPb
NPb
max,2
1
cvcv kk −− =   
and 
max,2
1
vcvc kk −− = . 
The rate constants of cRNA and vRNA degradation are  )  and  
, respectively. The rate constants of vRNP splitting  )  and  
 (see equation 2.2.2) are connected with each other by 
rck deg− (
1−h rvk deg−
)( 1−h
vCspl
k , (
1−h
nucSspl
k ,
)( 1−h
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nucv SsplsegCspl
kCk ,, = , 
where  (nucleotides/vRNA molecule) is the average number of nucleotides, 
contained in one segment. An influenza A (A/PR/8/34) virion consists of about 
 nucleotides (Knipe et al., 2001); therefore, the number of nucleotides 
contained in one segment is approximately 
segC
13588=virC
1699==
seg
vir
seg N
CC  nucleotides.  
The rate constant for the assembly of new M1-vRNP complexes is  ( . 
vCun
k , )
1−h
 
 
2.5 Capsid and Nonstructural Protein  
      Production 
 
(2.5.1)  cytircyticytinuccyti
rib
cyti
synti
cyti PkPk
d
C
k
dt
dP
,deg,,,
,
,
,
−− −−=  
(2.5.2)  nucirnuci
l
nuclvPunnucPsplcytinuccyti
nuci PkPCkSkPk
dt
dP
nucinuci ,deg,,,,,,
,
,, −− −−+= ∏  
                 , }2,1,1,,{ NSNSMNPPoli∈ }2,1,,{ NSMNPPoll∈  
Here,  (amino acids/cell) and  (amino acids/cell) are the numbers of 
molecules of the i-th protein in the cytoplasm and in the nucleus, respectively. 
cytiP , nuciP ,
 
The term 
rib
cyti
synti d
C
k ,,  in (2.5.1), proportional to the number of vmRNA molecules (see 
below), describes viral protein synthesis, and the two negative terms (  and 
) represent, correspondingly, the rates of the nuclear import and the 
degradation of cytoplasmic proteins. The term  in (2.5.2), responsible for 
vRNP splitting, is contained as well in (2.2.2); and a term, like , 
expressing the rate of new vRNP assembly, appears also in (2.4.2). The term 
 expresses the rate of viral protein degradation in the nucleus. 
cytinuccyti Pk ,, −
cytircyti Pk ,deg, −
nucPspl Sk nuci ,,
∏
l
nuclvPun PCk nuci ,, ,
nucirnuci Pk ,deg, −
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The synthesis of viral proteins is carried out by ribosomes, making up polysome 
complexes. Like viral polymerase complexes, ribosomes are also assumed to operate 
at the same speed (  ) ), and the distance between ribosomes in a polysome 
complex is about  nucleotides (Alberts et al., 2002). The rate coefficient 
 )  describes the synthesis of the i-th viral protein by cellular ribosomes. The 
influence of the number of cellular ribosomes on viral protein synthesis is neglected, 
assuming that a mammalian cell contains about  ribosomes (Alberts et al., 
2002), which is significantly higher than the number of vmRNA molecules to be 
processed (see section 4.8 below). Thus,  is assumed to be constant. The number 
of newly synthesized viral proteins increases proportional to 
Ribk (
1−h
80=ribd
syntik , (
1−h
6
0 105 ⋅=R
syntik ,
rib
cyti
d
C , , the number of 
ribosomes translating viral proteins. Furthermore, it is assumed that  does not 
depend on  as uninfected cells contain a pool of approximately  free 
amino acids (0.4% of cellular wet weight, 138 Dalton average weight of amino acids 
see Appendix A4), which would be sufficient to produce about 1.3⋅10
syntik ,
cellP
10101.3 ⋅=cellP
4 virions (about 
2.4⋅106 amino acids per virion, influenza A/PR/8/34). Additionally, it is known that 
soon after infection by influenza viruses an inhibition of cellular protein synthesis 
takes place (Park and Katze, 1995). Thus, the pool of cellular amino acids is not 
exhausted during virus replication, and  is a constant. The rate coefficient of the 
nuclear import of i-th proteins and the rate constant of their degradation in the 
cytoplasm are  )  and  ) , respectively. As the number of 
nuclear pores is also not reduced significantly during infection (see section 4.8 
below),  is also considered to be constant. The rate constant   is 
related to  )(  (see equation 2.2.2) by 
syntik ,
nuccytik −, (
1−h rcytik deg, − (
1−h
nuccytik −, nuciPsplk ,, )(
1−h
nucSspl
k ,
1−h
nucnuci SsplsegiPspl
kPk ,,, , = , 
where  is the average number of i-th proteins, contained in one vRNP. The rate 
constant for the assembly of new M1-vRNP complexes ( ) is discussed below (see 
equations 2.4.2, 2.7.1). The rate constant of the degradation of i-th proteins in the 
segiP ,
unk
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nucleus is  ) . NS1 proteins are absent in M1-vRNP complexes and, 
therefore,  
rnucik deg, − (
1−h
0
,1,
=
nucNSPun
k .  
On the other hand, at the early stages of the infection, M1, NS1, and NS2 proteins are 
not delivered into the nucleus together with vRNP complexes, that is  
0
,,
=
nuciPspl
k , .  ]2,1,1[ NSNSMi∈
Besides that, M1 proteins that are imported to the nucleus by passive diffusion do not 
seem to be involved in virus replication (Martin and Helenius, 1991a). 
 
 
2.6 Envelope Protein Production 
 
(2.6.1)  ERjrERjERjbudERj
Rib
cytj
syntj
ERj PkPk
d
C
k
dt
dP
,deg,,,
,
,
,
−− −−=  
(2.6.2)  budjrbudj
l
budlbudunPbudERjbudERj
budj PkPSkPk
dt
dP
budj ,deg,,,,,,
,
, −− −−= ∏  
},,2{, NAHAMlj ∈  
Here,  (amino acids/cell) and  (amino acids/cell) express, correspondingly, 
the numbers of molecules of the j-th protein in the ER and at the budding site, and 
 (M1-vRNP complexes/cell) is the number of newly synthesized M1-vRNP 
complexes at the budding site. 
ERjP , budjP ,
budunS ,
 
The right-hand side of equation (2.6.1), similar to the right-hand side of equation 
(2.5.1) describes the synthesis of envelope proteins, their transport to the budding site, 
and the degradation in the ER. The number of envelope proteins at the budding site 
decreases due to the incorporation of these proteins to progeny virus particles and due 
to their degradation. The former process is described by the term 
 in (2.6.2), which is proportional to the number of all molecules 
(vRNP complexes, M2, HA, and NA viral proteins) forming virions; and the latter is 
presented by . 
∏
l
budlbudunPbud PSk budj ,,, ,
budjrbudj Pk ,deg, −
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budERjk −,  )  and  )  are, correspondingly, the rate constants of the 
transport of j-th proteins to the budding site and their degradation in the ER,  
 is the rate constant of progeny virus particle assembly, and   is 
the rate constant of the degradation of j-th proteins at the budding site. 
( 1−h rERjk deg, − (
1−h
budjPbud
k
,,
)( 1−h rbudjk deg, − )(
1−h
 
 
2.7 Packaging 
 
(2.7.1)  nucunbudnucun
l
nuclvSun
nucun SkPCk
dt
dS
nucun ,,,,
,
, −−= ∏  
(2.7.2)  ∏−= −
s
budsbudunSbudnucunbudnucun
budun PSkSk
dt
dS
budun ,,,,,
,
,
 
}2,1,,{ NSMNPPoll∈ , },,2{ NAHAMs∈  
Here,  (M1-vRNP complexes/cell) and  (M1-vRNP complexes/cell) are, 
correspondingly, the numbers of newly synthesized M1-vRNP complexes in the 
nucleus and at the budding site. Assuming that vRNP complexes are packaged 
randomly (see section 1.6.8), M1-vRNP complexes carrying different genome 
segments are not distinguished here; their total number at the given cellular 
compartment is described by one state variable. 
nucunS , budunS ,
 
Similar to equations (2.4.2) and (2.5.2), equation (2.7.1) contains in its right-hand side 
the rate of M1-vRNP complex assembly ( ∏
l
nuclvSun PCk nucun ,, , ). The term 
 in (2.7.1) describes the nuclear export of newly assembled M1-vRNP 
complexes. The term 
nucunbudnucun Sk ,, −
∏
s
budsbudunSbud PSk budun ,,, ,  in (2.7.2) expresses the rate of progeny 
virus particle assembly. Such a term also appears in (2.6.2). 
  
The rate constant of the assembly of new M1-vRNP complexes   is 
related to  )  and  )  corresponding to equations (2.4.2) and 
(2.5.2) by:  
nucunSun
k
,,
)( 1−h
vCun
k , (
1−h
nuciPun
k
,,
( 1−h
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nucunv SunsegCun
kCk
,,,
=   
and  
nucunnuci SunsegiPun
kPk
,, ,,,
= .  
Here,  (amino acids/M1-vRNP complex) is the number of i-th proteins, contained 
in one M1-vRNP complex. The rate coefficient of the nuclear export of newly 
assembled M1-vRNP complexes is  ) . The rate constants of the 
assembly of progeny virus  )  are discussed in the section 2.8 (see equation 
2.8.1). 
segiP ,
budnucunk −, (
1−h
budk (
1−h
 
 
2.8 Virus Budding and Release 
 
(2.8.1)  budVrelbud
l
budlbudunVbud
bud VkPSk
dt
dV
budbud ,,,, −−= ∏  
},,2{ NAHAMl∈  
(2.8.2)  budVrelbud
rel Vk
dt
dV
rel,−=  
Here,  (virions/cell) and  (virions/nL) are the numbers of budding and 
released virions, respectively.  
budV relV
 
The term  in (2.8.1) describes the rate of progeny virus 
assembly. The term  in (2.8.1), as well as the corresponding term in 
(2.8.2), expresses the rate of progeny virus release to the extracellular medium. 
∏
l
budlbudunVbud PSk bud ,,,
budVrelbud Vk bud,−
 
The rate constant of the assembly of progeny virus particles (  )( ) is related 
to  )(  and  )(  (see equations (2.6.2) and (2.7.2)) via formulas: 
budVbud
k ,
1−h
budjPbud
k
,,
1−h
budunSbud
k
,,
1−h
budbudj VbudvirjPbud
kPk ,,, , =   
and  
budbudun VbudsegSbud
kNk ,, , = .  
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Here,  (amino acids/virion) is the number of molecules of j-th envelope proteins 
in the virus particle, and  is the rate coefficient of progeny virus release. 
The rate coefficients   and  )  are related via 
virjP ,
budVrelbud
k ,−
relVrelbud
k ,− )(
11 −− ⋅ hmL
budVrelbud
k ,− (
1−h
relbud Vrelbud
cells
r
Vrelbud kN
Uk ,, −− = . 
 
In total, the single cell model is formulated based on equations (2.1.1-3), (2.2.1-2) – 
(2.8.1-2). 
 
 
2.9 Reduced Model 
 
The biological system considered is described by a system of 43 ODEs. However, to 
use the model as a starting point for the development of structured population balance 
models1, as well as to reduce the number of unknown rate coefficients and to make 
the model easier in handling, it is useful to reduce the number of model variables and, 
correspondingly, the number of model equations. In the reduced model developed 
here, which comprises only 10 ODEs, only the most essential steps of the replication 
cycle, namely those representing the branch points of the process of the infection, are 
taken into account. All the steps making up linear sequences without branch points are 
lumped together.  
 
All the processes concerned with virus entry, vRNP uncoating, and transport into the 
nucleus constitute a linear sequence without branch points, and, therefore, can be 
lumped together. Additionally, as the dissociation of virus particles from the surface 
of the cell is not essential for virus replication (in particular, the virus yield is not 
sensitive to variations of its rate constants, see section 4.11.2.1 below), the 
corresponding terms in (2.1.1) ( ) and (2.1.2) will be neglected. Finally, the 
term  in (2.1.3) will be also omitted. If necessary, the effect of the 
sVexs Vk ex,−
endrend Vk deg−
                                                 
1 The numbers of viral components are considered as structure parameters of the cell population, i.e., 
the concentration of cells is a function of the number of vRNA molecules, viral proteins, etc. 
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degradation of “inactive” virions on virus production can be taken into account by 
decreasing the initial concentration of extracellular virions (see section 4.10). Thus, 
equations (2.1.1), (2.1.2), (2.1.3), (2.2.1), (2.2.2) can be reduced to one equation 
(2.9.1)  redexVspl
redex Vk
dt
dV
ex ,,
, −=  
Unlike function  (virions/nL) in equation (2.1.1), function  (virions/cell) in 
equation (2.9.1) is related to the cell. It does not account only for extracellular virions, 
but rather represents the total number of extranuclear virus particles (virus particles 
with a genome still not delivered into the nucleus). The term  in (2.9.1) 
expresses the rate of separation of delivered with incoming virions vRNP complexes 
into vRNA molecules, NP proteins, and polymerase complexes. It is proportional to 
the number of extranuclear virions with the rate constant  . 
exV redexV ,
redexVspl Vk ex ,,
exVspl
k , )(
1−h
 
The delivery of the viral genome into the nucleus is followed by the beginning of 
three different processes that must be considered separately: vmRNA production, 
genome replication, and viral protein synthesis. In respect to the production of viral 
components vmRNA molecules of different types are indistinguishable. 
Consequently, all vmRNA molecules produced can be considered as a single pool of 
nucleotides to be processed by ribosomes, individual vmRNA strands constituting the 
certain fraction of this pool (ωi, defined in section 3 below). Equations (2.3.1) and 
(2.3.2), considering the concentrations of all individual vmRNA molecules, can be, 
therefore, rewritten for the total number of vmRNA molecules in the nucleus and in 
the cytoplasm: 
(2.9.2)  nucrnucvmnuccytnucvmPolvmv
nuc CkCkPk
dt
dC
deg,, −−− −−=  
(2.9.3)  cytrcytvmnuccytnucvm
cyt CkCk
dt
dC
deg,, −− −=  
Here,  (nucleotides/cell) and  (nucleotides/cell) are the functions representing 
the total numbers of vmRNA molecules in the nucleus and in the cytoplasm, 
respectively. Thus, rate coefficients of the right-hand sides of equations (2.9.2) and 
(2.9.3), unlike those of the right-hand sides of equations (2.3.1) and (2.3.2) are 
deprived of index “i”, identifying individual types of vmRNA molecules. Besides 
nucC cytC
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that, as the cytoplasmic and nuclear pools of viral proteins are not distinguished in the 
reduced model (see below), the term  in (2.9.2), expressing the rate of 
vmRNA synthesis, is proportional to the total number of polymerase complexes. 
Polvmv Pk −
 
Two equations describing the replication of the viral genome (equations (2.4.1) and 
(2.4.2)) are introduced into the reduced model as 
(2.9.4)  crcPolcv
c CkPk
dt
dC
deg−− −=  
(2.9.5)  vrv
l
lvCpckredexredCsplPolvc
v CkPCkVkPk
dt
dC
vv deg,,,, −− −−+= ∏
 
}1,,{ MNPPoll∈  
Like  in (2.9.2), the terms  in (2.9.4) and  in (2.9.5), 
representing, correspondingly, the rates of cRNA and vRNA synthesis, are 
proportional to the total number of polymerase complexes. As in the reduced model 
the steps of the infection cycle from vRNP formation to progeny virus assembly are 
considered together (see below), the rate constants of packaging  )  in 
(2.9.5) and  )  in (2.4.2) differ from each other. The rate constant  
describes the packaging of viral components directly to progeny virions, whereas 
 refers to the assembly of vRNP complexes. Taking into account the 
corresponding equations of the detailed model and the relation between their rate 
coefficients, it can be seen that the rate constants of vRNP splitting   
and  )(  (see equation 2.9.1) are connected by 
Polvmv Pk − Polcv Pk − Polvc Pk −
vCpck
k , (
1−h
vCun
k , (
1−h
vCpck
k ,
vCun
k ,
redCspl v
k ,, )(
1−h
exVspl
k ,
1−h
exv VsplvirredCspl
kCk ,,, = . 
Here,  (nucleotides/virion) is the number of nucleotides contained in the virion 
(  nucleotides). 
virC
13588=virC
 
Among the viral proteins taking part in the nuclear phase of virus replication 
considered in the reduced model will be only M1 proteins, limiting virus replication 
(see section 4.9 below), NP proteins, essentially influencing the switch from vmRNA 
production to viral genome replication (see sections 1.6.3 and 1.6.4), and polymerase 
complexes, directly involved in transcription and genome replication. As NS1 and 
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NS2 proteins do not limit virus replication (see section 4.9 below) and are also not 
assumed to have any essential effects on the production of viral components, their 
number is not taken into account. Additionally, only one (nuclear) pool of each type 
of viral proteins will be considered; the nuclear import of newly synthesized proteins 
will be omitted. Thus, equations (2.5.1) and (2.5.2) can be rewritten as 
(2.9.6)  iri
l
lvPpckredexredPspl
rib
cyt
isynti
i PkPCkVk
d
C
k
dt
dP
ii deg,,,,,,
−−+= ∏ω  
}1,,{ MNPPoli∈ , }1,,{ MNPPoll∈  
Here,  (amino acids/cell) is the total number of i-th proteins. Taking into account 
that the number of vmRNA molecules of the i-th type is 
iP
cytiCω  (see section 3 below), 
it is evident that 
rib
cyt
isynti d
C
k ω,  in (2.9.6) resembles 
rib
cyti
synti d
C
k ,,  in (2.5.1). The 
connection between the rate constants  )  and  )  is similar to 
that between  and . It is expressed by 
exVspl
k , (
1−h redPspl ik ,, (
1−h
exVspl
k , redCspl vk ,,
exi VsplviriredPspl
kPk ,,,, = . 
Here,  (amino acids/virion) is the average number of i-th proteins contained in 
the virion. 
viriP ,
 
As shown in sections 4.9 and 4.11.1.1, it is the number of vRNP complexes that 
represents the bottleneck of virus replication at virus budding. It remains limiting at 
any variation of model parameters. The other viral components, namely, envelope 
proteins, are produced in redundant amounts and, therefore, do not limit virus 
production. It will be also revealed that the number of produced virions is not 
significantly influenced by variations of the rate constant of the virus assembly  
(see section 4.11.6). For these reasons, the functions representing the number of 
envelope proteins and, accordingly, equations (2.6.1) and (2.6.2), describing their 
change, are omitted in the reduced model. The role of envelope proteins in the 
infection cycle is expressed only in the rate coefficients of the model (e.g., the rate 
coefficients of internalization depend on the binding activity of HA proteins). 
budk
 
Thus, the dynamics of virus assembly is not influenced by changes of the number of 
envelope proteins and repeats the dynamics of vRNP complex formation with the 
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certain time delay concerned with the finite rate of virus assembly. Consequently, all 
the processes relating to the last steps of the infection cycle, starting with vRNP 
formation can be lumped together, and it is possible to reduce equations (2.7.1), 
(2.7.2), (2.8.1), and (2.8.2) to equation 
(2.9.7)  ∏=
l
lvVpck
redrel PCk
dt
dV
rel,
,
 
The meaning of function  (virions/cell) in equation (2.9.7) differs from that of 
function  (virions/nL) in equation (2.8.2). Function  is related to the cell. It 
does not account only for the number of released virions, but rather represents the 
total number of virions assembled in the cell. 
redrelV ,
relV redrelV ,
 
As follows from the corresponding equations of the detailed model and the relations 
between their rate coefficients, the connection of the rate constants  )  and 
 )  (see equations (2.9.5) and (2.9.6)) with the rate constant   is 
given by 
vCpck
k , (
1−h
iPpck
k , (
1−h
relVpck
k , )(
1−h
relv VpckvirCpck
kCk ,, =  
and 
reli VpckviriPpck
kPk ,,, = , 
respectively. 
 
Thus, the formulation of the reduced model is based on equations (2.9.1) – (2.9.7). 
 
 
2.10 Model with Reinfection 
 
So far it was assumed that progeny virus particles did not infect the cell repeatedly. 
The number of virions to enter the cell and the number of virions released from the 
cell were described by two different functions (  and ). However, based on the 
detailed single cell model formulated above, it is also possible to see what happens in 
the case when a reinfection of the cell by released virions is taken into account (Fig. 
2.2). For this purpose the model must be reformulated to consider all the virions in the 
exV relV
  
Model Formulation  79 
surrounding the cell volume of medium as one pool, a single function being used to 
describe the total number of extracellular virions.  
 
 
Figure 2.2 Scheme of the process addressed by the model with reinfection. Released 
virions can enter the cell again, and all extracellular virions are, hence, indistinguishable. 
 
If equation (2.1.1) is modified to include an additional term ( ) 
representing the rate of virus release (similar to equation (2.8.2)) 
budVrelbud VPk rel inf,−
(2.1.1”) budVrelbudsVexsexVsex
ex VPkVkVk
dt
dV
relexex inf,,, −−− ++−=  
function  will describe the total number of extracellular virions. At the same time, 
function  in (2.8.2) still remains meaningful; it represents the total number of 
produced by the cell virions. Experimental data shows that the total number of 
released virus particles contains only a small fraction of infectious virions (H. Sann, 
personal communication, not shown). For this reason,  in (2.1.1”) 
differs from the corresponding term in (2.8.2) by the factor  (-), equal to the 
probability for a virion to be infectious. The value of  is equal to approximately 
exV
relV
budVrelbud VPk rel inf,−
infP
infP
150
1
inf ≈P . 
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Thus, the model with reinfection is represented by equations (2.1.1”), (2.1.2-3), 
(2.2.1-2) – (2.8.1-2). 
 
 
2.11 Model for Continuous Infection 
 
Another situation that can be found in practice is the continuous infection of the cell. 
Assume that in the extracellular medium, besides the number of parental (initially 
seeded) virus particles there is a continuous supply of virus particles from an external 
source (e.g. other infected cells) (Fig. 2.3). To adjust the detailed single cell model to 
account for the considered case, equation (2.1.1) must be modified to include the term 
representing the rate of virus supply  (virions/(nL ⋅ h)): feedk
(2.1.1*) feedsVexsexVsex
ex kVkVk
dt
dV
exex
++−= −− ,,  
feedk  will be supposed to remain constant throughout the whole process of the 
infection. 
 
 
Figure 2.3 Scheme of the process addressed by the model for continuous infection. 
The cell is infected by both parental (initially seeded) virions and virions from the continuous 
supply. 
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The model for continuous infection is represented by equations (2.1.1*), (2.1.2-3), 
(2.2.1-2) – (2.8.1-2). 
 
 
2.12 Population Model 
 
Based on the single cell model formulated in sections 2.1 – 2.8, it is possible to 
develop a population model, which considers the populations of uninfected, infected, 
and dead cells, as well as the population of free virions.  
 
Like the single cell model, the population model considered here is unsegregated, i.e., 
concerned with the mass of average cells. It accounts for the processes of influenza 
virus production in microcarrier cultures, described by Genzel et al. (2004). The 
process comprises several stages; it starts with the cultivation and scale up of 
mammalian cells, followed by cell growth on microcarriers (Fig. 2.4). After medium 
change and infection virus replication occurs. It is the stage of virus replication that 
the model is mainly concerned with. After cell growth and virus replication further 
downstream processing is required. This comprises the clarification of virus culture 
by using 5 µm and 1 µm depth filters, concentration by ultrafiltration, and, finally, 
purification by gel filtration. 
 
The major components of the biological system considered are MDCK cells and 
equine influenza virus (H3N8). MDCK cells are polarized epithelial cells (see section 
1.5.4.2). For their growth they need a surface, which is supplied by microcarriers 
(Cytodex 1), small beads of about 200 µm in diameter. At the end of cell growth 
microcarriers are completely covered by uninfected cells, whereas at virus harvesting 
most of the cells are killed by virus infection and, therefore, separated from 
microcarriers (Fig. 2.4).  
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Figure 2.4 Scheme of the process of influenza virus production in microcarrier 
systems. The population model mainly focuses on the stage of virus replication, which starts 
as microcarriers are covered by a confluent monolayer of uninfected cells (left image) and 
finishes as virus infection kills most of the cells (resulting in the detachment of cells from 
microcarriers, right image). Genzel et al., 2004. 
 
A mathematical formulation of the population model can be posed by taking the 
system of equation underlying the detailed model for a single cells, substituting 
equations (2.1.1), (2.8.1), and (2.8.2), correspondingly, by equations (2.1.1**), 
(2.8.1**), and (2.8.2**), and adding equations (2.12.1) – (2.12.3). 
 
(2.1.1**) bud
in
VrelbudsVexsexVsex
ex V
Z
Z
PkVkVk
dt
dV
relexex
0
inf,,, −−− ++−=  
(2.8.1**)  bud
in
Vrelbud
l
budlbudunVbud
bud V
Z
ZkPSk
dt
dV
budbud
0
,,,, −−= ∏  
(2.8.2**)  drelvdbud
in
Vrelbud
rel ZVkV
Z
Z
k
dt
dV
rel
−= −
0
,  
(2.12.1) undtinununapunsinun
un ZkZZkZVk
dt
dZ −−−= − ,  
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(2.12.2) ininapunsinun
in ZkZVk
dt
dZ
,−= −  
(2.12.3) ininapinununapundt
d ZkZZkZk
dt
dZ
,, ++=  
 
Here, functions  (cells/nL),  (cells/nL), and  (cells/nL) represent, 
correspondingly, the numbers of uninfected, infected, and dead
unZ inZ dZ
2 cells.  (cells/nL) is 
the total number of cells (or the initial number of uninfected cells): 
0Z
dinun ZZZZ ++=0 . 
 
The term bud
in
Vrelbud VZ
Z
Pk
rel
0
inf,−  in (2.1.1
**) and the corresponding terms in (2.8.1**) 
and (2.8.2**) represent the rate of virus release. Like in the model with reinfection (see 
section 2.10), it is added to take into account the probability of infection by newly 
produced virions. Equation (2.8.2**) describes the dynamics of the total number of 
released virions (including secondarily internalized virions). The term  is the 
rate of virus degradation (   is its rate constant). As virus degradation is 
induced by proteases released from dead cells, the considered term is proportional not 
only to the number of released virions itself, but also to the number of dead cells.  
drelvd ZVk
vdk )(
1−⋅ hnL
 
Equations (2.12.1) – (2.12.3) express the population balances for uninfected, infected, 
and dead cells, respectively. The term  in (2.12.1) describes the infection 
of uninfected cells by attached virions.  )  is the rate coefficient of infection. 
Infected cells were shown to release to the extracellular medium signaling 
components, such as double-stranded RNA molecules (Ludwig et al., 2003) that 
might induce the apoptosis of uninfected cells. This process is considered by the term 
 in (2.12.1), proportional to the number of uninfected cells and to the 
unsinun ZVk −
inunk − (
1−h
inununap ZZk ,
                                                 
2 During the process dead cells continuously undergo lysis. However, for the formulation of the model 
it is not necessary to describe degraded cells by an independent function; function Zd represents the 
total number of both dead and degraded cells. 
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number of infected cells; its rate coefficient is  . The term  in 
(2.12.1) represents the detachment of uninfected cells from microcarriers. The rate 
constant of detachment is  ) . Because of the high cell density on 
microcarriers, detached cells are not supposed to attach again; they finally die within 
approximately 24 h (Y. Genzel, personal communication, not shown). The term 
 in (2.12.2) describes the death of infected cells due to the apoptosis induced 
by influenza virus infection. The rate coefficient of the apoptosis of infected cells is 
 ) . Finally, equation (2.12.3) expresses the increase of the total number of 
dead cells due to the detachment of cells from microcarriers and the apoptosis of both 
uninfected and infected cells. 
unapk , )(
1−⋅ hnL undt Zk
dtk (
1−h
ininap Zk ,
inapk , (
1−h
 
The formulation of the population model does not imply any assumptions concerning 
cell-to-cell or microcarrier-to-microcarrier spread of virus particles. Instead, it is 
assumed that all the components of the biological system considered are 
homogeneously mixed. As the ratio of the number of uninfected, infected, and dead 
cells continuously changes in time, for the precise description of the population 
dynamics it would be necessary to multiply each term in the right-hand sides of model 
equations (2.1.1**), (2.1.2-3), (2.2.1-2) – (2.7.1-2), (2.8.1**-2**) by a certain additional 
factor. This factor is equal to the ratio of the number of cells participating in the step 
of the infection cycle described by the considered term to the number of cells, in 
which the virions involved in the considered step have passed through the previous 
step of the infection cycle.  
 
For example, the term  in (2.1.2) representing the rate of endocytosis might be 
multiplied by factor 
sends Vk −
(2.12.4) 
)()(
)()(
endattinendattun
inun
end tZtZ
tZtZ
−− −+−
+= ττω , 
where endatt−τ  (h) is the time interval between attachment and internalization. Indeed, 
virus particles taken up by endocytosis attach to the number of cells that stays in the 
denominator of formula (2.12.4) (both attachment and endocytosis seem to be 
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executed only by living (uninfected and infected) cells). At the same time, some of 
living cells that are involved in virus attachment become dead by the beginning of 
endcytosis. Consequently, the number of cells participating in endocytosis (staying in 
the numerator of formula (2.12.4)) is lower than the number of cells, to which the 
considered virions attached. 
 
In general, model equations describing the dynamics of viral components (e.g., vRNA 
molecules or viral proteins) would have the following form: 
(2.12.5) ),,...,,(),(),...,((
)(
,1,1 imiiunni
i tttZtVtVF
dt
tdV ττ −−=  
)),...,,( ,1, imiiin tttZ ττ −−  
ni ...1=  
Here, n is the number of equations (i.e., the number of process steps considered in the 
model), mi is the number of terms in the right-hand side of the i-th equation,  
( ) (virions/nL or virions/cell) is the function defined by the i-th equation, 
iV
ni ...1= ji ,τ  
(j=1…mi) (h) is the time interval separating the beginning of the step represented by 
the j-th term in the right-hand side of the i-th equation and the beginning of the 
preceding step,  ( ) (  or ) are continuous nonnegative functions. iF ni ...1= 11 −− ⋅ hnL 1−h
 
The system of ODEs underlying the present population model represents a 
simplification of the system of time-delayed differential equations (2.12.5). Actually, 
instead of the real biological system it describes a certain model system, which, 
nevertheless, allows estimating the real number of newly produced virions and 
intracellular viral components (see below). The essential difference of the considered 
model system from the real system is that all the cells it contains (uninfected, infected, 
and dead cells) perform all the steps of the infection cycle until virus release (in 
reality, uninfected and dead cells, naturally, do not perform any steps). Virus release 
is, in contrast, assumed to occur only from infected cells, as it does in the real system. 
Thus, the only terms that must be multiplied by an additional factor are those 
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responsible for virus release, i.e., the term bud
in
Vrelbud VZ
Z
Pk
rel
0
inf,−  in (2.1.1
**) and the 
corresponding terms in (2.8.1**) and (2.8.2**). The factor is, evidently, equal to 
(2.12.6) 
0
)(
Z
tZin
rel =ω . 
The denominator corresponds to the assumption that all the cells are involved in the 
process, and the numerator shows that only infected cells produce virions. An 
essential advantage of the considered approach is that the denominator does not 
depend on time, and, consequently, the resulting system of equations does not contain 
time delays. 
 
As mentioned before, in the model system uninfected and dead cells, side by side with 
infected cells, are supposed to synthesize viral components. Consequently, a 
significant part of viral components produced by this model system is not produced in 
the reality. However, the assumption that only infected cells perform virus release 
(multiplying of corresponding terms by factor (2.12.6)) allows cutting off most of the 
“sham” viral components3. Consequently, the number of virions produced by the 
model system represents a reasonable approximation for the number of virions 
produced in the reality. Further in this section it will be also discussed how the 
formulated population model allows estimating the real concentrations of the 
intracellular viral components. 
 
Throughout the whole process of virus replication (except the first 1-2 h) it is the total 
number of released virions ( ) that represents the size of the population of free 
virions. Indeed, most of the parental virions internalize, and the rest of them make up 
an infinitesimal part of the total number of extracellular virions. The number of 
released virions participating in the infection of cells also seems to be much lower 
than their total number. At the same time, function  takes into account virus 
relV
exV
                                                 
3 To exclude all such components and to derive the more precise value for the number of released 
virions, multiplication of correspondent terms by additional factors might be carried out at every step 
of the infection cycle, as described by system (2.12.5). 
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internalization to dead cells, and, consequently, cannot be considered to characterize 
virus population. Function  and functions , , and , which represent, 
correspondingly the populations of uninfected, infected, and dead cells, are four major 
output functions of the considered population model. 
relV unZ inZ dZ
 
Other functions, describing the dynamics of intracellular viral components 
(intermediate functions), were investigated in detail in the single cell model. For the 
modeling of the population dynamics their exact meanings are not essentially 
important. Consequently, model assumption made above that all the cells are involved 
in virus production is relevant for the population modeling; it does not significantly 
influence the behavior of function , disturbing only the meanings of intermediate 
functions. On the other hand, as discussed in section 5.13, the lag between the 
beginning of the infection and the beginning of virus release is quite short in 
comparison with the duration of virus replication process. Consequently, even the 
number of viral components represented by intermediate functions can be estimated 
from the population model involved. To derive the value of the real concentration of 
the considered viral component at the given time point, the meaning of the function 
describing it must be multiplied by the factor 
relV
relω , given by formula (2.12.6)4.  
 
After all, the general model, in which the dynamics of viral components is represented 
by the system of equations (2.12.5), is also approximate. It accounts for the size of 
considered cell and virus populations only in the finite set of time points, whereas the 
infection of uninfected cells and cell death occur continuously. 
 
In the population model formulated here, like in the model with reinfection, the 
experimental fact that not all the released virions are infectious (see section 5.6 
below) is taken into account by introducing into the term bud
in
Vrelbud VZ
Z
Pk
rel
0
inf,−  in 
                                                 
4 It does not refer to the functions describing the number of viral components at the steps of virus entry 
and penetration into the nucleus (Vex, Vs, Vend, Scyt, Snuc). These viral components, unlike other viral 
components, are not produced by a cell; consequently the correspondent factor is already taken into 
account for them, when describing the step of virus release. 
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(2.1.1**) the probability that a virion is infectious (the factor ). There is also 
another method to formulate the equations of the population model, which does not 
require the introduction of the factor . It consists in the consideration of the 
probability of infection caused by a virion when choosing the values of the kinetic 
coefficients staying in the right-hand sides of population balance equations (2.12.1) – 
(2.12.3) (e.g., ). In this case, however, the number of parental extracellular 
virions ( ), which in the single cell model accounts for the number of infectious 
virions per cell, would imply the presence of noninfective virions. To keep the 
consistency of the population model with the other modifications of the single cell 
model, this approach is not used. 
infP
infP
inunk −
0exV
 
Thus, the formulation of the population model is based on equations (2.1.1**), (2.1.2-
3), (2.2.1-2) – (2.7.1-2), (2.8.1**-2**), (2.12.1-3). 
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3 Initial Conditions, Kinetic Parameters,  
   and Modeling Assumptions 
 
All simulations based on the detailed single cell model, the reduced model, the model 
with reinfection, and the model for continuous infection were performed for the initial 
virus concentration , and a cell surrounded by 10 10
−= nL Vex nL U r 1=  of medium. All 
the parental virions are assumed to be infectious. Additionally, it is assumed that the 
average lifetime of a cell is about T=12 h p.i. (according to experimental data for Mv-
1 lung cells (Roy et al., 2000) and for MDCK cells (J. Schulze-Horsel, Y. Genzel, 
personal communication, not shown), the average lifetime of a cell after infection is in 
the range from 10 to 12 hours, depending on experimental conditions).  
 
The values for several kinetic parameters were taken from the literature (Table 3.1). 
The rate for endocytosis was taken as  (Nunes-
Correia et al., 1999). The rate of peptide chain elongation was adjusted to 
 and the rate of RNA synthesis to  (Alberts et al., 2002). 
Other parameters, particularly at the early steps of infection, were estimated based on 
the general information available from the literature concerned with the dynamics of 
the influenza virus infection cycle (see section 4.1 below). To estimate the kinetic 
parameters for the transfer of vRNP complexes into the nucleus, particularly the rate 
coefficient of endosomal virus degradation (k
114 936.0s 106.2 −−−− =⋅= hk ends
1s  0.5 −=Ribk 1s 0.30 −=Plk
end-degr) (Fig. 1.7, step 2), it was also 
taken into account that "active" virus particles (able to be released from the 
endosome) made up 65-70% of the total number of endosomal viruses5 (Martin and 
Helenius, 1991a). The nuclear concentration of NP proteins defines the switch from 
vmRNA production to genome replication, and the switch parameters were estimated 
as  and  (to achieve the appropriate number of released 5100.2 −⋅=NPa 6100.1 ⋅=NPb
                                                 
5 The rate coefficient of vRNP nuclear export (kcyt-nuc) was put equal to zero, and the ratio of the 
number of segments in the cytoplasm to the number of internalized virions (Scyt/Vex0) was controlled. 
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virions at 12 h p.i.). All data for the stoichiometry of influenza A virus (A/PR/8/34; 
the lengths of polypeptides and vmRNA molecules encoding viral proteins, the 
numbers of viral proteins in the virion, etc.) were taken from Knipe et al. (2001) 
(Table 1.1). 
 
Rate coefficients, contained in the right hand sides of model equations, and the time 
scale of the process are closely related to each other. Since the matrix of coefficients 
for the system of differential equations considered is a sparse matrix, one can adjust 
rate coefficients, relying on the overall time scale (see section 4.1). The results of 
these estimations are summarized in Table 3.2. 
 
Table 3.1 Kinetic parameters, reported in the literature. 
Parameter Value Source 
Rate constant for endocytosis ks-end (s-1) 2.6⋅10-4 1 
Rate of peptide chain elongation krib (s-1) 5.0 2 
Rate of RNA synthesis kPl (s-1) 30.0 2 
1: Nunes-Correia et al., 1999 
2: Alberts, 2002 
 
Table 3.2 Estimated rate coefficients. 
Rate coefficient Value Rate coefficient Value 
sVsex
k ,−  (h
-1) 100.0 rvk deg−  (h
-1) 100.0 
sVexs
k ,−  (h
-1) 0.1 nuccytik −,  (h
-1) 1.0 
endsk −  (h-1) 0.936 rcytik deg, −  (h
-1) 0.01 
endVcytend
k ,−  (h
-1) 14.0 rnucik deg, −  (h
-1) 5.0 
rendk deg−  (h
-1) 6.0 budERjk −,  (h
-1) 1.0 
nuccytk −  (h
-1) 5.0 rERjk deg, −  (h
-1) 0.01 
nucSspl
k ,  (h
-1) 1.0 rbudjk deg, −  (h
-1) 5.0 
cytnucivmk −,,  (h
-1) 1.0 
nucunSun
k
,,
 (h-1) 1.0 
rnucivmk deg,, −  (h
-1) 0.1 budnucunk −,  (h
-1) 1.0 
rcytivmk deg,, −  (h
-1) 0.01 
budVbud
k ,  (h
-1) 1.0 
rck deg−  (h
-1) 100.0   
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The same data set and the dynamics of viral component productions obtained from the 
detailed model allowed estimating the rate coefficients of the reduced model (Table 
3.3). The parameters were adjusted in a way that at 12 h p.i. the number of virions 
assembled in a cell in the reduced model fitted the number of virions released per 
nanoliter in the detailed model. 
 
Table 3.3 Estimated rate coefficients (reduced model). 
Rate coefficient Value Rate coefficient Value 
exVspl
k ,  (h
-1) 0.6 rck deg−  (h
-1) 10.0 
cytnucvmk −,  (h
-1) 0.17 rvk deg−  (h
-1) 10.0 
rnucvmk deg, −  (h
-1) 0.04 rik deg,  (h
-1) 3.25 
rcytvmk deg, −  (h
-1) 0.01 
relVpck
k ,  (h
-1) 0.082 
 
For the simulations based on the population model the concentration of cells was still 
considered equal to 1 cell/nL (106 cells/mL). However, the concentration of virions 
was assumed to be 105 virions/mL, which corresponds to the value of the MOI equal 
to 0.1 virions/cell (a typical value for the considered fermentation experiments is 
0.025 virions/cell, Genzel et al., 2004). The default values for the rate coefficient of 
the apoptosis of uninfected cells ( ) and for the rate constant of virus detachment 
( ) were put equal to zero (see section 4.15.3). The other rate coefficients of the 
population model, i.e., rate coefficients of infection ( ), apoptosis of infected 
cells ( ), virus release ( ), and virus degradation ( ) were estimated based 
on experimental data concerning the overall dynamics of cell and virus populations 
(see section 4.15.1 below). Their estimates are given in Table 3.4. Reasoned by the 
difference in the structure of corresponding equations ((2.8.2) and (2.8.2
unapk ,
dtk
inunk −
inapk , relbudk − vdk
**)), the 
meaning of the rate coefficient of virus release ( ) in the population model 
differs from that in the detailed single cell model. 
relbudk −
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Table 3.4 Estimated rate coefficients (population model). The values of the other rate 
coefficients are given in Table 3.2. 
Rate coefficient Value Rate coefficient Value 
inunk −  (h-1) 0.7 relbudk −  (h-1) 0.013 
inapk ,  (h
-1) 0.1 vdk  (nL⋅h-1) 0.003 
 
In section 2.5 it is assumed that all ribosomes operate at a constant rate and that 
vmRNA molecules are translated by several ribosomes, separated by  
nucleotides (Alberts et al., 2002). Therefore, the synthesis rate is the same for all viral 
proteins and equal to  (amino acids/h). The model also implies that the viral 
polymerase complexes process all 8 genome segments at the same rate  
(nucleotides/h). Therefore, the vmRNA molecule coding for the i-th viral protein is 
synthesized at the rate 
80=ribd
Ribk
Plk
Plikω , where iω  (-) is the fraction of the nucleotides making 
up vmRNA molecules encoding i-th viral proteins from the entire number of 
nucleotides produced. For vmRNA molecules encoding polymerase complexes 
8
3=Plω   
(three polymerase subunits encoded by three genome segments), and for NP, HA and 
NA vmRNA molecules 
8
1=== NAHANP ωωω .  
For vmRNA molecules encoding M1 and M2 proteins  
11 8
1
MM σω = ; 
22 8
1
MM σω = .  
Here, 1Mσ  is a fraction of M1 encoding nucleotides in the 7th genome segment and  
12 1 MM σσ −= .  
The same applies to nucleotides encoding NS1 and NS2 proteins in the 8th genome 
segment: 
11 8
1
NSNS σω = ; 
22 8
1
NSNS σω = . 
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Numerical algorithms to solve the given system of ODEs were provided by DIVA 
(Kroener et al., 1990) and ProMoT (Traenkle et al., 1999), a software package to 
build structured dynamic simulation models. 
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4 Results 
 
Presented in this section will be the results obtained from the single cell model 
(Sidorenko and Reichl, 2004). Considered in the beginning are the overall dynamics 
of virus replication and the behavior of the number of viral components in different 
cellular compartments, particularly, the dynamics of progeny virus release. After that, 
it will be shown how virus infection depends on the pools of cellular resources, and 
what bottlenecks limit virus replication. Further, the sensitivity of the system in 
respect to changes of model parameters and initial conditions will be described. 
Finally, results provided by model modifications (the model with reinfection, the 
model for continuous infection, and the population model) will be reported in a 
similar way. 
 
 
4.1 Overall Dynamics 
 
According to literature (Roy et al., 2000; Nunes-Correia et al., 1999) and simulation 
results, most of the virions are attached to the cellular membrane within 2 to 5 min 
p.i.6. Internalization via receptor-mediated endocytosis is accomplished in about 10 
min6. As a consequence, within 15 to 20 min p.i. all the virions enter the cell7. As 
soon as the first vRNP complexes reach the nucleus (about 30 min p.i.)8, vmRNA 
molecules are being transcribed in high numbers of copies. The switch from vmRNA 
production to virus genome replication takes place at about 3 h p.i., when a significant 
                                                 
6 The rate coefficients of attachment (kex-s) and detachment (ks-ex) were adjusted in such a way that in 5 
min p.i. about 99% of the virions are internalized (Vex makes up about 1% of its initial value) and in 10 
min p.i. the number of endosomal virions (Vend) reaches its maximum. 
7 It can be seen by putting the rate coefficient of virus release from the endsome (kend-cyt) equal to zero 
and controlling the time point when about 99% of internalizing virions reach the endosome. 
8 The time point when the number of vRNP complexes in the nucleus reaches half of its maximal value 
(adjusted by kcyt-nuc). 
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amount of newly produced NP proteins accumulate in the nucleus. As a result, vRNA 
molecules start being intensively replicated by viral polymerase complexes, followed 
by the assembly of new vRNP complexes. At approximately 4 h p.i., newly produced 
virus particles are released into the extracellular medium9. The cell produces about 
8000 virions before it dies at about 12 h p.i. due to the virus interfering with basic 
cellular processes or apoptosis (see section 5.15).  
 
 
4.2 Dynamics of Virus Entry  
 
Functions, describing the virus entry into the host cell show a similar dynamic 
behavior. Indeed, at the early stages of the infection a certain amount of incoming 
viral components is successively transported from one compartment to another (from 
the extracellular medium to the surface of the cell, from the cellular surface to the 
endosome, etc. – see equations (2.1.1), (2.1.2), (2.1.3), (2.2.1), (2.2.2), (2.4.2)). 
During such transport processes an exponential increase of the number of the 
corresponding component caused by the import of the component from the previous 
compartment is followed by an exponential decrease due to the export to the next 
compartment (naturally, the number of extracellular virions exponentially decreases 
from the beginning of the infection) (Fig. 4.1). Finally, as the incoming vRNP 
complexes reach the nucleus, the number of vRNA molecules arising from the vRNP 
splitting also starts to exponentially increase. 
 
                                                 
9 Adjusted by the choice of the rate coefficients of transport. 
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Figure 4.1 Internalization of viral components. The exponential increase of the number of 
cytoplasmic vRNP complexes (Scyt) caused by the release of the viral genome from the 
endosome is followed by the exponential decrease due to nuclear import. Inset: exponential 
decrease of the number of extracellular virions (Vex). 
 
 
4.3 Dynamics of vmRNA Production 
 
At the early stages of the infection (0.0 – 0.5 h p.i.) the total number of vmRNA 
molecules produced increases exponentially in time (Fig. 4.2). Indeed, since the 
number of NP proteins is small at this period: 
(4.3.1)   (exponential stage) 1, <<nucNPNP Pa
the term nucPol
nucNPNP
ivmv PPa
k ,
,
max,, 1
1
+−  in (2.3.1), describing the increase of the 
number of vmRNA molecules, is proportional only to the number of polymerase 
complexes. At the same time, the term 
rib
cyti
synti d
C
k ,,  in (2.5.1), which describes the 
increase of the number of viral capsid proteins (including the number of 
polymerases), is proportional to the number of corresponding vmRNA molecules. The 
solution to such a system of equations represents exponentially increasing functions 
of time for both the number of viral proteins and the number of vmRNA molecules.  
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Figure 4.2 Total number of vmRNA molecules. The number of vmRNA molecules, after 
initial exponential stage (0 – 0.5 p.i., see inset), increases linearly. Transitional stage takes 
place at about 0.5 - 2.0 h p.i. 
 
At the next stage of the infection the number of NP proteins becomes high enough to 
inhibit vmRNA synthesis (2.0 – 12.0 h p.i.) (Fig. 4.2): 
(4.3.2)   (linear stage) 1, >>nucNPNP Pa
It can be shown, that at this stage the number of vmRNA molecules increases obeying 
a polynomial law. Indeed, the process of vmRNA synthesis is affected by two factors; 
its rate is proportional to the number of polymerase complexes and inversely 
proportional to the number of NP proteins (see equation (2.3.1)). The model implies 
that the proportion, in which viral proteins are produced, is kept constant throughout 
the whole process of the infection. Consequently, the factors considered are cancelled 
by each other, resulting in the certain constant rate of vmRNA synthesis. As the rate 
constant of vmRNA degradation is assumed to be quite low, it can be concluded that 
at moderate values of time (2.0 – 12.0 h p.i.) the number of vmRNA molecules 
increases linearly in time.  
 
At the late stages of the infection, when the number of vmRNA molecules produced is 
high, the degradation of vmRNA molecules can become appreciable. In this situation 
(not achieved at 12 h p.i. at the considered set of model parameters), the number of 
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vmRNA molecules tends to constant (see equations (2.3.1) and (2.3.2)).  
 
Thus, the number of vmRNA molecules has two growth stages: initial exponential 
and late polynomial. The first stage turns to the second through the transitional stage 
(approximately 0.5 – 2.0 h p.i.), which is defined by the value of the switch parameter 
. The transitional stage satisfies the relation NPa
(4.3.3)    (transitional stage) 1, ≈nucNPNP Pa
 
 
4.4 Dynamics of Viral Protein Synthesis 
 
As it can be seen from 
rib
cyti
synti d
C
k ,,  in (2.5.1) and the corresponding term in (2.6.1), the 
rate of viral protein synthesis is proportional to the number of vmRNA molecules. 
Since the rate constant of protein degradation is assumed to be high, the number of 
viral proteins in the nucleus (except M1 proteins, representing a limiting factor during 
the assembly of M1-vRNP complexes, see section 4.9), similar to the number of 
vmRNA molecules, exponentially increases at the early stages (0 – 2.0 h p.i.) (Fig. 
4.3), linearly increases as the growing number of NP proteins becomes essentially 
inhibiting vmRNA synthesis (4.0 – 12.0 h p.i.) (relation (4.3.2) is satisfied), and, 
finally, tends to constant at the latest stages (beyond the average lifetime of the cell, 
not shown) (see equations (2.5.1), (2.5.2), and section 4.3). The difference between 
the time courses of vmRNA and viral protein production results from the finite rates 
of the nuclear export of vmRNA molecules and the nuclear import of viral proteins. 
 
Unlike nuclear viral proteins, those incorporated into progeny virus particles are not 
influenced by nuclear protein degradation. Consequently, the number of proteins, 
consumed for virus production (and, consequently, the number of produced viral 
proteins and the total number of viral proteins in the system) after initial exponential 
increase growths first proportional to the second and then to the first power of time 
(beyond the average lifetime of the cell) (Fig. 4.4). 
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Figure 4.3 Polymerase complexes in the nucleus. The number of polymerase complexes 
in the nucleus (PPol,nuc) (as well as the number of other proteins except M1) increases first 
exponentially (0 – 2.0 h p.i., see inset), then linearly (4.0 – 12.0 h p.i.). 
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Figure 4.4 Polymerase complexes incorporated into progeny virions. The initial 
exponential stage is followed by the second order polynomial increase. 
 
The dynamics of envelope protein synthesis is similar to that of capsid protein 
synthesis. Since envelope proteins are not limiting at the stage of virus particle 
formation (the bottleneck at this stage is the number of M1-vRNP complexes, see 
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section 4.9), they accumulate at the budding site in the same manner, as capsid 
proteins do in the nucleus (Fig. 4.3). 
 
 
4.5 Dynamics of Viral Genome Replication 
 
Among all the functions considered, the one describing the number of vRNA 
segments ( ) in the nucleus has the most complex behavior. As shown in section 
4.2, it increases first exponentially due to virus internalization (0.0 – 0.3 h p.i.) (Fig. 
4.5). This initial stage is followed by a short interval of linear growth (approximately 
0.3 – 1.0 h p.i). During the considered interval only a certain fixed number of 
internalized vRNA segments is replicated, providing the constant rate of vRNA 
synthesis. Later, the law of the increase changes again to exponential (approximately 
1.0 – 4.0 h p.i.). Indeed, as revealed in section 4.3, the number of polymerases 
increases exponentially at the early stages of the infection (when relation (4.3.1) is 
satisfied) and, consequently, the term 
vC
nucPol
nucNPNP
nucNP
vc PPb
P
k ,
,
,
max, +−  in (2.4.2) also 
increases in the same manner. As NP proteins become inhibiting vmRNA synthesis 
(relation (4.3.2) is satisfied), the number of vRNA molecules starts increasing 
parabolically (proportional to the 2nd power of time) (approximately 4.0 – 7.0 h p.i.). 
The matter is that the mentioned above term is now proportional to two linear factors 
(
nucNPNP
nucNP
Pb
P
,
,
+  and , see section 4.4). Additionally, it is assumed that the rate 
constant of genomic vRNA degradation is high, which does not permit an increase 
proportional to the third power of time. After changing of the relationship between 
 and  (see below) only one linear factor remains in the term 
nucPolP ,
NPb nucNPP ,
nucPol
nucNPNP
nucNP
vc PPb
P
k ,
,
,
max, +−  in (2.4.2), another factor tending to constant. As a result, 
vRNA growth turns to its second linear stage. Finally, at the latest stages of the 
infection both factors tend to constant (see sections 4.4), and, correspondingly, the 
number of genomic vRNA molecules also tends to constant. 
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Figure 4.5 Synthesis of vRNA molecules. The increase of vRNA number (Cv) comprises 
several stages: two exponential (0 – 0.3 h p.i. and 1.0 – 4.0 h p.i.) and two polynomial (0.3 – 
1.0 h p.i. and 4.0 – 12.0 h p.i.). Inset: initial exponential and linear stages. 
 
The transition from the parabolic to the linear growth stage of genomic vRNA number 
is determined by the number of NP proteins in the nucleus. If  
(4.5.1)    (parabolic stage) NPnucNP bP <<,
both factors making up nucPol
nucNPNP
nucNP
vc PPb
P
k ,
,
,
max, +−  in (2.4.2) are linear and the 
number of vRNA molecules increases proportional to the second power of time (due 
to the high value of the rate constant of vRNA degradation). In the opposite case, i.e., 
when 
(4.5.2)    (linear stage) NPnucNP bP >>,
the rate of vRNA production becomes proportional to only one linear factor, and, 
consequently, the number of vRNA molecules itself starts to increase linearly. At  
(4.5.3)    (transitional stage)  NPnucNP bP ≈,
the transitional stage of vRNA growth takes place. At some sets of model parameters 
it can happen that relations (4.3.2) and (4.5.1) are not satisfied together at any time 
interval. In this case the second exponential stage of vRNA growth turns directly to 
the linear stage, bypassing the parabolic stage. 
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The value of  chosen for the simulations is , whereas at 12 h p.i. the 
number of NP protein molecules in the nucleus is about  (not 
shown). The transitional stage of vRNA growth (relation (4.5.3) is satisfied) starts at 
about 7 h p.i. (not shown), whereas the linear stage (relation (4.5.2) is satisfied) 
cannot be achieved within the lifetime of the cell. Thus, the time point when the cell 
dies (12 h p.i.) corresponds to the transitional stage between the parabolic and linear 
stages. 
NPb
610=NPb
5
, 106)12( ⋅=nucNPP
 
Similar to viral proteins incorporated into progeny virus particles, vRNA molecules 
consumed for virus production are also not influenced by nuclear degradation. At the 
parabolic stage of nuclear vRNA increase the number of packaged genomic vRNA 
molecules could grow proportional to the third power of time (see equations (2.4.1), 
(2.4.2)). However, since at these stages viral proteins are produced proportional to the 
square of time (see section 4.4), the number of vRNA molecules incorporated into 
virions must grow in the same manner, the redundant amount of produced vRNA 
molecules being degraded in the nucleus. It is also remarkable, that the number of 
packaged proteins goes on growing exponentially until NP proteins become inhibiting 
vmRNA production (while relation (4.3.1) is satisfied), lacking the first linear growth 
phase, peculiar to the number of vRNA molecules. Consequently, during its linear 
growth stage the number of vRNA molecules consumed for virus formation also 
increases exponentially in time, the redundancy of vRNA molecules accumulating 
and degrading in the nucleus. 
 
Unlike vRNA segments, cRNA segments are not delivered into the nucleus with 
incoming virus particles. Thus, the increase of cRNA number lacks the first linear 
stage, taking place for the increase of vRNA number. Instead, initial exponential 
increase goes on continuously until turning to the parabolic stage. Further behavior of 
cRNA number is similar to that of vRNA number (Fig. 4.6). 
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Figure 4.6 Synthesis of cRNA molecules. The law of the increase of cRNA number (Cc) is 
similar to that of vRNA number, however it lacks the first linear stage. The initial exponential 
increase (see inset) directly turns to the second order polynomial stage. 
 
 
4.6 Dynamics of the Production of M1-vRNP  
      Complexes 
 
The function describing the number of newly produced M1-vRNP complexes, as well 
as other functions presenting virus release, behaves similar as the function describing 
the number of progeny virus particles (Fig. 4.14). For this reason it will not be 
considered individually. Indeed, being limiting during virus budding (see section 4.9), 
it is the number of M1-vRNP complexes that defines the dynamics of virus release. 
Since the rates of transport of viral components (nuclear export of vmRNA molecules, 
nuclear import of viral proteins, and nuclear export of M1-vRNP complexes) and the 
rate of virus budding are limited, the difference can be only in the time scale of the 
considered processes. The time behavior of the number of progeny virions will be 
considered below (section 4.7). 
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4.7 Dynamics of Progeny virus Release 
 
Finally, having made clear the dynamics of viral component synthesis, it is possible to 
make a series of conclusions concerning the behavior of the number of released 
virions. In this section it will be shown, that at the given set of model parameters the 
number of progeny virus particles increases exponentially at the early stages of the 
infection, whereas at the late stages it obeys a polynomial law. Besides that, the 
conditions peculiar to each stage will be specified, and further (see section 5.9 below) 
it will be discussed if other qualitatively different solutions to the considered system 
of equations are possible for the number of produced virus. 
 
 
4.7.1 Exponential Stage 
 
As shown in sections 4.4 and 4.5, at the early stages of the infection (when the 
number of NP proteins is low, see relation (4.3.1)) the number of viral components 
(viral proteins and vRNA molecules) consumed for virus production increases 
exponentially. Consequently, the number of progeny virions itself also increases 
exponentially at this stage.  
 
The exponential stage of virus release goes on until the number of NP proteins 
becomes high enough to inhibit vmRNA synthesis. As relation (4.3.3) starts being 
satisfied, the number of progeny virions turns to the transitional stage, at which its 
behavior changes from exponential to polynomial. The time interval corresponding to 
the transitional stage of virus release, similar to that corresponding to the transitional 
stage of vmRNA production (see section 4.3) depends on the value of the switch 
parameter . An increase of  makes the transitional stage shorter, and a 
decrease of  elongates it. It is remarkable, however, that the “middle” of the 
transitional phase is not influenced by variations of  (see section 4.11.1.3 below). 
To a lower extent, the transition from the exponential to the polynomial stage is also 
influenced by virus internalization dynamics. When the process of virus 
internalization is fast the polynomial stage of virus growth begins as soon as the rate 
NPa NPa
NPa
NPa
  
Results  105 
of vmRNA synthesis becomes constant (relation (4.3.2) starts being satisfied), 
whereas a slow delivery of the viral genome into the nucleus delays the transitional 
stage.  
 
 
4.7.2 Polynomial Stage 
 
The stage of polynomial growth consists of two phases. During its first phase the 
number of virus particles produced is proportional to the square of time. It 
corresponds to the situation, when the number of vmRNA molecules increases 
linearly (relation (4.3.2) is satisfied), without a significant influence of degradation. 
Indeed, as it is seen from sections 4.4 and 4.5, in this case the number of all viral 
components incorporated into progeny virus particles, and, consequently, the number 
of virions itself increases parabolically. 
 
The second phase of polynomial growth is the phase of the linear increase of progeny 
virus number. It starts, when the degradation of vmRNA molecules becomes 
appreciable and the number of vmRNA molecules tends to constant. In this situation 
the number of viral components produced increases linearly (see section 4.4), which 
results in a linear increase of the number of produced virions. 
 
At the conditions chosen for simulations, the linear phase of progeny virus release is 
not achievable. It would start as late as at about 150 h p.i. (not shown), which is 
definitely beyond the lifetime of the cell. However, as it will be seen later (see section 
4.11.8.1) at certain sets of model parameters a linear phase of virus growth can be 
found within the cellular lifetime.  
 
The change of vmRNA dynamics by the increasing number of NP proteins (which 
happens within 0.5 – 1.5 h p.i., see section 4.3) becomes influencing the dynamics of 
virus release within 4.0 – 7.0 h p.i. (not shown). The time delay results from the 
finiteness of transport rates of viral components. Consequently, the transitional stage 
between the exponential and polynomial stages of virus growth occurs at the period 
4.0 – 7.0 h p.i. At 7.0 h p.i. the number of released virions starts growing proportional 
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to the square of time, remaining in the parabolic phase until reaching the time point of 
cell death (12 h p.i.) (Fig. 4.14). 
 
Remarkably, the degradation of vmRNA molecules is the only reason that causes the 
change from the parabolic growth phase to the linear growth phase. In the absence of 
degradation the polynomial law of progeny virus growth would be parabolic 
throughout the whole replication cycle. 
 
 
4.8 Use of Cellular Resources 
 
The model allows an estimation of the number of cellular resources (e.g. surface 
receptors or amino acids) required for influenza virus replication and a comparison 
with the total number of these resources in the cell.  
 
As mentioned before (see section 2.1), the cell has about  binding sites for 
influenza virus and approximately 200 endosomes, which exceeds by far the number 
of virus particles bound to the cell and the number of endosomes required for virus 
incorporation at low multiplicities of infection. Thus the number of cellular receptors 
and endosomes is not significantly reduced at the beginning of the infection cycle. 
54 10  to10
 
In a typical mammalian cell, the nuclear plasma membrane has approximately 3000 to 
4000 nuclear pores. Assuming a transfer rate of  molecules per second, 
typical for membrane transport proteins (Lodish et al., 2000),  viral 
molecules (vmRNA and vRNA molecules, vRNP complexes, viral proteins) could 
pass the nuclear membrane per hour. As simulations show, nuclear pores are mainly 
used for the transfer of newly synthesized viral proteins, e.g. M1 and NP, into the 
nucleus. The maximum rate of this process is . The rates of other 
processes of viral component transport requiring nuclear pores are significantly lower 
and can be neglected. Thus, influenza viruses use only a negligible part of the transfer 
capacity of nuclear pores for their replication. 
42 10  to10
119 10  to10
1710 −h ~k max,por
 
  
Results  107 
The number of free cellular nucleotides and amino acids consumed for virus 
production (1.7⋅108 nucleotides and 2.2⋅1010 amino acids) is much lower than the total 
cellular pool of these components (1.3⋅1010 nucleotides and 3.1⋅1010 amino acids, see 
Appendix A4) (Fig. 4.7). Even assuming that the synthesis of free cellular nucleotides 
and amino acids is stopped early during the infection, their total number is much 
higher than their number necessary for synthesizing 8000 virus particles. Accordingly, 
Monod-type kinetics is not used in the model for the rate coefficients of viral protein 
and RNA synthesis. 
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Figure 4.7 Cellular resources consumed for virus replication. Free cellular nucleotides 
(⎯) and amino acids (---).  
 
The maximum number of vmRNA molecules in the cytoplasm never exceeds 
 molecules (Fig. 4.2). Therefore, the number of ribosomes involved in 
the synthesis of viral proteins is significantly smaller than the estimated total number 
of cellular ribosomes (approximately ). Consequently, the number of cellular 
ribosomes does not limit viral protein production, and the rate coefficients  (see 
equation 2.5.1) and  (see equation 2.6.1) are considered to be constant. Also, the 
number of heterogeneous nuclear precursor mRNA molecules, which is about 2.2⋅10
5
max, 10~vmC
710
syntik ,
syntjk ,
5 
molecules (Kaufman, 2000), is not limiting for vmRNA synthesis (Fig. 4.2). 
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4.9 Limiting Factors 
 
During several processes of the infection cycle (e.g., the assembly of M1-vRNP 
complexes and the formation of progeny virus particles), one, more complex viral 
component, is synthesized from other, simpler viral components. A simple model 
accounting for this kind of processes is formulated in Appendix A1. It is, particularly, 
shown that in the case when there are more than two viral components to be 
assembled, and the considered viral components have different ratios of the rate of 
their synthesis to the rate of their packaging, one of viral components invariably 
represents a limiting factor for the process of assembly: the whole amount of it 
incorporates into complex components, whereas the other simple components 
accumulate at the place of the assembly. 
 
By now little is known concerning the mechanisms, by which influenza virus 
regulates the synthesis of its proteins and vRNA molecules, therefore, such 
mechanisms are not considered in the model. As the balance between the rate of the 
synthesis of viral components and the rate of their packaging is not assumed to be 
controlled, the situation described above takes place for all the processes of the 
incorporation of simple viral components into complex ones; i.e., one of the simple 
viral components limits the formation of complex components. 
 
The model provides a possibility to reveal factors that limit the rate of progeny virus 
release. Simulations show that during the assembly of M1-vRNP complexes (Fig. 1.7, 
step 7), as well as during virus budding (Fig. 1.7, step 8), one of the newly produced 
viral components is completely consumed for progeny virus particle formation. As a 
result, the consumption rates of other components and, hence, the rate of the whole 
correspondent process becomes limited. This leads to the accumulation of viral 
proteins and vRNA molecules in the nucleus and to the accumulation of viral 
membrane proteins at the budding site, respectively. 
 
For instance, the formation of M1-vRNP complexes in the nucleus (Fig. 1.7, step 7) it 
is the number of M1 proteins that represents a limiting factor (Fig. 4.8). M1 proteins 
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do not accumulate in the nucleus – all their molecules are consumed for the 
production of M1-vRNP complexes. At the same time, the other viral proteins (NS1, 
NS2, NP, and polymerase complex subunits), as well as vRNA molecules, are 
synthesized in redundant amounts. Their incorporation into newly formed M1-vRNP 
complexes is restricted by the number of M1 proteins produced, while NS1 
nonstructural proteins are not incorporated at all. These viral components accumulate 
in the nucleus; their number increases linearly in time. An insignificant increase of the 
number of M1 proteins early in the infection (Fig. 4.8) can be explained by a low rate 
of packaging during this period of time. Indeed, the rate of the assembly of M1-vRNP 
complexes is proportional to the number of vRNA molecules and all viral proteins 
making up M1-vRNP complexes (see equation 2.4.2).  
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Figure 4.8 Viral components in the nucleus. M1 proteins (⎯) are limiting the formation of 
new M1-vRNP complexes, whereas other capsid proteins, e.g. NP proteins (---), and vRNA 
molecules accumulate in the nucleus. 
 
A similar situation takes place during virus budding (Fig. 1.7, step 8). Newly 
synthesized M1-vRNP complexes represent a limiting factor (Fig. 4.9). Simulation 
results show, that the number of M1-vRNP complexes at the budding site is close to 
zero. The reason for its small increase at the initial stage of the infection is that the 
rate of budding, proportional to the number of M1-vRNP complexes and all envelope 
proteins to be incorporated into virions, is not yet high enough at this period. Viral 
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membrane proteins (HA, NA, and M2) accumulate at the budding site, and, similar to 
the previous case, their number increases linearly in time (Fig. 4.9). As discussed 
above, the formation of M1-vRNP complexes is limited by the number of newly 
produced M1 proteins. Since M1-vRNP complexes are limiting at virus budding, M1 
proteins can be considered as the major determinant of the virus yield. This inference 
is particularly used for the development of the reduced model (see sections 2.9 and 
5.14.2). 
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Figure 4.9 Viral components at the budding site. Newly synthesized M1-vRNP complexes 
(⎯) represent a limiting factor, while viral envelope proteins (HA proteins, ---) accumulate at 
the budding site. 
 
 
4.10 Influence of Initial Condition Changes on  
        Virus Growth and Limiting Factors 
 
For the achievement of purposes of the model mentioned in section 1.4, particularly 
for the optimization of the virus yield, it is important to investigate the sensitivity of 
the system behavior to variations of initial conditions. The only nonzero initial 
condition is the initial concentration of extracellular virions (see section 3): 
0)0( exex VV = . 
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The number of virions and viral components in all cellular compartments is equal to 
zero. Thus, this section considers the dependency of the number of produced virions 
on the MOI (virions/cell), the ratio of the concentration of virus particles added per 
cell at the time of infection ( , (virions/nL)) to the initial concentration of 
uninfected cells ( , (cells/nL)) (Licari and Bailey, 1992): 
0exV
0Z
0
0
Z
V
MOI ex= . 
 
To investigate, how the MOI affects the number of virions produced at different time 
points, consider two values of the MOI: MOI1 and MOI2: MOI1<MOI2. Let Vrel,1(t) 
and Vrel,2(t) denote the number of virions produced at the time point t, corresponding 
to MOI1 and MOI2 respectively. Simulations show, that if MOI1 and MOI2 are high 
enough (higher than 3 virions/cell) there is a time point t0, at which Vrel,1(t0)=Vrel,2(t0); 
for t<t0 Vrel,1(t)<Vrel,2(t), and for t>t0 Vrel,1(t)>Vrel,2(t) (Fig. 4.10). In other words, an 
increase of the MOI results in an increase of the number of produced virions at the 
early stages of the infection and in a decrease of the number of produced virions at the 
late stages of the infection.  
 
If the values of MOI1 and MOI2 are lower than 3 virions/cell, Vrel,1(t) and Vrel,2(t) do 
not intersect (Fig. 4.10). In this case Vrel,1(t) < Vrel,2(t) at any value of t; an increase of 
the MOI results in an increase of the number of produced virions at any time point. In 
the situation when MOI1 < 3 virions/cell < MOI2 the existence of the point of 
intersection for the plots of Vrel,1(t) and Vrel,2(t) depends on the vicinity of the values 
of MOI1 and MOI2 to the value of 3 virions per cell. 
 
Let now the value of MOI2 be fixed. Simulations show that when decreasing the value 
of MOI1, the value of t0  (if Vrel,1(t) and Vrel,2(t) intersect) increases and at the certain 
value of MOI1 turns to infinity (Vrel,1(t) and Vrel,2(t) do not intersect). Consequently, 
although for any value of MOI2 there is a time point t0, at which a decrease of the 
MOI becomes profitable for virus production10 (in the particular case it can be 
                                                 
10 Results in the increase of the number of released virions at t→∞. 
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infinite), the value of t0 can be beyond the lifetime of the cell T=12 h. Feasible values 
for t0 are, hence limited by T:  
Tt ≤≤ 00 . 
 
0 1 2 3 4 5
0
20
40
60
80
100
120
140
160
180
Time [h]
 
Vi
rio
ns
 re
le
as
ed
 [1
/nL
]
0 0.5 1 1.5 2 2.5 3
0
1
2
3
4
5
6
Time [h]
 
Vi
rio
ns
 re
le
as
ed
 [1
/nL
]
 
Figure 4.10 The number of released virions (Vrel) for different values of the MOI. The 
maximal number of virions is produced at MOI=3 virions/cell (⎯). Inset: the curve 
corresponding to MOI=3 virions/cell (⎯) intersects the curve corresponding to MOI=100 
virions/cell (-⋅-) and has no intersection with the curve, corresponding to MOI=1 virion/cell      
(---). 
 
Therefore, it can be concluded that there is a value of the MOI (MOIopt) optimal for 
the virus yield. Function Vrel,opt(t), corresponding to this value possesses the following 
property. Every curve Vrel,1(t), corresponding to the value MOI1<MOIopt intersects the 
plot of function Vrel,opt(t) at the time point t0>T (possibly, t0=∞), whereas every curve 
Vrel,2(t), corresponding to the value MOI2>MOIopt intersects the plot of function 
Vrel,opt(t) at the time point t0<T (Fig. 4.10). Consequently, at the time point t=T 
function Vrel,opt(t) in any case provides the maximal number of produced virions.  
 
As the model refers to the infection of a single cell, it is clear that the range of 
relevant values of the MOI is limited from below by 1 virion/cell. On the other hand, 
consideration of MOI values higher than 100 virions/cell can bring to the situation 
when the number of cellular endosomes limits virus replication (the cell contains 
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about 200 endosomes, Alberts et al., 2002). Thus, it is reasonable to perform 
simulations for the values of the MOI changing in the range from 1 virion/cell to 100 
virions/cell. As follows from simulation data summarized in Table 4.1, the number of 
produced virions represents a monotonously decreasing function of the MOI in the 
interval of MOI values from 3 virions/cell to 100 virions/cell, whereas at the interval 
of MOI values from 1 virion/cell to 3 virions/cell it increases, MOIopt≈3 virions/cell 
(the abscissa of the maximum) representing the optimal value of the MOI at the 
considered set of model parameters. At the same time, table 4.1 shows that the impact 
of the MOI chages in the rage from 1.0 virion/cell to 10.0 virions/cell on the virus 
yield is rather small. It becomes appreciable only if the MOI is significantly increased 
(from 10.0 virions/cell to 100.0 virions/cell). 
 
Table 4.1 Virus yield and limiting factors of virus replication for different values of the MOI 
(virions/cell) 
MOI 1.0 2.0 3.0 4.0 5.0 10.0 100.0 
Vrel 8140 8270 8300 8290 8260 8020 6170 
LF B B B B A A A 
LF:  Limiting factor 
A: M1 proteins 
B:  vRNA molecules and M1 proteins 
 
Variations of the MOI also have an influence on limiting factors of virus replication. 
It can be seen from Table 4.1 that if the values of the MOI are lower than 
approximately 4 virions/cell, genomic vRNA molecules are limiting at the early 
stages of the infection, M1 proteins becoming limiting only at the late stages. At the 
same time, for the values of the MOI higher than 4 virions/cell M1 proteins represent 
a bottleneck of virus production throughout the whole infection cycle. 
 
 
4.10.1 Theoretical Confirmation 
 
As follows from the conclusions made in section 4.7 and model equations describing 
the production of viral components, the main determinant of the dynamics of virus 
release is the rate of vmRNA synthesis. Indeed, the synthesis rates of all viral proteins 
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are proportional to the number of vmRNA molecules encoding them (see equations 
(2.5.1) and (2.6.1)); at the same time vRNA molecules are redundant at the stage of 
the assembly of M1-vRNP complexes and do not significantly influence the processes 
of the infection cycle. As it can be seen from equation (2.3.1), the rate of vmRNA 
synthesis vmv−µ  (nucleotides/h), is proportional to the number of viral polymerase 
complexes in the nucleus and inversely proportional to the number of NP proteins in 
the nucleus: 
(4.10.1) 
nucNPNP
nucPol
Polvmvvmv Pa
P
k
,
,
max,, 1+= −−µ . 
Here, the formula for kv-vm,Pol (as an example, the synthesis of vmRNA molecules 
encoding polymerase complexes is considered) from equation (2.3.1) right-hand side 
was taken into account. Assuming that the numbers of produced viral proteins are 
proportional to each other throughout the whole process of the infection (see section 
4.3) and taking into consideration formula (4.10.1), it can be concluded that vmv−µ  is 
an increasing function of the number of viral polymerase complexes and NP proteins. 
It approaches to its maximum, as the concentrations of viral polymerase complexes 
and NP proteins become high enough. The value of the maximal rate of vmRNA 
synthesis is defined by the ratio of the numbers of polymerase complexes and NP 
proteins produced in the cell, and is independent of the numbers of polymerase 
complexes and NP proteins internalized with incoming virions. 
 
The ratio of the number of polymerase complexes produced in the cell to the number 
of NP proteins produced in the cell (approximately 1.3, not shown) is much higher 
than the ratio of the number of polymerase complexes contained in the virion to the 
number of NP proteins contained in the virion (approximately 0.05, Table 1.1). 
Consequently, as follows from formula (4.10.1), the maximal rate of vmRNA 
synthesis prodvmv ,−µ  (nucleotides/h) corresponding to the ratio of the numbers of viral 
components produced in the cell significantly exceeds the maximal rate of vmRNA 
synthesis virvmv ,−µ  (nucleotides/h) corresponding to the ratio of the numbers of viral 
components delivered with incoming virions. As viral proteins start being intensively 
produced, the rate of vmRNA synthesis changes from its lower value virvmv ,−µ  towards 
its higher value prodvmv ,−µ . The number of vmRNA molecules produced and, hence, 
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the number of viral proteins produced and the number of virus particles released 
depend on how fast the rate of vmRNA synthesis approaches to prodvmv ,−µ .  
 
On the one hand, the lower the number of viral components internalized with 
incoming virions the lower the number of newly synthesized viral proteins (viral 
polymerase complexes and NP proteins) necessary to compensate the difference 
between virvmv ,−µ  and prodvmv ,−µ . On the other hand, however, the more viral 
components are delivered into the nucleus, the higher the initial rate of vmRNA 
production, and, accordingly, the initial rate of viral protein production. The behavior 
of the virus yield as a function of the MOI depends on the relation between two 
mentioned above effects. 
 
At the MOI changing in the range from 1 virion/cell to 3 virions/cell the increase of 
the initial rate of vmRNA synthesis is determinant for the behavior of the number of 
released virions; the virus yield increases with an increase of the MOI (Fig. 4.11). At 
higher values of the MOI (from 3 virions/cell to 100 virions/cell) an increase of the 
value of the MOI is, in contrast, not profitable for vmRNA production; the increase of 
the number of newly synthesized viral proteins necessary to compensate the 
difference between virvmv ,−µ  and prodvmv ,−µ  is predominant over the increase of the 
initial rate of vmRNA synthesis (Fig. 4.11). As a result, the virus yield decreases with 
an increase of the MOI. 
 
As discussed in section 4.11.1.1, limiting factors at a delay in the switch from 
transcription to genome replication (introduced by an increase of bNP) differ from 
those at the initial set of model parameters. As NP proteins promote the switch (see 
sections 1.6.3 and 1.6.4), and a decrease of the MOI invariably leads to a decrease of 
the concentration of incoming NP proteins, it is the delayed switch at low values of 
the MOI that is responsible for the effect of MOI variations on limiting factors. 
 
  
Results  116 
0 0.5 1 1.5 2 2.5 3 3.5 4
0
1
2
3
4
5
6 x 10
6
Time [h]
vm
RN
A 
sy
nt
he
sis
 ra
te
 [n
uc
leo
tid
es
/h]
0 0.5 1 1.5 2 2.5 3 3.5 4
0
1
2
3
4
5
6 x 10
6
Time [h]
vm
RN
A 
sy
nt
he
sis
 ra
te
 [n
uc
leo
tid
es
/h]
 
Figure 4.11 The rate of vmRNA synthesis (µv-vm) for different values of the MOI. At the 
initial stages of the infection the rate of vmRNA synthesis corresponding to the optimal value 
of the MOI (MOI=3 virions/cell, ⎯) is higher than vmRNA synthesis rates corresponding to 
MOI=1 virion/cell (---) and MOI=10 virions/cell (---, see inset). At the late stages of the 
infection all three curves naturally tend to the same constant, equal to µv-vm,prod. 
 
 
4.11 Influence of Parameter Changes on the  
        Virus Yield and Limiting Factors  
 
Both for a better understanding of the dynamics of virus replication and for the 
identification of possible ways to increase the efficiency if virus replication in a cell it 
is necessary to explore the influence of parameter changes on the main functions 
describing the behavior of the considered biological system. Besides that, knowing 
the set of model parameters, variations of which do not significantly change the 
behavior of the system, can be helpful for the development of the reduced model, 
taking into account only the most essential steps of the process (see section 2.9). 
Particularly important is to reveal the character of changes in the number of produced 
virions and in the number of viral components limiting virus replication, when the 
values of model parameters are varied.  
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All model parameters can be classified into several groups: rate coefficients of 
internalization (rate coefficients of all processes related to delivery of the viral 
genome to the nucleus: , , , , , ), rate coefficients of 
transport (rate coefficients of all transport processes taking place after viral genome 
starts being processed: , , , ), rate coefficients of 
macromolecule synthesis ( , , , , , ), rate constants  of virus 
assembly ( , ), rate coefficients of virus release ( ), rate constants of 
degradation (all rate coefficients supplied with the index “degr”), and switch 
parameters ( , ). For the convenience here and further in this section the 
indexes defining the correspondence of rate coefficients to certain equations are 
omitted (e.g., for both rate coefficients of virus attachment  and  the 
common designation  is used). Although both the first and the second group of 
parameters refer to transport processes, it is reasonable to consider rate coefficients of 
internalization separately. The matter is that the beginning of nuclear phase of virus 
replication is an essential branch point; it is a starting point of several processes, such 
as transcription, genome replication, and viral protein production. Additionally, rate 
coefficients of internalization, unlike other rate coefficients of transport, depend not 
only on the properties of the cell, but also on the individual features of virus (e.g., 
binding and fusion activities of HA proteins). 
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4.11.1 Variations of Switch Parameters 
 
Limiting factors of virus replication, as well as the virus yield, depend on the switch 
from vmRNA production to genome replication, which is correlated with the nuclear 
concentration of NP proteins (see section 1.6.4). The extent, in which NP proteins 
influence the switch, i.e., inhibit vmRNA production and promote vRNA replication, 
is defined by the ability of NP proteins to bind to elongating vRNA and cRNA strands 
and to block poly(A) addition (Portela and Digard, 2002), expressed by two model 
parameters,  and  (see equations (2.3.1), (2.4.1), and (2.4.2)). NPa NPb
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4.11.1.1 Influence on Limiting Factors  
 
Depending on the values of  and , two types of system behavior are possible. 
Previously presented results were obtained for small values of  compared to the 
number of NP protein molecules in the nucleus (about 10
NPa NPb
NPb
6). It corresponds to a 
situation when the switch occurs relatively early (vRNA molecules start being 
intensively produced at about 1.0 h p.i., see section 4.5). As shown in section 4.9, in 
this case M1 proteins are limiting all the way. 
 
However in the case when the switch takes place at the late stages of the infection, 
which corresponds to high values of  (e.g. ), simulation results become 
qualitatively different from those described above. Until about 2 h p.i. the level of 
vRNA production is very low, and vRNA molecules limit virus replication at this 
stage. M1 proteins are, in contrast, produced in redundant amounts and accumulate in 
the nucleus. At about 2.5 h p.i., when the switch is accomplished, vRNA molecules 
start being intensively produced, and M1 proteins become limiting (Fig. 4.12). 
NPb
710≈NPb
 
Variations of the parameter  have no influence on limiting factors of virus 
replication, affecting only the virus yield (see section 4.11.1.2 below).  
NPa
 
Limiting factors of virus budding are influenced neither by variations of  and , 
nor by variations of other model parameters. At any set of model parameters M1-
vRNP complexes remain limiting throughout the whole infection cycle. 
NPa NPb
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Figure 4.12 Viral components in the nucleus at high values of bNP. M1 proteins (⎯) limit 
virus replication after about 2 h p.i. At the early stages of the infection vRNA molecules (---) 
represent a limiting factor, whereas M1 proteins accumulate. 
 
 
4.11.1.2 Influence on the Virus Yield 
 
Variations of  and  also influence the number of released virions. Table 4.2 
summarizes the results of simulations for  changed by different factors from 0.5 
(the earliest switch) to 5.0 (the latest switch). This data shows that if the factor is less 
than approximately 2.3, the virus yield is slightly sensitive to variations of . 
Indeed, at the value of  changed by a factor of 2.3, the rate coefficient  in 
(2.4.2) already at the early stages of the infection becomes close to its maximal value. 
Consequently, any further decrease of  cannot significantly change the behavior of 
the system. In this range M1 proteins are limiting for virus replication throughout the 
whole period of the infection.  
NPa NPb
NPb
NPb
NPb cvk −
NPb
 
For  increased by a factor greater than 2.3, further increase of this parameter 
results in a decrease of released virus number.  increased by a factor of 2.5 and 
higher corresponds to the situation when vRNA molecules is limiting during the early 
NPb
NPb
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stages of the infection. It could be supposed that the delay of the switch, giving M1 
proteins the possibility to accumulate in the nucleus, might result in an increase of the 
virus yield, since the drawback of vRNA molecules can be fast compensated when 
M1 proteins become limiting. However, as vRNA molecules limit virus production, it 
is the number of vRNA molecules that defines the number of released virions. And as 
the delay of the switch leads to a decrease of the number of produced genomic vRNA 
molecules, the number of released viruses also decreases. Consequently, if the impact 
of NP proteins on vRNA replication is not strong (which is not the case at the 
considered set of model parameters, see above), a decrease of  can result in an 
increase of the virus yield. 
NPb
 
Table 4.2 Virus yield and limiting factors of virus replication for the switch parameter bNP 
changed by different factors 
Factor 0.5 1.0 2.3 2.5 3.0 4.0 5.0 
Vrel 8020 8020 8020 8019 8005 7960 7914 
LF A A A B B B B 
LF:  Limiting factor 
A: M1 proteins 
B:  vRNA molecules and M1 proteins 
 
It can be concluded from Table 4.2 that the impact of variations of  on the virus 
yield is rather small. At the same time, variations of  can significantly change the 
number of virions released. Simulations were performed for  changed by the 
factors 0.1, 0.5 and 2.0. According to simulation data (see Table 4.3), the virus yield 
increases with a decrease of . Indeed, a decrease of  makes the process of 
vmRNA production faster, and, accordingly, all viral proteins are produced more 
efficiently. Thus, reducing the inhibitory effect of NP proteins on vmRNA synthesis 
(i.e., decreasing the value of the parameter ) can be considered as an effective 
way for improving virus production. Furthermore, as shown in section 5.9.1, a 
decrease of  results in an extension of the exponential stage of progeny virus 
growth, and at low values of  the law of virus growth is close to exponential. 
NPb
NPa
NPa
NPa NPa
NPa
NPa
NPa
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Table 4.3 Virus yield for the switch parameter aNP changed by different factors  
Factor 0.1 0.5 1.0 2.0 
Vrel 82980 16510 8020 3810 
 
 
4.11.1.3 Switch Parameters and vmRNA Dynamics 
 
It could be supposed that by decreasing  it is possible to make the rate of vmRNA 
synthesis 
NPa
vmv−µ  being proportional to the first power of time instead of remaining 
constant, increasing thus the order of the polynomial law of virus release. Indeed, a 
decrease of  makes the rate coefficient of vmRNA synthesis  (see equation 
(2.3.1)) less sensitive to an increase of the nuclear concentration of NP proteins; 
higher values for the number of NP proteins are required to essentially increase the 
denominator in the expression for . However, as discussed above, any decrease 
of the parameter  invariably results in an increase of NP protein concentration. 
For example, tenfold decrease of  value leads to the change of the number of NP 
proteins (at 12 h p.i.) from approximately 5.5⋅10
NPa ivmvk ,−
ivmvk ,−
NPa
NPa
5 to 5.5⋅106, i.e., also by a factor of 
approximately 10.0. Consequently, the product of the parameter  and nuclear 
concentration of NP proteins does not change.  
NPa
 
The time point when the number of vmRNA starts to increase linearly also does not 
change as  is varied. However, the term NPa nucPol
nucNPNP
ivmv PPa
k ,
,
max,, 1
1
+−  in (2.3.1) is 
still sensitive to  changes. A decrease of  makes its increase in time sharper 
and the value it tends to higher (otherwise, it would not result in an increase of 
vmRNA and viral protein production). 
NPa NPa
 
Thus, variations of the parameter  do not provide an option to make vmRNA 
number increasing faster, than proportional to the first power of time. Accordingly, 
the maximal order for the polynomial law of viral protein growth, as well as for the 
polynomial law of virus release, is second. 
NPa
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4.11.2 Variations of Internalization Dynamics 
 
Virus internalization has an essential influence on the number of progeny virus, 
limiting factors, and the behavior of some viral components. This section shows 
possible changes in virus replication dynamics caused by variations of internalization 
rate coefficients, which are mainly defined by binding and fusion activities of viral 
HA proteins. 
 
As variations of individual rate coefficients of internalization, except the rate constant 
of dissociation ( ) result in similar effects, it makes sense to increase all these rate 
coefficients simultaneously by the same factor in each trial. Simulations were 
performed for internalization rate coefficients changed by factors from 0.5 to 2.0. The 
number of virions produced in 12 h p.i. for different values of the rate coefficients of 
internalization is presented in Table 4.4. 
exsk −
 
Table 4.4 Virus yield and limiting factors of virus replication for the internalization rate 
coefficients changed by different factors 
Factor 0.5 0.6 0.7 1.2 1.3 1.4 2.0 
Vrel 8009 8069 8069 7999 7995 7997 8071 
LF B B A A A A A 
Phase 1 1 2 2 2 3 3 
LF:  Limiting factor 
A: M1 proteins 
B:  vRNA molecules and M1 proteins 
1:  Initial increase  
2:  Decrease 
3:  Late increase 
 
Simulations show that at the increase of the rate coefficients from 50% of their initial 
values the number of produced virions first increases, and at about 60-70% of the 
initial values of the rate coefficients of internalization there is a local maximum. 
Further increase of the rate coefficients of internalization results in a decrease of the 
virus yield. The local minimum takes place at the values of internalisation rate 
coefficients equal to approximately 130% of their initial values. Finally, the increase 
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of the rate coefficients of internalization from 130% to 200% of their initial values 
result again in the increase of released virus number. Thus, the behavior of the 
number of produced virions as a function of the internalization rate coefficients can be 
subdivided into three phases, the origin of which will be explained below. These 
phases are initial increase, decrease, and late increase. 
 
Variations of the rate coefficients of internalization also affect limiting factors of virus 
replication (Table 4.4). If the values of the rate coefficients are greater than 
approximately 60% of their initial values (which corresponds to the phases of 
decrease and late increase), M1 proteins are limiting throughout the whole infection 
cycle (Fig. 4.8). In the opposite case (the phase of initial increase), the bottleneck at 
the early stages of the infection is represented by vRNA strands, M1 being limiting at 
the late stages (similar to the case of the delayed switch discussed in section 4.11.1.1, 
Fig. 4.12). 
 
Initial increase. If the values of the rate coefficients of internalization are low, their 
increase naturally leads to an increase of the number of released virions. Indeed, to 
start virus production, the delivery of viral components is required. Additionally, in 
this situation vRNA molecules are limiting at the early stages of the infection. Since 
the rate of vRNA production is proportional to the number of NP proteins (see 
equation (2.4.2)), an increase of NP protein concentration (resulting from an increase 
of the rate coefficients of internalization) directly leads to an increase of the number 
of M1-vRNP complexes, and, consequently, to an increase of the number of virions 
produced. 
 
Decrease and late increase. For the internalization rate coefficients increased by 
factors from 0.7 to 2.0 M1 proteins represent a limiting factor of virus growth 
throughout the whole infection cycle. The number of produced virus particles is, 
hence, no longer directly dependent on vRNA production. It is the number of vmRNA 
molecules that mainly affects the number of M1 proteins produced.  
 
Incoming virus particles deliver NP proteins and viral polymerase complexes into the 
nucleus of the cell, the former inhibiting vmRNA synthesis and the latter promoting 
it. As pointed out in section 4.10.1, the increase of the number of internalized viral 
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components affects the production of vmRNA molecules depending on the relation 
between two effects accompanying it: the increase of the number of newly 
synthesized viral proteins required to compensate the difference between the lower 
and the higher values of vmRNA synthesis rate ( virvmv ,−µ  and prodvmv ,−µ , introduced in 
section 4.10.1) and the increase of the initial rate of vmRNA production. 
 
Thus, in the range of the rate coefficients of internalization from 70% to 130% 
(corresponding to the decrease phase) of their initial values any increase of the 
internalization rate coefficients does not increase vmRNA production (Fig. 4.13). 
Newly synthesized viral proteins are transported into the nucleus much earlier than 
the whole amount of incoming viral components is internalized, and the increased 
number of newly synthesized viral proteins necessary to compensate the difference 
between virvmv ,−µ  and prodvmv ,−µ  is predominant over the increased initial rate of 
vmRNA synthesis. As a result, the virus yield decreases with an increase of the rate 
coefficients of internalization. 
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Figure 4.13 The rate of vmRNA synthesis for different values of internalization rate 
coefficients. Rate coefficients of internalization increased by a factor 1.3 (⎯) correspond to 
the minimal rate of vmRNA synthesis. E.g., their variations by factors of 0.7 (---) and 2.0 (---, 
see inset) result in higher values of vmRNA synthesis rate at the early stages of the infection. 
 
  
Results  125 
At the rate coefficients of internalization in the interval from 130% to 200% of their 
initial values (late increase phase) an increase of the rate coefficients of 
internalization causes only an increase of the initial rate of vmRNA synthesis (Fig. 
4.13). The number of viral proteins required for the compensations of the difference 
between virvmv ,−µ  and prodvmv ,−µ  remains practically unchanged. Indeed, internalization 
of incoming viral components is accomplished earlier than the significant amount of 
newly synthesized viral proteins enters the nucleus and starts changing the rate of 
vmRNA synthesis towards prodvmv ,−µ . Consequently, an increase of the internalization 
rate coefficients results in an increase of the number of released virions. 
 
 
4.11.2.1 Variations of Rate Constants of Dissociation 
 
According to simulation results, the behavior of the system, particularly the virus 
yield is not significantly sensitive to vatiations of the rate constants of virus 
dissociation from the cellular surface ( ), correlated with the affinity of viral HA 
proteins to cellular surface receptors. Even an increase or a decrease of the considered 
rate constants by a factor of 10.0 does not result in noticable changes in the number of 
produced virions (not shown). This observation provides the possibility not to 
consider virus dissociation in the reduced model (see section 2.9). 
exsk −
 
 
4.11.3 Variations of Rate Coefficients of Transport 
 
The model takes into account different cellular compartments involved in the virus 
replication cycle, such as cytoplasm, nucleus, ER, and budding site. The transfer of 
viral components from one compartment to another is carried out with a certain finite 
rate. Side by side with rate coefficients of virus internalization, rate coefficients of 
transport events, defined by the functional properties of corresponding signal 
sequences (i.e., NLSs and NESs), also represent an important determinant of virus 
dynamics. 
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Simulations allow exploring, what will happen with system behavior (particularly 
with the number of produced virus particles) if the transport of viral components 
between cellular compartments is speeded up or slowed down. In each trial all the rate 
coefficients of transport were increased simultaneously by the same factor. Table 4.5 
summarizes the results of simulations for the number of virus particles released after 
12 h p.i. Relying on this data it can be concluded that variations of the rate 
coefficients of transport do not result in any unusual effects; an increase of the 
transport rate coefficients naturally leads to an increase of the number of produced 
virions. As this increase of the virus yield is rather appreciable, the increasing of the 
efficiency of viral component transport might be one of possible ways of virus 
production optimization. The situation remains the same if the simulations are 
performed at increased or decreased values of internalisation rate coefficients (not 
shown). Indeed, the faster the transport of viral components, the faster the beginning 
of vmRNA processing and the assembly of M1-vRNP complexes. The switch from 
vmRNA production to genome replication does not depend on the rate coefficients of 
transport; consequently, any negative effects of the increase of the transport rate 
coefficients on the virus yield are excluded.  
 
Table 4.5 Virus yield for the transport rate coefficients changed by different factors  
Factor 0.5 0.6 0.7 1.0 1.5 2.0 
Vrel 3170 4270 5340 8020 11070 13010 
 
 
4.11.3.1 Minimal Value of the Delay of Virus Release 
 
The model also allows estimating the minimal time post-infection when virions can 
start being produced. According to simulation results, when all the rate coefficients of 
transport are increased by a factor of 2.0, virus release starts at approximately 3 h p.i. 
(at the initial values of the rate coefficients of transport it starts at about 4 h p.i.). It 
can be also seen that at further increase of the transport rate coefficients the time point 
of the beginning of virus release tends to approximately 1.7 h p.i., which represents 
the value for the minimal possible time interval between the beginning of the 
infection and the beginning of virus release. This value is much less than the average 
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lifetime of the cell (T=12h). Therefore it can be concluded that the infected cell 
produces virions during the major part of its life. 
 
 
4.11.4 Combined Variations of Rate Coefficients of  
           Internalization and Transport 
 
As pointed out in section 4.11.2, the number of released virions, as a function of the 
rate coefficients of internalization, has two local extremes. Existence and location of 
these extremes, however, depend on the other model parameters, particularly on the 
rate coefficients of transport. To explore this dependency, simulations were performed 
for the same values of the internalization rate coefficients as in the section 4.11.2 and 
for the values of the transport rate coefficients changed by factors of 2.0 and 0.5. The 
results are summarized in Tables 4.6 and 4.7 respectively. 
 
Table 4.6 Virus yield and limiting factors of virus replication for the internalization rate 
coefficients changed by different factors (the transport rate coefficients are multiplied by 2.0) 
Factor 0.5 0.7 0.8 0.9 1.5 2.0 2.5 
Vrel 12910 13060 13060 13040 12890 12860 12890 
LF B B A A A A A 
LF:  Limiting factor 
A: M1 proteins 
B:  vRNA molecules and M1 proteins 
 
Table 4.7 Virus yield and limiting factors of virus replication for the internalization rate 
coefficients changed by different factors (the transport rate coefficients are multiplied by 0.5) 
Factor 0.3 0.4 0.5 0.6 1.0 1.5 2.0 
Vrel 2930 3080 3150 3160 3170 3240 3350 
LF B B B A A A A 
LF:  Limiting factor 
A: M1 proteins 
B:  vRNA molecules and M1 proteins 
 
Comparing the data from Tables 4.4 and 4.6, it can be concluded that in both cases the 
abscissa of the maximum corresponds to the point where the distribution of limiting 
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factors change; on the left from the point of the maximum first vRNA molecules and 
then M1 proteins are limiting, and on the right from it M1 proteins are limiting 
throughout the whole infection cycle (this phenomenon is explained in section 
4.11.2). It is also seen that at the values of the rate coefficients of transport increased 
by a factor of 2.0 the decrease comes later and lasts longer, than at their initial values 
(see below for the explanation).  
 
Table 4.7 shows that a twofold decrease of the rate coefficients of transport leads to a 
situation when two discussed above extremes no longer appear, and the virus yield 
represents a monotonously increasing function of the rate coefficients of 
internalization. With slowing down transport processes, the interval of the decrease of 
the virus yield diminishes and finally disappears. The observed effect can be 
explained by the following way. As the nuclear export of newly produced vmRNA 
molecules and nuclear import of newly produced viral proteins are essentially slowed 
down, even at low values of the internalization rate coefficients the process of 
internalization accomplishes earlier than newly synthesized viral proteins are 
transported in significant amounts into the nucleus, resulting in the increase of the rate 
of vmRNA synthesis (the situation described in section 4.11.2 for the late increase 
phase). Additionally, at low values of the rate coefficients of transport there is more 
time for polymerase complexes internalized with incoming virus particles to produce 
vmRNA molecules (and, hence, to increase the efficiency of viral protein synthesis), 
which make the positive effect of faster internalization even more appreciable. As a 
result, at all considered values of the rate coefficients of internalization the phase of 
the initial increase is directly followed by the phase of the late increase, the phase of 
the decrease being bypassed. Since the increase of the rate coefficients of 
internalization is profitable for vmRNA production, it results in the increase of the 
number of viral proteins produced (particularly in the increase of the number of 
limiting for virus replication M1 proteins) and, finally, in the increase of the number 
of virions released.  
 
For the existence of the decrease of the number of produced virus particles as a 
function of the rate coefficients of internalization the following criterion can be 
formulated. The decrease takes place if and only if viral polymerase complexes 
internalized with incoming virions synthesize the number of vmRNA molecules 
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sufficient to initiate the synthesis of the number of viral proteins suppressing the 
increase of the number of viral proteins required for the compensation of the 
difference between virvmv ,−µ  and prodvmv ,−µ . Thus, at low values of the rate coefficients 
of transport (particularly, if newly produced viral proteins are delivered to the nucleus 
later than the whole amount of incoming viral components is internalized) there is no 
decrease phase, and with an increase of the rate coefficients of internalization the 
virus yield monotonously increases. 
 
 
4.11.5 Variations of Macromolecule Synthesis Rates  
 
According to the results of simulations, the number of produced virions is mainly 
influenced by variations of two model parameters: viral polymerase speed, and the 
translation efficiency of viral proteins. The former parameter expresses the ability of 
the PB1 subunit of the polymerase complex to catalyze the nucleotide addition to 
growing viral RNA strands (Flint et al., 2000), whereas the later is mainly defined by 
the effectiveness of the processing of mRNA molecules (Knipe et al., 2001). Speeding 
up viral polymerase complexes leads to an accelerated transcription of all types of 
vRNA molecules, whereas an increased synthesis rate of ribosomes results in the 
increased production rates of all viral proteins, including M1 proteins, which limit 
virus replication, and polymerase complexes required for transcription.  
 
The polymerase speed  was successively increased by factors of 0.5, 1.5, and 2.0. 
The results of simulations are summarized in Table 4.8. It is seen that the increase of 
 by a factor of 2.0 causes a more than twofold increase of the number of released 
virions (Fig. 4.14). Similar results can be obtained by an increase of the translation 
efficiency of viral proteins (the parameter ).  
Plk
Plk
Ribk
 
Thus, one of the most effective ways for obtaining more progeny virus particles are 
speeding up viral polymerase complexes or increasing of the translation efficiency of 
viral proteins. Additionally, it can be concluded that one possible reason why viruses 
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have different replication rates is the difference in their polymerase speed and in their 
ability to produce proteins. 
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Figure 4.14. The number of released virions for different values of viral polymerase 
speed. The number of progeny virions, after the initial exponential stage (0.0 – 4.0 h p.i., see 
inset) and the transitional stage (4.0 – 7.0 h p.i.) increases proportional to the second power 
of time. Presented plots correspond to a polymerase speed kPl increased by factors of 1.0 
(⎯), 1.5 (-⋅-) and 2.0 (---). 
 
Table 4.8 Virus yield for polymerase speed (kPl) changed by different factors 
Factor 0.5 1.0 1.5 2.0 
Vrel 3660 8020 12590 17270 
 
 
4.11.6 Variations of Rate Constants of Virus Assembly 
 
To investigate the sensitivity of the virus yield to variations of the rate constants of 
the assembly of M1-vRNP complexes ( ), simulations were performed for the 
values of these rate constants increased by factors of 0.5 and 2.0. It can be concluded 
that the number of produced virions is not significantly affected by changes of the rate 
constants of the assembly of M1-vRNP complexes. Indeed, the production of new 
M1-vRNP complexes, and, hence, virus release are limited by the production of M1 
unk
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proteins. Consequently, the rate of virus release cannot be increased by the increase of 
the rate constants of the assembly of M1-vRNP complexes. The considered rate 
constants define only the initial increase of the number of M1 proteins preceding the 
formation of M1-vRNP complexes. 
 
Simulations also show that variations of the rate constants of progeny virus assembly 
( ) slightly influence the number of produced virions, changing only the initial 
increase of the number of M1-vRNP complexes. In fact, virus production is limited by 
the rate of the formation of M1-vRNP complexes, and, accordingly, speeding up virus 
assembly cannot result in an increase of the number of released virus particles. 
budk
 
The negligible sensitivity of the virus yield on the rate constants of viral component 
assembly makes possible to lump together or even omit the last steps of the process in 
the reduced model (see section 2.9). 
 
 
4.11.7 Variations of Rate Coefficients of Virus Release 
 
It is natural to suppose that the number of released virions is sensitive to variations of 
the rate coefficients of virus release, defined by the cleavage activity of viral NA 
proteins. Simulations were performed for the rate coefficients of virus release 
( ) increased by factors from 0.5 to 2.0. The results are summarized in Table 
4.9. The number of released virions naturally increases with an increase of . 
However, if the values of the rate constants of release are high enough, the influence 
of their further increase becomes less significant.  
relbudk −
relbudk −
 
Table 4.9 Virus yield for the rate coefficients of release (kbud-rel) changed by different factors  
Factor 0.5 1.0 1.5 2.0 
Vrel 6420 8020 8690 9050 
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4.11.8 Variations of Rate Constants of Degradation  
 
The rate constants of viral component degradation express the activity of cellular 
decomposing enzymes, such as nucleases and proteases. Their variations to a different 
degree influence the virus yield and limiting factors. As the values of the degradation 
rate constants used for modeling are not precisely defined, the ranges for their 
variations were chosen to be quite wide in comparison with those for other model 
parameters. 
 
 
4.11.8.1 Degradation of Incoming Virus Particles 
 
As discussed in section 1.6.2, a certain number of virus particles delivered to the 
endosomes (“inactive” virions) are transported to the lysosomes for degradation. The 
ratio of “active” and “inactive” virions can be changed by several mechanisms, such 
as the specific inhibition of M2 ion channel activity by the anti-influenza virus drug 
amantadine (Flint et al., 2000). In the presence of amantadine the interaction of M1 
proteins with vRNP complexes is not disrupted, and, accordingly, vRNP complexes 
cannot be released from the endosomal membrane.  
 
It could be supposed that the virus yield might monotonously decrease with an 
increase of the rate constant of endosomal virus degradation ( ). However, 
simulations show that this is not the case. Simulations were performed for the value of 
the rate constant involved changed by different factors. The results are summarized in 
Table 4.10. It can be seen, that a moderate increase of the rate constant of endosomal 
virus degradation results in an increase of the number of released virions. Only when 
the rate constant of endosomal virus degradation becomes approximately 100.0 times 
higher than its initial value the virus yield becomes less than it is at the initial value of 
the degradation rate constant. 
rendk deg−
 
In section 4.10.1 slowing down of virus production with an increase of the MOI was 
explained by the difference in the rates of vmRNA production corresponding to the 
ratios of the number of viral polymerase complexes to the number of NP proteins in 
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the virion and in the cell after the beginning of intensive viral protein production. 
Provided that the MOI is high, an increased initial rate of vmRNA synthesis, caused 
by the increased number of internalized viral components, is suppressed by the 
increased number of viral proteins to be synthesized for the compensation the 
difference between virvmv ,−µ  and prodvmv ,−µ , whereas at low values of the MOI the 
former effect is, in contrast, prevalent over the latter. The observed behavior of the 
virus yield with respect to variations of the rate constant of endosomal virus 
degradation can be explained in the similar way. A moderate increase of the rate 
constant of endosomal virus degradation, resulting in a decrease of the number of 
incoming viral proteins, speeds up vmRNA production, which results in an increase of 
the number of viral proteins produced. At the same time, at a significant increase of 
the considered rate constant a resulting strong decrease of the number of internalized 
viral components is, in contrast, not profitable for vmRNA production and, hence, for 
the virus yield. 
 
Table 4.10 Virus yield for the rate constant of “inactive” virus degradation (kend-degr) changed 
by different factors 
Factor 0.1 0.5 1.0 4.0 5.0 10.0 100.0 
Vrel 7840 7930 8020 8280 8320 8360 7930 
LF A A A A B B B 
LF:  Limiting factor 
A: M1 proteins 
B:  vRNA molecules and M1 proteins 
 
 
4.11.8.2 vmRNA Degradation 
 
An increase of vmRNA degradation rates naturally results in a decrease of virus 
production. The data from simulations performed for the rate constants of nuclear 
(knuc-degr) and cytoplasmic (kcyt-degr) vmRNA degradation changed by different factors 
is summarized in Tables 4.11 and 4.12, respectively. From this data it can be seen that 
variations of the rate constants of nuclear vmRNA degradation have a stronger impact 
on virus production than variations of the rate constants of cytoplasmic vmRNA 
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degradation. Indeed, the decrease of the number of cytoplasmic vmRNA molecules 
can be compensated by the delivery of new vmRNA molecules from the nucleus. 
 
Table 4.11 Virus yield for the rate coefficients of nuclear vmRNA degradation (kvm,i,nuc-degr) 
changed by different factors 
Factor 0.1 0.5 1.0 5.0 10.0 100.0 
Vrel 8580 8320 8020 6180 4780 830 
 
Table 4.12 Virus yield for the rate coefficients of cytoplasmic vmRNA degradation (kvm,i,cyt-degr) 
changed by different factors  
Factor 0.1 0.5 1.0 5.0 10.0 100.0 
Vrel 8200 8120 8020 7280 6500 1930 
 
However, variations of the rate constants of cytoplasmic vmRNA degradation can 
alter virus dynamics. The increase of these rate constants by a factor of 100.0 results 
in the situation when the linear phase of virus growth is within the average life span of 
the cell (Fig. 4.15). Indeed, in the considered situation the number of vmRNA 
molecules approaches a steady state earlier than at 12 h p.i. As this happens, the 
number of newly synthesized viral proteins and, accordingly, the number of progeny 
virions increase linearly in time. 
 
Simulations did not reveal any influence of vmRNA degradation on limiting factors of 
virus replication. 
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Figure 4.15 Virus production at high values of the rate coefficients of cytoplasmic 
vmRNA degradation (kvm,I,cyt-degr). The picture demonstrates all three phases of virus growth, 
including the linear phase, which is within the lifetime of the cell. The linear phase starts at 
about 9 h p.i., when the number of cytoplasmic vmRNA molecules approaches a steady state 
(see inset). 
 
 
4.11.8.3 vRNA and cRNA Degradation 
 
Variations of the rate constants of degradation for full-length vRNA and cRNA 
molecules have no significant effect on the virus yield and do not change limiting 
factors of virus replication. Actually, even in the case when vRNA degradation is 
increased by a factor of 100.0, vRNA molecules remain redundant both for the 
production of progeny virions and for the synthesis of vmRNA molecules by viral 
polymerase complexes.  
 
 
4.11.8.4 Viral Protein Degradation 
 
The model shows that the number of released virions as a function of the rate 
constants of nuclear protein degradation has an extreme. Simulations were performed 
for the rate constants of nuclear protein degradation (polymerase, NP, M1, NS1, NS2) 
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changed by different factors. It is assumed that the rate constant of degradation is the 
same for all viral proteins, and, accordingly, in each trial this rate constant is changed 
by the same factor. The results are summarized in Table 4.13.  
 
Table 4.13 Virus yield for the rate coefficients of nuclear protein degradation (ki,nuc-degr) 
changed by different factors  
Factor 0.1 0.5 0.7 1.0 1.3 1.5 10.0 
Vrel 7590 7930 7990 8020 8020 8010 5580 
LF A A A A B B B 
LF:  Limiting factor 
A: M1 proteins 
B:  vRNA molecules and M1 proteins 
 
It could be supposed that slowing down of protein degradation leads to an increase of 
the virus yield. However, making the values of the rate constants of nuclear protein 
degradation lower than their initial values results in a decrease of the number of 
produced virions. Indeed, as discussed in section 5.7, the number of internalized 
polymerase complexes and, consequently, the rate of their degradation, are much 
lower than those of NP proteins. Additionally, as shown in section 4.10.1, the lower 
the number of the internalized viral components kept in the nucleus, the less newly 
synthesized viral components is required to bring the rate of vmRNA production to its 
maximal value. Thus, a decrease of the rate constants of protein degradation, resulting 
to the increase of the number of internalized viral proteins kept in the nucleus and 
increasing the ratio of the number of internalized polymerase complexes to the 
number of internalized NP proteins, leads to a decrease of the rate of vmRNA 
production (Fig. 4.16). A decrease of vmRNA synthesis rate, in turn, results in a 
decrease of the rate of viral protein production. Limiting factors of virus replication 
do not seem to be sensitive to a decrease of the rate constants of nuclear protein 
degradation; M1 proteins remain limiting throughout the whole replication cycle. 
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Figure 4.16 The rate of vmRNA synthesis for different values of rate coefficients of 
nuclear protein degradation. Presented plots correspond to rate coefficients of nuclear 
protein degradation (knuc-degr) changed by factors of 1.0 (⎯) and 0.1 (---). 
 
Simulations show that a significant increase of the rate constants of nuclear protein 
degradation also leads to a decrease of the number of produced virus particles. Indeed, 
if the rate constants of degradation are high, an essential part of internalized and 
produced proteins is degraded, and further increase of the degradation rate constants 
naturally cannot result in an increase of the virus yield. In the considered situation the 
increase of the ratio of the number of polymerase complexes to the number of NP 
proteins in the nucleus by newly produced viral proteins is not essential for virus 
dynamics; the need for internalized viral components is prevalent over it. Due to a 
low number of NP proteins in the nucleus, at high values of the rate constants of 
nuclear protein degradation vRNA molecules are limiting at the early stages of the 
infection (as discussed in sections 1.6.4 and 2.4, NP proteins promote vRNA 
production). 
 
Thus, it can be concluded that there are optimal (in respect to the virus yield) values 
for the rate constants of viral protein degradation. The maximal value of the virus 
yield is achieved at the values of the rate constants of degradation equal to those used 
for simulations (changed by a factor of 1.0).  
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The number of degraded cytoplasmic proteins, unlike that of nuclear proteins, cannot 
be compensated by the transport of proteins from other cellular compartments. For 
this reason, variations of the rate constants of degradation of cytoplasmic proteins 
have more significant effect on the virus yield than variations of the rate constants of 
nuclear proteins degradations. On the other hand, limiting factors of virus replication 
do not change at speeding up or slowing down the cytoplasmic protein degradation. 
The simulation data concerning the influence of variations of the rate constants of 
cytoplasmic protein degradation on the virus yield is summarized in Table 4.14. As it 
could be expected, the number of released virions represents a monotonously 
decreasing function of the rate constants involved. 
 
Table 4.14 Virus yield for the rate coefficients of cytoplasmic protein degradation (ki,cyt-degr) 
changed by different factors 
Factor 0.1 0.5 1.0 5.0 10.0 
Vrel 8080 8050 8020 7780 7490 
 
Variations of the rate constants of degradation for the proteins bound to the budding 
site and to the membrane of the ER have an infinitesimal influence on the number of 
produced virions. Even in the case when the values of these rate constants are 100.0 
times higher than their initial values, the virus yield practically does not change with 
respect to that at the initial values of the rate constants of degradation. The number of 
envelope proteins produced is so high in comparison with their number required for 
virus production that at significantly increased rate constants of degradation it still 
remains redundant, and the number of released virions is defined by the number of 
newly synthesized M1-vRNP complexes. 
 
 
4.12 Model Reduction  
 
As expected, the dynamics of viral component production provided by the reduced 
model is similar to that provided by the detailed model. For the reduced model it is 
possible to find a set of parameters, at which the functions representing the number of 
assembled virions and the number of viral proteins, as well as limiting factors of virus 
replication, behave similar to the corresponding functions in the detailed model. 
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However, the reduced model, which does not take into account several process steps, 
has some peculiarities. For example, the time course of viral component production 
slightly differs from that in the detailed model. In the following, the dynamics of viral 
components, as well as specific features of the reduced model will be discussed. 
 
 
4.12.1 Dynamics of Viral Component Production  
 
The number of extranuclear virions in the reduced model, similar to the number of 
extracellular virions in the detailed model decreases exponentially in time (Fig. 4.17). 
However, since extranuclear virions, unlike extracellular virions are delivered directly 
into the nucleus, the time course of internalization is different in the two models 
considered. The total number of vmRNA molecules (Fig. 4.18), the number of vRNA 
and cRNA molecules (Fig. 4.19), and the number of viral proteins in the nucleus (Fig. 
4.21) increase in the same way in the reduced model and in the detailed model. The 
finite rate of vmRNA nuclear export, as it does in the detailed model, defines the 
difference between the time courses of vmRNA and viral protein production.  
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Figure 4.17 Virus internalization. Like the number of extracellular virions from the detailed 
model, the number of extranuclear virions from the reduced model exponentially decreases in 
time. 
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Figure 4.18 The total number of vmRNA molecules (in the nucleus and in the 
cytoplasm) from the detailed model (⎯) and the reduced model (---). 
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Figure 4.19 The number of vRNA molecules in the nucleus from the detailed model (⎯) 
and the reduced model (---). 
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Figure 4.20 The number of M1 proteins in the nucleus from the detailed model (⎯) and 
the reduced model (---). 
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Figure 4.21 The number of polymerase complexes in the nucleus from the detailed 
model (⎯) and the reduced model (---). 
 
The number of assembled virions in the reduced model behaves similar to the number 
of released virions in the detailed model (Fig. 4.22). As in the reduced model newly 
produced viral proteins are immediately packaged to progeny virions, there is no lag 
between the beginning of viral protein production and the beginning of virus 
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assembly. Accordingly, the time course of virus assembly in the reduced model 
slightly differs from the time course of virus release in the detailed model. 
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Figure 4.22 The number of released virions from the detailed model (⎯) and the 
number of assembled virions from the reduced model (---). 
 
 
4.12.2 Limiting Factors 
 
Like the detailed model, the reduced model reveals factors limiting virus replication. 
As viral proteins are packaged to form M1-vRNP complexes, M1 proteins are 
completely consumed (Fig. 4.20), whereas redundant amounts of polymerase 
complexes and NP proteins accumulate in the cell  (Fig. 4.21). 
 
The increase of the switch parameter  from  (its initial value) to  (the delay 
of the switch) in the reduced model, as well as that in the detailed model, results in the 
situation when M1 proteins become a bottleneck of virus production only at the late 
stages of the infection, whereas vRNA molecules are limiting at the early stages of the 
infection. 
NPb
610 710
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4.12.3 Variations of Model Parameters and Initial  
           Conditions  
 
As shown in section 4.11.2, the dependency of the number of released virions on the 
rate coefficients of internalization in the detailed model can be subdivided into three 
phases (initial increase, decrease, and late increase). Table 4.15 indicates that for the 
reduced model the situation is not the same. For the rate coefficient of internalization 
( ) changed by factors from 0.5 to 1.5 the number of assembled virions ( ) is 
a decreasing function of , and for higher values of  it increases with an 
increase of . However, the phase of the initial increase is not achievable at 
moderate variations of . As pointed out in section 4.11.4, an increase of the values 
of transport rate coefficients in the detailed model results in the expansion of the 
interval of the decrease. And since in the reduced model all the rate coefficients of 
transport (except the rate coefficient of vmRNA nuclear export) are omitted or, in 
other words, assumed to be infinite, it is not surprising that the phase of the decrease 
is wider than it is in the detailed model.  
splk redrelV ,
splk splk
splk
splk
 
Table 4.15 The number of assembled virions for the rate coefficients of vRNP splitting (kspl) 
changed by different factors in the reduced model 
Factor 0.5 0.7 1.0 1.5 2.0 
Vrel 8170 8030 7920 7880 7900 
 
Like in the detailed model, variations of the rate coefficient of transport ( ) in 
the reduced model have a significant influence on the virus yield (the simulation data 
are presented in Table 4.16); an increase of  leads to an increase of the 
number of assembled virions. Simulations performed at high values of  
provide the same value of the minimal delay of virus production as reported in section 
4.11.3 (1.7 h p.i.). 
cytnucvmk −,
cytnucvmk −,
cytnucvmk −,
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Table 4.16 The number of assembled virions for the rate coefficient of vmRNA nuclear export 
(kvm,nuc-cyt) changed by different factors in the reduced model 
Factor 0.5 0.7 1.0 1.5 2.0 
Vrel 4320 5890 7920 10600 12610 
 
Variations of viral polymerase speed and the translation efficiency for viral proteins in 
the reduced model bring to the same results as those in the detailed model. The two 
parameters involved have the most significant effect on the number of virions 
assembled.  
 
In section 4.11.6 it is shown that in the detailed model the virus yield is not 
significantly influenced by variations of the rate constants of viral component 
assembly  and . Similarly, in the reduced model the number of produced 
virions is not sensitive to variations of the assembly rate constants  (as done 
before, indexes “C
unk budk
pckk
v”, “Pi”, and “Vrel” will be omitted, and all the rate coefficients 
involved will be designated by one symbol). In fact, virus production is limited by M1 
protein production, and, hence, an increase of the assembly rate constants cannot 
result in an increase of the rate of virus release. The rate constants  define only 
the value of the initial increase of the number of M1 proteins. 
pckk
 
The impact of variations of the rate constants of the nucleic acid degradation on the 
virus yield in the reduced model is similar to that in the detailed model. Namely, the 
number of produced virions represents a monotonously decreasing function of the rate 
constants of cytoplasmic and nuclear vmRNA degradation and does not significantly 
change when the rate constants of vRNA and cRNA degradation are varied. The same 
refers to variations of the rate constants of protein degradation. It can be seen from 
Table 4.17 that the number of virions assembled, as a function of the rate constants of 
protein degradation, has a maximum, which corresponds to a factor of about 3.0. 
 
Table 4.17 The number of assembled virions for the rate coefficients of protein degradation 
(ki,degr) changed by different factors in the reduced model 
Factor 0.1 1.0 2.0 3.0 4.0 5.0 7.0 
Vrel 7030 7920 8090 8100 8060 7950 7590 
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An increase of the values of the switch parameters  and  in the reduced model, 
similar to that in the detailed model (see section 4.11.1), results in a decrease of the 
virus yield.  
NPa NPb
 
The dependency of the virus yield on the MOI represents a monotonously decreasing 
function (Table 4.18). In contrast to the situation, taking place in the detailed model 
the optimal value of the MOI is less than 1, i.e., beyond the range of relevant values. 
The difference in the abscissas of the optimum can be explained by the assumption of 
the reduced model that the incoming virions are delivered directly to the nucleus, 
which implies earlier in comparison with the detailed model start of viral component 
production. Consequently, in respect to the vicinity to the optimum, the certain value 
of the MOI in the detailed model corresponds to the lower value of the MOI in the 
reduced model. 
 
Table 4.18 The number of assembled virions for different values of the MOI (virions/cell) in 
the reduced model 
MOI 1.0 2.0 10.0 100.0 
Vrel 8850 8750 7920 5760 
 
 
4.13 Reinfection 
 
Simulations based on the formulated in section 2.10 model with reinfection were 
performed for the values of the MOI changing in the range from 1 virion/cell to 100 
virions/cell. At the given set of model parameters the difference between the 
simulation data obtained based on the models with reinfection and without reinfection 
is not significant. For this reason, to investigate the influence of the reinfection on 
virus dynamics the “amplified” reinfection was considered; the value of factor Pinf in 
(2.1.1”) were put equal to 1.0 (which corresponds to the assumption that all the 
released virions are infectious). Simulation results are summarized in Table 4.19. 
Comparing these results with those obtained in the model without reinfection (see 
section 4.10, Table 4.1), it can be concluded that at the fixed value of the MOI the 
total number of produced virions is slightly higher when newly produced virions do 
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not infect the cell again. Indeed, in the case of the reinfection incoming virions deliver 
into the nucleus an additional portion of polymerase complexes and NP proteins, and, 
as shown in section 4.10.1, the ratio of the numbers of delivered viral components is 
lower than the ratio of the numbers of viral components produced in the cell. As a 
result, vmRNA synthesis, and, consequently, viral protein production is inhibited. The 
negative effect of incoming virus particles on the virus yield will be also referred to in 
section 4.14 below. 
 
Table 4.19 Virus yield for different values of the MOI (virions/cell) in the model with reinfection 
MOI 1.0 2.0 3.0 4.0 5.0 10.0 100.0 
Vrel 7930 8050 8080 8070 8030 7800 6000 
 
On the other hand, the qualitative dependency of the number of released virions on 
the MOI in the model with reinfection is similar to that in the model without 
reinfection (Tables 4.19 and 4.1). Particularly, the virus yield as a function of the MOI 
also reaches the maximum at the value of the MOI equal to about 3 virions/cell. 
 
 
4.14 Continuous Infection. Optimal Strategy of  
        Infection 
 
To apply the model formulated in section 2.11 for the investigation of the impact of 
the continuous infection on the virus yield, simulations were performed for different 
values of the MOI and the rate coefficient of virus supply ( ). Particularly, the 
case of the MOI=0 virions/cell (when only supplied virions infect the cell) was 
investigated. As at the values of the MOI more than 3 virions/cell the number of 
released virions represents a decreasing function of the MOI (see section 4.10), it can 
be easily shown that at these values of the MOI the virus yield represents a decreasing 
function of . Indeed, if an increase of the number of internalizing virions leads to 
a decrease of the number of released virions, the rate of vmRNA production is defined 
by the ratio of the number of newly synthesized viral polymerases to the number of 
newly synthesized NP proteins. Internalization of additional viral components will 
feedk
feedk
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result in a decrease of this ratio, and, hence, in a decrease in the rate of vmRNA 
production and the virus yield. Consequently, at the values of the MOI more than 3 
virions/cell any increase of the virus yield due to virus supply during the infection 
cycle cannot be expected. 
 
Simulation results are summarized in Table 4.20. The data for the values of the MOI 
higher than 3 virions/cell confirms the conclusion made above that in this range the 
virus yield decreases with an increase of . On the other hand, it can be seen that 
even at sufficiently low values of the MOI (e.g., 1 virion/cell) virus supply is not 
favorable for virus production; the maximal virus yield is achieved at the value of the 
rate coefficient of virus supply equal to zero. At the MOI=0 virions/cell the value of 
the rate coefficient of virus supply corresponding to the maximal number of produced 
virions, naturally, differs from zero (it is equal to about 3 virions/h). However, the 
maximal virus yield at the continuous infection at the MOI=0 virions/cell is lower 
than the virus yield at the MOI=3 virions/cell (the optimal value of the MOI). 
feedk
 
Table 4.20 Virus yield for different values of the rate of virus supply (kfeed, virions/(nL ⋅ h)) 
and the MOI (virions/cell) in the model for continuous infection 
 kfeed =0.0 kfeed =1.0 kfeed =2.0 kfeed =3.0 kfeed =4.0 kfeed =5.0 
MOI=0.0 0 7510 7640 7680 7660 7620 
MOI=1.0 8140 8100 8050 8000 7920 7840 
MOI=3.0 8300 8230 8150 8070 7980 7900 
MOI=5.0 8260 8170 8090 8010 7940 7870 
 
Therefore, a continuous infection does not result in an increase of the number of 
released virions. Consequently, the optimal way of the infection in respect to the 
maximization of the virus yield seems to be the infection of the cell at the initial time 
point without further supply of virions. 
 
The conclusion made here, can be also confirmed from the theoretical point of view. 
At the late stages of the infection it is the ratio of the numbers of newly synthesized 
viral proteins that defines the rate of vmRNA synthesis ( prodvmv ,−µ , defined in section 
4.10.1). Consequently, if the certain number of virions, in which the ratio of the 
numbers of viral components corresponds to the lower value of the rate of vmRNA 
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synthesis ( virvmv ,−µ ), internalizes relatively late after the initial infection, vmRNA 
synthesis, and, accordingly, viral proteins production and progeny virus release will 
slow down. An increase of the viral yield at the early stages of the infection with an 
increase of  at the MOI=0 virions/cell is explained by the need of viral 
components for the initiation of the process of virus replication.  
feedk
 
 
4.15 Population Modeling 
 
As pointed out in section 2.12, the main state variables of the population model are 
the numbers of uninfected, infected, and dead cells ( , , and , respectively) 
and the total number of released virions ( ). Experimental obervations and 
simulations performed at the time interval 0 – 90 h p.i. (a typical duration of virus 
replication stage in the considered fermentation experiments is 60-70 h, Genzel et al., 
2004) allowed revealing major features of the dynamics of the populations involved 
(see section 4.15.1). For simulations and the following discussion, the rate 
coefficients of the degradation of extracellular virions and apoptosis of uninfected 
cells were put equal to zero. The values of the other model parameters, as well as the 
initial conditions, are reported in section 3. 
unZ inZ dZ
relV
 
 
4.15.1 Dynamics of Cell and Virus Populations 
 
The number of uninfected cells is, evidently, a decreasing function of time (Fig. 4.23). 
It decreases first due to a primary infection11 (0 – 4 h p.i.) and further due to a 
secondary infection (4 – 90 h p.i.). At about 20 h p.i. practically no uninfected cells 
remain in the system.  
 
                                                 
11 The term primary infection indicates the infection by parental viruses (virus seeds, added to the 
culture at the time of infection). It differs from the term initial infection, which commonly referrers to 
the infection of all uninfected cells (Hu and Bentley, 2000). 
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The number of infected cells (Fig. 4.23) first increases due to the primary infection (0 
– 2 h p.i.). At the time interval between the end of the internalization of parental 
virions and the beginning of the secondary infection (2 – 8 h p.i.) the number of 
infected cells decreases due to cell death. A further increase (8 – 20 h p.i.) results 
from the secondary infection. Finally, as all the cells are infected the number of 
infected cells is again brought down by cell death (20 – 90 h p.i.). Such a time course 
of the infection is mainly defined by the rate coefficient of infection ( ) and the 
rate coefficient of cell death due to virus-induced apoptosis ( ). It corresponds to 
experimental observations, particularly to the data from the fluorescence experiments 
(Genzel et al., 2004; Moehler et al., in press). As expected for low MOI values, the 
peak corresponding to the secondary infection is higher than that corresponding to the 
primary infection.  
inunk −
inapk ,
 
It is clear, that the number of dead cells equals to the difference between the total 
number of cell in the system and the number of living cells (infected and uninfected 
cells) monotonously increases in time (Fig. 4.23). Because of the big difference 
between the number of cells and virions involved in the secondary infection and in the 
primary infection, the increase corresponding to the secondary infection is much 
sharper than that corresponding to the primary infection. As pointed out in section 2, 
more than 90% of cells die within 48 h p.i. (Y. Genzel, personal communication, see 
Appendix A5).  
 
The number of released virions in the population model, unlike that in the single cell 
model, is not a monotonously increasing function of time (Fig. 4.24). At about 72 h 
p.i., when the last cells die, the number of released virions start decreasing due to their 
degradation. Thus, the time point 72 h p.i., at which the virus yield reaches its 
maximal value, is the optimal time point for virus harvesting. The maximal number of 
released virions is in good agreement with experimental observations (HA test; H. 
Sann, personal communication, not shown). 
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Figure 4.23 Dynamics of cell populations. The number of infected (Zin, ⎯), uninfected (Zun, 
---), and dead (Zd, -⋅-) cells related to the total number of cells in the system. Images (H. 
Sann) show that, for example, at 6 h p.i. only a low number of cells produce virions 
(fluorescent cells), whereas at 22 h p.i all cells in the system are infected; they fast die due to 
virus induced apoptosis and separate from microcarriers. 
 
 
4.15.1.1 Estimation of the Average Lifetime of a Cell 
 
The dynamics of the population of dead cells obtained based on the population model 
allows estimating the average lifetime of a cell. The average lifetime of a cell, clearly, 
decreases with an increase of the MOI. Applying the method reported in Appendix 
A3, it can be calculated that at the considered MOI (MOI=0.1 virions/cell) the 
average cell of the population survives after infection about 22 h. Furthermore, the 
average lifetime of an infected cell can be also estimated from the population model. 
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For a high value of the MOI (MOI=10.0 virions/cell), which implies that all the cells 
of the population are immediately infected, the method indicates that the average 
lifetime of a cell is approximately 10 h. As expected (see equation (2.12.2)), further 
increase of the MOI (taking, for example, MOI=100.0 virions/cell) has no impact on 
this estimate. 
 
 
4.15.2 Influence of MOI Changes on Population  
           Dynamics 
 
The population model, unlike the single cell model, allows considering values of the 
MOI less than 1 virion/cell (particularly, the initial value of the MOI was taken equal 
to 0.1 virions/cell, see section 3). While the single cell model reveals the optimal 
value of the MOI in respect to the virus yield (even in the case when the reinfection is 
taken into account), simulations based on the population model show that the number 
of virions produced at the late stages of the process monotonously decreases with an 
increase of the MOI (Fig. 4.24).  
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Figure 4.24 The number of released virions (Vrel) for different values of the MOI. The 
MOI is taken equal to 0.01 (---, maximum: 12100 virions/cell), 0.1 (⎯, maximum: 9600 
virions/cell), and 1.0 (-⋅-, maximum: 5400 virions/cell). 
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To explain this dependency, consider two possible scenarios of infection. Suppose 
first that the MOI is so high that most of the cells in the system are infected during the 
primary infection. Then the number of virions produced during the secondary 
infection can be neglected, and only one replication cycle remains. As follows from 
results obtained for the single cell model for high values of the MOI, a decrease of the 
MOI value corresponds to an increase of the number of produced virions. Assume 
now that after infection at low MOI the major part of the cells remains uninfected. It 
means that at the late stages of the process the virus yield is defined by the number of 
virions produced during the secondary infection. In the considered case lower values 
of the MOI correspond to lower numbers of primarily infected cells (Fig. 4.25) and, 
hence, to lower numbers of virions produced by the end of the primary infection (Fig. 
4.24). Assuming that virus particles produced during the primary infection infect all 
the remaining uninfected cells (which is, particularly, the case for the given set of 
model parameters), the situation for the secondary infection will resemble the 
situation the previous case deals with.  
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Figure 4.25 The number of infected cells (Zin) related to the total number of cells in the 
system (Z0) for different values of the MOI. The MOI is taken equal to 0.01 (---), 0.1 (⎯), 
and 1.0 (-⋅-). 
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At low MOI, however, there is also another reason, which causes the decrease of the 
virus yield with the increase of the MOI. This reason is a consequence of the model 
structure, i.e., the assumption that viral components are produced by a mass of 
average cells. As the synthesis of viral components in the average cell starts 
immediately after infection, the number of virions produced by secondarily infected 
cells is overestimated. Consequently, these results must be treated cautiously. 
 
Nevertheless, whatever the primary or the secondary infection provides the number of 
virions making up the major part of the total number of released virions, the virus 
yield represents a monotonously decreasing function of the MOI. Accordingly, in the 
cases when the contributions of both considered stages of the infection are 
comparable, it will also decrease with a decrease of the MOI. 
 
At the early stages of the process higher values of the MOI, in contrast, correspond to 
higher values of the virus yield. Indeed, an increase of the initial number of virions in 
the extracellular medium results in an increase of the initial rate of infection (the term 
 in (2.1.1exVsex Vk ex,−
**)). Thus, it can be concluded that any two plots of the function 
Vrel(t) corresponding to different values of the MOI always have a point of 
intersection (Fig. 4.24). For example, those corresponding to values of the MOI equal 
to 0.1 virions/cell and 1.0 virions/cell intersect at approximately 23 h p.i.  
 
Based on experimental observations (roller bottle experiments) (Y. Genzel, personal 
communication, see Appendix A5), it was determined that the dynamics of virus 
release at the early stages of the process depended on the MOI in the same way, as it 
did according to simulation results. Although no effect of the MOI variations on the 
maximal number of released virions was revealed by the considered experiments, a 
series of studies confirmed the model outcome that the maximal number of released 
virions decreases with an increase of the MOI (see section 5.1). 
 
The data concerning the influence of MOI variations on the number of uninfected, 
infected, and dead cells are shown on Figures 4.27, 4.25, and 4.26, respectively. At 
higher values of the MOI the infection and death of the cells occur faster than it does 
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at lower values of the MOI. However, as discussed above, the maximal number of 
infected cells at higher MOI values is lower than that at lower MOI values. 
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Figure 4.26 The number of dead cells (Zd) related to the total number of cells in the 
system (Z0) for different values of the MOI. The MOI is taken equal to 0.01 (---), 0.1 (⎯), 
and 1.0 (-⋅-). 
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Figure 4.27 The number of uninfected cells (Zun) related to the total number of cells in 
the system (Z0) for different values of the MOI. The MOI is taken equal to 0.01 (---), 0.1 
(⎯), and 1.0 (-⋅-). 
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4.15.3 Influence of Parameter Changes on Population  
           Dynamics 
 
The influence of changes of different model parameters on the number of virions 
produced by a single cell within 12 h was investigated in detail in section 4.11. Now it 
will be shown how variations of the ability of a single cell to produce virions 
influence the dynamics of the populations involved (released virions and uninfected, 
infected, and dead cells). For this purpose, consider the behavior of population sizes 
for different values of one of model parameters, variations of which have a significant 
influence on the function describing the number of virions released from a single cell. 
Such a parameter is, for example, the rate of polymerase operation ( ). Among all 
model parameters it has the strongest influence on the virus yield in the single cell 
model (see section 4.11.5); particularly, its twofold increase results in approximately 
twofold increase of the virus yield (Fig. 4.14). 
Plk
 
Simulations based on the population model show that the number of virions produced 
in the system increases with an increase of the number of virions produced by a single 
cell (i.e., with an increase of ) (Fig. 4.28). However, the extent, in which variations 
of  influence the virus yield in the population model, is lower than it is in the 
single cell model; instead of about twofold increase of the number of produced virions 
in the single cell model, in the population model the twofold increase of  results in 
the increase of the virus yield by a factor of approximately 1.6. Indeed, in the 
population model the process of virus production is accompanied by cell death, which 
brings the virus yield down. 
Plk
Plk
Plk
 
An increase of the number of virions produced in the system at the given time point, 
in turn, leads to an increase of the rate of infection (the term  in (2.12.1)) 
and, correspondingly, to an increase of the rate of cell death (the term  in 
(2.12.2)). Thus, at higher numbers of virions produced by a single cell, the decrease of 
the number of uninfected cells (Fig. 4.29) and, correspondingly, the increase of the 
unsinun ZVk −
ininap Zk ,
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number of dead cells (Fig. 4.30) occur faster than those at lower numbers of virions 
produced by a single cell. The number of infected cells in the former case changes 
faster and have higher maximal values than in the latter case (Fig. 4.31). 
 
The population model contains two parameters that are absent in the single cell 
model. These parameters are the rate coefficient of infection ( ) and the rate 
coefficient of the death of infected cells due to virus-induced apoptosis ( ). 
Evidently, an increase of the later rate coefficient reduces the size of the population of 
infected cells and, hence, causes a decrease of the virus yield (Fig. 4.32, 4.33). To 
demonstrate this tendency, the rate coefficient was changed by the factors 1.0, 1.5, 
and 2.0.  It is also clear that under these circumstances the number of uninfected cells 
decreases more slowly than it does at the initial value of  (Fig. 4.34). An increase 
of the rate coefficient of infection, in contrast, leads to a faster decrease of the number 
of uninfected cells (Fig. 4.35). Additionally, it results in an increase of the number of 
primarily infected cells  (Fig. 4.36) and, hence (see section 4.15.2), to a decrease of 
the number of produced virions (Fig. 4.37). It is also clear that at the early stages of 
the process higher numbers of released virions correspond to higher values of  
(Fig. 4.37). 
inunk −
inapk ,
inapk ,
inunk −
 
The remaining parameters included in the population model are the rate coefficients 
of the apoptosis of uninfected cells ( ) and the rate constant of the detachment of 
uninfected cells from microcarriers ( ). The values of these parameters are not 
assumed to be high enough to have an essential influence on virus dynamics, and their 
default values were put equal to zero (it particularly implies that the only reason for 
cell death is virus infection, see equation (2.12.1)). An increase of  clearly 
results in a decrease of the number of uninfected and infected cells and, hence, to a 
decrease of the virus yield (to demonstrate this tendency, the behavior of the system 
for  equal to 0.0 h
unapk ,
dtk
unapk ,
unapk ,
-1, 0.1 h-1, and 0.2 h-1 was considered, Fig. 4.38, 4.39, 4.40). 
Similar changes in the system behavior also take place at the increase of . dtk
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Figure 4.28 The number of released virions (Vrel) for different values of viral polymerase 
speed. Polymerase speed (kPl) is increased by factors of 1.0 (⎯, maximum: 9600 
virions/cell), 1.5 (-⋅-, maximum: 12800 virions/cell) and 2.0 (---, maximum: 15900 virions/cell). 
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Figure 4.29 The number of uninfected cells (Zun) related to the total number of cells in 
the system (Z0) for different values of viral polymerase speed. Polymerase speed (kPl) is 
increased by factors of 1.0 (⎯), 1.5 (-⋅-) and 2.0 (---). 
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Figure 4.30 The number of dead cells (Zd) related to the total number of cells in the 
system (Z0) for different values of viral polymerase speed. Polymerase speed (kPl) is 
increased by factors of 1.0 (⎯), 1.5 (-⋅-) and 2.0 (---). 
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Figure 4.31 The number of infected cells (Zin) related to the total number of cells in the 
system (Z0) for different values of viral polymerase speed. Polymerase speed (kPl) is 
increased by factors of 1.0 (⎯), 1.5 (-⋅-) and 2.0 (---). 
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Figure 4.32 The number of released virions (Vrel) for different values of the rate 
coefficient of apoptosis of infected cells. The rate coefficient of apoptosis of infected cells 
(kap,in) is changed by factors of 1.0 (⎯, maximum: 9600 virions/cell), 1.5 (-⋅-, maximum: 5000 
virions/cell) and 2.0 (---, maximum: 3400 virions/cell). 
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Figure 4.33 The number of infected cells (Zin) related to the total number of cells in the 
system (Z0) for different values of the rate coefficient of apoptosis of infected cells. The 
rate coefficient of apoptosis of infected cells (kap,in) is changed by factors of 1.0 (⎯), 1.5 (-⋅-) 
and 2.0 (---). 
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Figure 4.34 The number of uninfected cells (Zun) related to the total number of cells in 
the system (Z0) for different values of the rate coefficient of apoptosis of infected cells. 
The rate coefficient of apoptosis of infected cells (kap,in) is changed by factors of 1.0 (⎯), 1.5 
(-⋅-) and 2.0 (---). 
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Figure 4.35 The number of uninfected cells (Zun) related to the total number of cells in 
the system (Z0) for different values of the rate coefficient of infection. The rate 
coefficient of infection (kun-,in) is changed by factors of 1.0 (⎯), 1.5 (-⋅-) and 2.0 (---). 
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Figure 4.36 The number of infected cells (Zin) related to the total number of cells in the 
system (Z0) for different values of the rate coefficient of infection. The rate coefficient of 
infection (kun-,in) is changed by factors of 1.0 (⎯), 1.5 (-⋅-) and 2.0 (---). 
 
0 10 20 30 40 50 60 70 80 90
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
Time [h]
Vi
rio
ns
 re
le
as
ed
 [1
/nL
]
 
Figure 4.37 The number of released virions (Vrel) for different values of the rate 
coefficient of infection. The rate coefficient of infection (kun-,in) is changed by factors of 1.0 
(⎯, maximum: 9600 virions/cell), 1.5 (-⋅-, maximum: 8100 virions/cell) and 2.0 (---, maximum: 
7200 virions/cell). 
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Figure 4.38 The number of released virions (Vrel) for different values of the rate 
coefficient of apoptosis of uninfected cells. The rate coefficient of apoptosis of uninfected 
cells ( ) is taken equal to 0.0 hunapk ,
-1 (⎯, maximum: 9600 virions/cell), 0.1 h-1 (-⋅-, maximum: 
8400 virions/cell), and 0.2 h-1 (---, maximum: 7400 virions/cell). 
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Figure 4.39 The number of infected cells (Zin) related to the total number of cells in the 
system (Z0) for different values of the rate coefficient of apoptosis of uninfected cells. 
The rate coefficient of apoptosis of uninfected cells ( ) is taken equal to 0.0 hunapk ,
-1 (⎯), 0.1 
h-1 (-⋅-), and 0.2 h-1 (---). 
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Figure 4.40 The number of uninfected cells (Zun) related to the total number of cells in 
the system (Z0) for different values of the rate coefficient of apoptosis of uninfected 
cells. The rate coefficient of apoptosis of uninfected cells ( ) is taken equal to 0.0 hunapk ,
-1 
(⎯), 0.1 h-1 (-⋅-), and 0.2 h-1 (---). 
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5 Discussion 
 
Developed in the present study was a structured model for the reproductive cycle of 
Influenza A virus in mammalian cells. The single cell model, as well as its possible 
modifications taking into account the reinfection, the continuous infection, and the 
dynamics of cell populations (uninfected, infected, and dead cells), were investigated. 
Unlike most of the existing models of virus infection, which take into account only 
certain steps of the replication cycle, the present model considers all the steps of the 
process, form virus entry into the host cell to progeny virus release. 
 
As pointed out in section 1.1.2, when a very small number of virions infect a 
population of host cells, it is possible to describe the events of the replication cycle by 
stochastic approaches (Schreiber et al., 2001; Srivastava et al., 2002). However, in the 
present model stochastic events are not taken into account. Instead, a single cell, 
which is infected at least by one virion, is considered. As a consequence, virus 
attachment and entry are described by differential equations, the structure of these 
equations being similar to that of the equations used to describe other intracellular 
processes. 
 
In the present section it will be discussed how the results of simulations correlate with 
the results provided by other models. Further, the importance of the reinfection for the 
adequate description of virus dynamics will be considered. Sections 5.3 – 5.11 will 
mainly discuss the detailed single cell model itself. It will be shown, how many 
virions the cell would be able to produce if it did not die due to apoptosis. 
Furthermore, different possible mechanisms of transcription, replication, and 
packaging of the viral genome will be presented; it will be discussed, which of them 
the most relevant for the considered biological system and the most appropriate for 
the modeling are. The influence of NP proteins on virus replication dynamics will be 
investigated. Besides that, addressed again will be limiting factors of virus replication; 
the relative demands of newly produced viral components for the production of 
progeny virions will be discussed. Possible changes of the law of virus growth and 
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several modifications that could be introduced into the model will be also considered 
here. Further subsections will be concerned with methods to improve the virus yield, 
as well as with some ideas for the optimization of vaccine production processes and 
possible targets for antiviral therapies. After that, the particularities of the population 
model and the reduced model will be addressed. Finally, the end of the section will be 
devoted to the discussion of virus-induced apoptosis, the most likely reason for the 
early cell death and with the identification of directions for the further experimental 
work. 
 
 
5.1 Agreement with Other Models 
 
The overall dynamics obtained based on the present model agrees well with results 
obtained by other models. For example, similar results for the dynamics of genome 
transcription, viral protein production and progeny virus release were obtained from a 
structured model of HIV-1 infection (Reddy and Yin, 1999). In particular, polynomial 
increase of the number of released virus particles is reported. However, as the right-
hand sides of the equations describing the number of viral proteins in the membrane 
do not contain any terms responsible for the assembly of progeny virions (the authors 
consider the total number of newly produced viral proteins), no limiting components 
were identified during virus assembly. 
 
Unlike the model of Reddy and Yin (1999), which assumes that the virus was already 
internalized into its host cell (and, thus, does not provide data concerning the initial 
stages of the infection), a model of Dee and Schuler (1997) focuses on the dynamics 
of virus entry. The structure of equations underlying this model is similar to the 
structure of the first equations of the detailed single cell model presented here. 
Particularly, extracellular, surface, endosomal, and cytoplasmic virions are considered 
individually. Moreover, baculovirus particles, like influenza virus particles, are 
partially inactive and degraded in endosomes; therefore a term describing the 
endosomal sorting of virus particles is taken into account in the model equations. 
Thus, it is not surprising that the behavior of the functions expressing the number of 
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extracellular and internalized virus particles resembles that of the corresponding 
functions in the detailed single cell model. In addition, the process of infection has a 
similar time scale. Simulation results are also comparable with those obtained for a 
model of Semliki Forest virus internalization (Dee at al., 1995). However, the time 
scale of Semliki Forest virus trafficking is clearly different from that of influenza 
virus and baculovirus replication.  
 
Qualitative data for the replication of bacteriophage T7 in Escherichia coli provided 
by Endy et al. (1997) shows similar results for the number of progeny phages when 
compared to simulations based on the present model; an initial exponential stage is 
followed by a polynomial increase of the number of released virions. At the same 
time, unlike simulation results obtained at the given set of model parameters, in the 
model of Endy et al. (1997) cellular concentrations of vmRNA molecules and viral 
proteins achieve steady state within simulation time. 
 
The dynamics of cell populations obtained from the modification of the present model 
(the population model, see section 2.12) is also comparable with the results obtained 
from other models. For example, the qualitative behavior and the time scale of the 
function describing the number of dead cells in the present population model 
resembles that of the function describing the number of infected cells in the model of 
Hu and Bentley (1999) for baculovirus infection (this model does not account for cell 
death, considering a population of dead cells as a part of the population of infected 
cells). According to both approaches, the infection of uninfected cells and, 
correspondingly, cell death occur faster at higher MOI. Besides that, the number of 
uninfected cells decreases obeying similar laws; both models show a faster decrease at 
higher MOI. The dynamics of virus entry and release presented by Hu and Bentley 
(1999) and that provided by the population model presented here are also comparable, 
however, as the present model takes into account virus degradation, simulations 
reveal a decrease of the number of released virions at the late stages of the process. 
According to simulations based on the model of Hu and Bentley (1999), the overall 
virus yield increases with a decrease of the MOI. Moreover, the maximal number of 
produced virions is achieved earlier at higher MOI, i.e., a decrease of the MOI is 
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profitable for virus production only at the late stages of the process. Both conclusions 
closely agree with the results obtained from the present model (see section 4.15.2).  
 
Another study that investigates the optimal conditions for virus production, in 
particular the MOI (Likari and Bailey, 1992) also shows a dependency of the virus 
yield on the MOI similar to that obtained from the present model. The dependency of 
the number of released virions on the MOI agrees well with the data presented in the 
article when the MOI changes in the range from 0.1 virions/cell to 100 virion/cell. 
However, for a low MOI (less than 0.1 virions/cell) the authors report that the virus 
yield represents an increasing function of the MOI. Furthermore, the qualitative 
behavior of the number of uninfected and infected cells, obtained from the population 
model presented here, is in agreement with the population dynamics reported by Jang 
et al. (2000). This article also reveals dependencies of the number of viable cells and 
the number of produced virions on the MOI, which resemble those obtained in the 
present model. 
 
 
5.2 Importance of a Reinfection  
 
Hu and Bentley (1999) pointed out that a reinfection had an influence on the virus 
concentration and the probability of infection; therefore they incorporated it into a 
stochastic model. The authors show that a reinfection is particularly important for low 
values of the MOI. 
 
For a population model formulated in section 2.12 the terms describing the reinfection 
( bud
in
Vrelbud VZ
ZPk
rel
0
inf,−  in (2.1.1
**) and the corresponding term in (2.8.2**)) is also 
crucial. The reinfection affects the dynamics of cell populations, as well as the 
number of produced virions. Similar to that in the model of Hu and Bentley (1999), 
the effect of a reinfection on system behavior is stronger for lower MOI. Indeed, for a 
high MOI (more than 1 virion/cell) most of the cells are infected by the primary 
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infection, and the number of virions produced during a secondary infection is 
negligible. 
 
On the other hand, as follows from the results presented in section 4.13 for the single 
cell model, a reinfection does not play an important role for the virus dynamics. 
Indeed, the values of the virus yield provided by single cell models with reinfection 
(Table 4.19) and without reinfection (Table 4.1) do not differ significantly. Besides 
that, the factors limiting virus production, as well as the dependency of the number of 
produced virions on the MOI, are the same for both models. 
 
 
5.3 Maximal Number of Produced Virions  
 
The single cell model considers a small number of virions infecting the cell (10 
virions/cell) and an average lifetime of infected cells of about 12 hours. As discussed 
in section 4.8, under the initial conditions considered, the initial cellular pools of 
nucleotides and amino acids are much bigger than the virus requires for its replication. 
However, if the cell is infected with significantly higher number of virions or if the 
cell survives longer, cellular resources such as cellular precursor mRNA molecules, 
free nucleotides and amino acids would be exhausted during virus replication.  
 
Suppose that the lifetime of the cell is not limited by T=12h; the cell does not undergo 
the apoptosis and survives and produces virions until one of its resources is exhausted. 
Simulation results show that the most critical resource is the number of free amino 
acids (  amino acids, see section 2.3). As mentioned in section 2.5, the 
cellular pool of free amino acids would allow the production of about 1.3⋅10
10101.3 ⋅=cellP
4 virions 
(Fig. 5.1), which is in the range of yields typically obtained for equine influenza A 
virus replication in MDCK cells from large-scale microcarrier cultures (6500 to 
13000 virions per cell, data not shown).  
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Figure 5.1 The number of released virions (Vrel) for the expanded lifetime of the cell. 
Inset: the number of free cellular amino acids incorporated into progeny virions. 
 
Simulations provide an indication of the lower limit of the lifetime of the cell and the 
capacity of the cell to produce virions. Assuming that the cell does not die until the 
exhaustion of one of its resource, and it does not synthesize or take up amino acids, it 
would survive at least Tmax=15 h (Fig. 5.1). A more realistic scenario and an 
estimation of the upper limits for the quantities involved would require the extension 
of the existing model to include aspects of cell death, as well as other relevant parts of 
cellular metabolism. In the latter case, Monod-type kinetics rather than constant rate 
coefficients would be required for the description of the corresponding steps of the 
infection cycle. For example, the rate coefficient  (see equation (2.3.1)) would 
not only depend on the nuclear concentration of NP proteins ( ) but also on the 
number of cellular precursor mRNA molecules ( ) and on the number of free 
cellular nucleotides ( ). Additionally, it must be taken into account that according 
to experimental observations, an increase of amino acid concentrations in the 
extracellular medium was detected directly after infection (Genzel et al., 2004). The 
most likely reason for this is that the cell does go on producing new amino acids after 
infection. However, the excretion of amino acids already existing in the cell (the 
reduction of intracellular pools of amino acids) is also not excluded. 
i,vmvk −
nuc,NPP
cellmC ,
cellC
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5.4 Dynamics of Transcription and Genome  
      Replication  
 
The operation of viral polymerase complexes involved in the processes of vmRNA 
production and viral genome replication depends on the ratio of the number of 
polymerase complexes to the number of template segments (vRNA or cRNA 
segments). Besides the case when the number of genome segments is much higher 
than the number of polymerase complexes (assumed in the model), the option that it is 
comparable or lower than the number of polymerase complexes will be also 
considered in this section. 
 
 
5.4.1 Redundancy of Genome Segments 
 
When formulating the model, particularly the equations describing the replication of 
the viral genome, it is assumed that the number of vRNA molecules significantly 
exceeds the number of polymerase complexes; all polymerase complexes are 
supposed to be involved in the process and to operate at the same speed. Under the 
assumptions made it is possible to consider the whole amount of vRNA segments 
participating in the genome replication as a uniform mass of nucleotides being 
processed by the given number of polymerase complexes. The rate of vRNA (cRNA) 
production is then proportional to the number of polymerase complexes (the terms 
 in (2.4.1) and  in (2.4.2)). nucPolcv Pk ,− nucPolvc Pk ,−
 
Having processed one vRNA (cRNA) segment, the polymerase complex is released 
and can theoretically process another vRNA (cRNA) segment. Thus, it could be 
supposed that shorter genome segments lose their polymerase complexes more often 
than longer segments do, and, hence, their production (in nucleotides per hour) should 
be slower in respect to the production of longer segments. Nevertheless, the vRNA 
(cRNA) segment nearest to the polymerase complex is the segment that has just been 
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processed (or its copy), and, therefore, this segment will most likely be bound and 
processed again. Consequently, once bound to a vRNA (cRNA) segment, the 
polymerase complex is supposed to go on processing this segment. 
 
On the other hand, it could be speculated that shorter segments, being produced in 
higher copy numbers, recruit more newly produced polymerase complexes than 
longer segments, and, therefore, their synthesis rates (measured in nucleotides per 
hour) should be higher than those of longer segments. However, it is evident, that at 
the given initial conditions (one segment of each sort, provided by a polymerase 
complex processing it) the number of copies of the i-th genome segment produced per 
hour (Nv,i, (molecules/h)) is inversely proportional to the length of this segment (Lv,i, 
(nucleotides)): 
(5.4.1)  
iv
iv L
N
,
,
1~ . 
At the same time, the probability that an incoming polymerase complex binds an i-th 
vRNA segment (Pv,i, (-)) (according to the assumption made above, the number of i-th 
vRNA segments bound by other polymerases makes up just a minor part of the total 
number of these segments) is proportional to the number of nucleotides contained in 
the copies of this segment: 
(5.4.2)   iviviv LNP ,,, ~ .
Thus, as follows from formulas (5.4.1) and (5.4.2), the probability to be bound by a 
newly synthesized polymerase complex is equal for all sorts of vRNA (cRNA) 
segments. 
 
According to the arguments discussed above, the total number of newly produced 
nucleotides is uniformly distributed among all sorts of segments. To calculate the 
number of copies of the i-th genome segment produced per hour (Nv,i, (molecules/h)), 
the total number of nucleotides produced per hour (CT, (nucleotides/h)) must be 
divided by the number of different genome segments (Nseg = 8 molecules) and by the 
length of the i-th segment (Lv,i, (nucleotides)): 
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(5.4.3)  
ivseg
T
iv LN
CN
,
, = . 
 
 
5.4.2 Redundancy of Polymerase Complexes 
 
Consider now the opposite case, i.e., when the number of polymerase complexes 
significantly exceeds the total number of vRNA and cRNA segments. In this situation 
it is the number of vRNA and cRNA segments rather than the number of polymerase 
complexes that defines the rate of segment copying. Now genome segments to be 
processed can no longer be considered as a uniform mass of nucleotides. Indeed, as 
soon as vRNA (cRNA) segments are produced, free polymerase complexes 
immediately bind them, and, therefore, the synthesis rate (measured in nucleotides per 
hour) is different for different sorts of segments. The synthesis rates of i-th vRNA and 
cRNA segments (they will be denoted by icv ,−µ  (nucleotides/h) and ivc ,−µ  
(nucleotides/h), respectively), are proportional to the number of these segments (Cv,i  
(nucleotides/cell) and Cc,i (nucleotides/cell), respectively) and inversely proportional 
to their length (Lv,i (nucleotides)). In the considered case, for example, the term 
 in (2.4.1), expressing the synthesis rate of cRNA segments, would be 
replaced by term 
nucPolcv Pk ,−
(5.4.4)  iv
iv
icv
icv CL
k
,
,
,
,
−
− =µ , 
where  )  is the rate coefficient of cRNA synthesis, calculated by the formula 
similar to that for the rate coefficient  in section 2.4. 
icvk ,− (
1−h
cvk −
 
 
5.4.3 General Case 
 
In the intermediate case, when the number of vRNA and cRNA segments is 
comparable with the number of polymerase complexes, the calculation of the 
synthesis rate of complementary segment becomes more complicated. In general, 
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cRNA (vRNA) synthesis rate depends on both the number of polymerase complexes 
and the number of processed vRNA (cRNA) segments. It can be expressed using a 
Monod-type kinetics: 
(5.4.5)  ⋅+= −− nucNPNP
nucNP
icvicv Pb
P
k
,
,
max,,,µ  
nucPolivcvP
nucPol
ivnucPolcvC
iv
PCK
P
CPK
C
nucPoliv ,,,
,
,,,
,
)()(
,,
+⋅+⋅ −−
, 
where half-saturation functions  (nucleotides/cell) and  (amino 
acids/cell) (representing the analogues of Monod constants) depend on the total 
number of polymerase complexes and the total number of i-th vRNA segments, 
respectively. 
cvC iv
K −,, cvP nucPolK −,,
 
 
5.4.4 Choice of Model Assumption 
 
In the case of genome segment redundancy all genome segments can be considered as 
one pool of nucleotides. Consequently, to describe the dynamics of genome 
replication it is enough to consider only two functions, representing the total numbers 
of vRNA and cRNA segments (in equations (2.4.1) and (2.4.2) these functions are, 
correspondingly,  and ) and calculate the number of copies of the i-th segment 
by formulas like (5.4.3).  
vC cC
 
In the case of polymerase complex redundancy, as well as in the general case, the 
number of copies must be described individually for each sort of segments. 
Consequently, genome replication dynamics is now described by sixteen functions 
(instead of two in the previous case): eight functions representing the numbers of 
vRNA segments and eight functions representing the numbers of cRNA segments. 
Additionally, as follows from formula (5.4.5), the general case requires the 
identification of more model parameters in comparison with the particular cases 
considered before. For example, functions  and  depending on the 
complex interaction of polymerase complexes with genome segments must be 
defined. 
ivC
K
, nucPolP
K
,
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So far little is known about an individual control of transcription and translation. 
Therefore, for the simplicity of the model it is reasonable to assume that the number 
of polymerase complexes is much lower than the number of genome segments. 
Simulation results show that this assumption is well satisfied for the late stages of the 
infection cycle, but violated at the early stages of the infection (Fig. 5.2). 
Nevertheless, the overestimate of the number of vRNA and cRNA segments produced 
at the early stages of the infection (at this time interval the number of polymerase 
complexes exceeds the number of vRNA segments) can be compensated by the 
decreasing of the rate coefficients of vRNA and cRNA synthesis in the right-hand 
sides of equations (2.4.1) and (2.4.2) (  and , respectively). vck − cvk −
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Figure 5.2 vRNA molecules and polymerase complexes in the nucleus. At the late stages 
of the infection the number of vRNA molecules (Cv) exceeds the number of viral polymerase 
complexes (PPol,nuc). 
 
 
5.4.5 Particularities of Transcription Dynamics 
 
As the number of polymerase complexes is supposed to be much lower than the 
number of vRNA segments to be transcribed, the number of produced vmRNA 
molecules, like the number of vRNA segments, can be considered as a uniform mass 
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of nucleotides. The number of nucleotides belonging to vmRNA molecules encoding 
the i-th protein (Ci,cyt (nucleotides/cell), used, particularly, in the equations describing 
viral protein production) is calculated by formula 
(5.4.6)  cytiicyt CC ω=, , 
where Ccyt (nucleotides/cell) is the total number of nucleotides in vmRNA molecules 
produced (see section 3). Such an approach is applied for the formulation of the 
reduced model (see section 2.9). However, as pointed out in section 2.3, in the 
detailed model the numbers of vmRNA molecules encoding different proteins are still 
considered separately to keep the possibility of model modifications. Factors iω  (-) 
are taken into account when calculating the rate coefficient of the synthesis of 
vmRNA molecules encoding the i-th protein. 
 
In the case of polymerase complex redundancy the term  in (2.3.1), 
representing the rate of the synthesis of vmRNA molecules encoding the i-th protein 
(
nucPolivmv Pk ,,−
ivmv ,−µ  (nucleotides/h)), would be proportional to the number of i-th vRNA segments 
(for ; segments 7 and 8 are spliced), i.e., replaced by term 6...1=i
(5.4.7)  iv
ivm
ivmv
ivmv CL
k
,
,
,
,
−
− =µ . 
Here,  )  is the rate coefficient of vmRNA synthesis, calculated by the same 
formula, as it is in section 2.3, and L
ivmvk ,− (
1−h
vm,i  (nucleotides) is the length of the vmRNA 
molecule encoding the i-th protein. For the calculation of the numbers of vmRNA 
molecules produced from the 7th and 8th genome segments (encoding M and NS 
proteins, respectively), the corresponding fractions of nucleotides of the segments 
involved must be taken into account (like it was done in section 3). At the same time, 
since in the previous case vmRNA molecules encoding different proteins are also 
considered separately, the number of equations describing vmRNA production is the 
same in both particular cases considered. 
 
Finally, the formula for the rate of the synthesis of vmRNA molecules encoding the i-
th proteins is similar to formula (5.4.5) for the synthesis rate of cRNA segments: 
(5.4.8)  ⋅+= −− nucNPNPivmvivmv Pa
k
,
max,,, 1
1µ  
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5.5 Dynamics of Viral Protein Production  
 
As discussed in sections 1.6.5 and 1.6.6, the synthesis of viral proteins is carried out 
by the cellular translation machinery. The rate of protein synthesis depends on the 
relation between the number of cellular ribosomes and the number of cytoplasmic 
vmRNA molecules to be translated. The former number makes up  
ribosomes/cell, which significantly exceeds the latter number throughout the whole 
process of the infection (see sections 2.5 and 4.8). The situation when the number of 
cytoplasmic vmRNA molecules is higher than the number of cellular ribosomes is 
excluded and therefore not worth being considered. Consequently, it is reasonable to 
assume that the rates of viral protein synthesis, expressed by 
6
0 105 ⋅=R
rib
cyti
synti d
C
k ,,  in (2.5.1) and 
the corresponding term in (2.6.1), are proportional to the number of vmRNA 
molecules in the cytoplasm. Furthermore, since the number of cellular ribosomes does 
not seem to be significantly reduced by virus replication, it can be assumed to remain 
constant, which particularly allows considering the rate coefficients of viral protein 
synthesis  as constants.  syntik ,
 
Cellular ribosomes involved in protein synthesis are organized in polysome 
complexes (see section 1.5.2.3). In the model a polysome complex is assumed to 
incorporate the maximal number of ribosomes, i.e., equal to the ratio of the length of a 
vmRNA molecule to the distance between ribosomes on it (this assumption is taken 
into account by the term 
rib
cyti
synti d
C
k ,,  in (2.5.1) and the corresponding term in (2.6.1)). 
In reality, however, the number of ribosomes making up a polysome is not necessarily 
maximal. As reported, for example, by Singh (1996), polysome complexes involved 
in the translation of vmRNA molecules encoding a given protein have a certain size 
distribution, which changes in time and depends not only on the length of the 
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molecules considered, but also on such parameters as the rate of initiation, 
translocation, and release of ribosomes. Thus, the real number of viral proteins 
produced seems to be overestimated by the model. To improve this estimate, the rate 
coefficients , which are assumed in the model to be constants, should be treated 
as time-dependent functions of several parameters.  
syntik ,
 
 
5.6 Mechanisms of Viral Genome Packaging  
 
As pointed out before, the genome of influenza virus consists of 8 different RNA 
segments. So far, it is not clear if each of viral genome segments is selectively 
incorporated into a progeny virus particle or packaging of genome segments is a 
purely random process. Both hypotheses have an experimental support (Bancroft and 
Parslow, 2002; Fujii et al, 2003). In the case when the packaging of genome segments 
obeys a selective strategy (Fujii et al, 2003), each virus particle produced by a cell is 
most likely infectious (it contains 8 different genome segments), whereas random 
packaging (Bancroft and Parslow, 2002) implies that the number of infectious virus 
particles makes up just a low percentage of the total number of released virions. In 
addition, a virion might incorporate more than eight genome segments (Enami et al., 
1991), which in the case of random packaging increases the probability that it is 
infectious. 
 
Experimental data (H. Sann, personal communication, not shown) implies that not all 
virions are able to infect cells, which is also confirmed by Roy et al. (2000). In the 
case of selective packaging this fact can be explained by cellular events, e.g., related 
to virus binding, endocytosis, viral protein synthesis, and genome replication. 
However, according to experimental data (H. Sann, personal communication, not 
shown), the total number of released virions exceeds the number of infectious virions 
so significantly (by about two orders) that purely selective packaging does not seem 
to take place. It is rather reasonable to assume for modeling that vRNP complexes are 
packaged in a random, nonspecific manner. 
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In the model it is assumed for simplicity, that all virus particles contain eight genome 
segments. If all segments were produced in equal amounts, the probability for a virus 
particle to be infectious would be 
400
1
8
!8
8inf ==P  (Knipe et al., 2001). However, the 
real number of produced genome segments might be different. Indeed, the segments 
of the viral genome have different lengths (e.g. the vRNA encoding PB2 proteins has 
2341 nucleotides and the vRNA encoding M1 and M2 proteins has 1027 nucleotides, 
Table 1.1), and the rates of their synthesis seem to differ from each other. Based on 
the assumption that viral polymerase complexes operate at the same rate on vRNA 
molecules of different length, it can be calculated that the probability for a released 
virion to be infectious is as small as 
667
1
inf ≈P  (see Appendix A2).  
 
On the other hand, according to experimental observations, produced virus particles 
are infectious with a probability of 
150
1
expinf, ≈P  (H. Sann, personal communication, 
not shown), which is appreciably higher than the values derived above for a random 
packaging of genome segments. There are two possible scenarios explaining this 
discrepancy.  
 
The value of the infection probability increases, if more than eight segments are 
assumed to incorporate into progeny virus particles. Such a hypothesis was 
experimentally supported in 1991 (Enami et al., 1991), when a transfectant influenza 
virus particle, containing nine genome segments was artificially created. The 
probability that a virus particle containing nine genome segments has at least one 
copy of each gene is in the range from 
50
1  to 
90
1  (Roy et al., 2000; own calculations, 
not shown), which is higher than . Thus, assuming, for example, that released 
virions can contain either eight or nine genome segments, it could be possible to find 
the ratio of the number of eight segment-containing virions to the number of nine 
segment-containing virions, corresponding to the experimental value of the infection 
probability. 
expinf,P
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The other scenario is based on the assumption that the packaging of virus genome is 
not purely random, but rather involves some selective mechanisms. Such mechanisms 
might be performed with the participation of short noncoding sequences surrounding 
coding regions of genome segments. It was particularly shown that these noncoding 
sequences contained signals required for transcription, replication, and packaging of 
genome segments (Nicholson et al., 1998; Luytjes et al., 1989).  
 
In the model with reinfection and in the population model the presence of 
noninfective virions were taken into account by introducing the additional factors into 
the terms  in (2.1.1”) and budVrelbud VPk rel inf,− bud
in
Vrelbud VZ
Z
Pk
rel
0
inf,−  in (2.1.1
**). These 
factors are equal to the probability that a virion is infectious ( ), i.e., to its 
experimental value . 
infP
expinf,P
 
 
5.6.1 Method to Identify the Mechanism of Packaging 
 
It is remarkable that the factors limiting virus production do not depend on the 
packaging of the viral genome. Indeed, according to section 4.9, M1-vRNP 
complexes limit virus replication at the stage of virus budding. Under the assumption 
of random packaging, it means that the whole amount of newly produced M1-vRNP 
complexes is incorporated into progeny virus particles. Accordingly, when the 
selective packaging is assumed, completely consumed for progeny virus production 
are only M1-vRNP complexes of one sort (produced in the lowest amount), while 
M1-vRNP complexes of other sorts, together with viral envelope proteins, accumulate 
at the budding site.  
 
Therefore, an experimental method to identify if the packaging of the viral genome is 
purely random or partially selective would be as follows. If an accumulation of M1-
vRNP complexes is not observed at the budding site, the genome segments are 
packaged randomly; otherwise, a specific selection of appropriate genome segments 
does take place during virus budding. 
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5.7 Influence of NP Proteins on Virus Dynamics  
 
The property of NP proteins to inhibit vmRNA production seems to affect virus 
dynamics at the early stage of the infection. According to the assumptions made so 
far, the nuclear concentration of NP proteins starts increasing earlier than that of other 
viral proteins (at approximately 0.3 h p.i.). This early increase is a consequence of the 
transfer of NP proteins with the incoming virus particles. Indeed, if the corresponding 
term ( ) is excluded from equation (2.5.2) for NP proteins, the number of 
NP proteins behaves similar to the number of other viral proteins (except M1 proteins, 
which are limiting, see section 4.4). About  amino acid residues of NP protein 
are transported into the cell with 10 virions (Table 1.1), which has an appreciable 
negative effect on vmRNA synthesis (see equation (2.3.1), ). During the 
first hours after infection an essential part of redundant NP proteins is degraded. The 
degradation ends at about 1.5 h p.i., when vmRNA molecules and, consequently, viral 
proteins start being synthesized at the maximal rate. 
nucPspl Sk nucNP ,,
6105 ⋅
610−≈NPa
  
Besides NP proteins, internalized virus particles deliver viral polymerase complexes 
to the nucleus. These polymerase complexes are also degraded, however, the system 
is less sensitive to polymerase degradation, which is, unlike NP protein degradation, 
not required for the initiation of transcription. Additionally, the number of 
internalized polymerase complexes and, consequently, the rate of their degradation, 
are much lower than those of NP proteins. Thus, protein degradation is profitable for 
vmRNA production; it results to the increase of the ratio of the number of polymerase 
complexes to the number of NP proteins, and, therefore, to the increase of vmRNA 
synthesis rate. 
 
The event described in this section provides the example, when the reversibility of the 
switch from transcription to vRNA production (see section 1.6.4) plays an important 
role. Indeed, internalisation of the number of NP proteins comparable with the value 
of  (10NPb
6) mediates the direct switch from transcription to genome replication, 
whereas after the degradation of redundant NP proteins the reverse switch takes place. 
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As high enough number of viral components is synthesized and transported into the 
nucleus, the direct switch occurs again. The effect involved takes place for all values 
of the rate coefficients of internalization from 50% to 200% of their initial values. 
 
 
5.7.1 Are Incoming NP Proteins Favorable for Virus  
         Production? 
 
To examine the influence the nuclear import of NP proteins on virus dynamics the 
term presenting the transfer of incoming NP proteins into the nucleus ( ) 
was excluded from (2.5.2) for NP proteins. Since vmRNA production is no longer 
inhibited by the presence of NP proteins, the synthesis of all viral proteins starts 
earlier (at about 0.4 h p.i.) than in the situation when the incoming NP proteins are 
taken into account (about 1.5 h p.i.) (not shown). As discussed in section 1.6.2, NP 
proteins play an important role for the nuclear import of the viral genome (they carry 
NLSs). However, simulation results indicate that if NP proteins themselves did not 
enter the nucleus with vRNA segments, the number of produced virions would be 
approximately 9500 virions per cell (19% higher than in the case when NP proteins 
enter the nucleus, not shown). 
nucPspl Sk nucNP ,,
 
Additionally, if NP proteins from internalized virions were absent in the nucleus, an 
increase of the rate coefficients of internalization would invariably result in an 
increase of the virus yield. Indeed, as in the considered situation NP proteins are not 
internalized at all, the rate of vmRNA synthesis corresponding to the ratio of the 
numbers of internalized viral components is, evidently, higher than that corresponding 
to the ratio of the numbers of newly synthesized viral components; the faster the 
internalization of viral components the more efficient the process of vmRNA 
synthesis. This statement is confirmed by simulation data summarized in Table 5.1: 
simulations, performed for the values of the rate coefficients of internalization 
changing from 90% to 200% of their initial values show that the virus yield represents 
a monotonous function of the internalization rate coefficients. 
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Table 5.1 Virus yield and limiting factors of virus replication for internalization rate coefficients 
changed by different factors in the case when NP proteins are not delivered into the nucleus 
(kspl,NP =0) 
Factor 0.9 1.0 1.1 1.2 1.5 
Vrel 9393 9529 9644 9748 10010 
LF B B A A A 
LF:  limiting factor 
A: M1 proteins 
B:  vRNA molecules and M1 proteins 
 
 
5.8 Limiting Factors. Hierarchy of Redundantly  
      Produced Viral Components  
 
As shown in section 4.9, if it is assumed that the influenza virus does not control the 
synthesis of its proteins and vRNA molecules, some of viral components accumulate 
in the nucleus and at the budding site. Other viral components are limiting for virus 
replication. Appendix A1 shows that the numbers of such viral components in most 
cases tend to zero (complete consumption for the production of new virions); 
however, in some situations they can also tend to constants or even increase. 
 
Model modifications provide a possibility to reveal, which of the viral components 
are more critical for virus replication in comparison with others, and which of them 
are, in contrast, produced in redundant amounts. Based on an analysis of the 
numerical (and, sometimes, analytical) solution of model equations, it is usually also 
possible to predict the dynamics of viral components at the modifications involved. 
 
M1 proteins were shown to limit virus production at the step of M1-vRNP complex 
formation and to be present in the nucleus in extremely low amounts (see section 4.9). 
This result can be confirmed by several arguments. For example, as pointed out in 
section 1.6, M1 is a matrix protein; among all proteins, making up a virus particle, it 
is the most abundant (Table 1.1). Thus, it could be expected that M1 proteins are 
critical for virus production. Besides that, experimental results show that M1 proteins 
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are found in the nucleus only in the association with vRNP complexes (Martin and 
Helenius, 1991b). In other words, M1 proteins do not accumulate in the nucleus and 
are completely consumed for the production of M1-vRNP complexes, necessary for 
the formation of progeny virions. 
 
 
5.8.1 NP Proteins are the Second Critical Component  
         at the Assembly of M1-vRNP Complexes 
 
Suppose now that the number of M1 proteins in the nucleus is artificially maintained 
to be high enough for the synthesis of new M1-vRNP complexes. In the model this 
situation can be realized by excluding factor  from the term 
, describing the assembly of M1-vRNP complexes in (2.7.1) and 
from the corresponding terms in (2.4.2) and in (2.5.2) for NP and NS2 proteins and 
polymerase complexes. Furthermore, the term 
nucMP ,1
∏
l
nuclvSun PCk nucun ,, ,
∏
l
nuclvPun PCk nucM ,, ,1  in (2.5.2) for M1 
proteins has to be removed. As after such a transformation of the model M1 proteins 
are no longer limiting, one of the other viral components must become a bottleneck 
for the assembly of M1-vRNP complexes. Simulation results reveal that the most 
critical viral component is now the number of NP proteins. This is also in agreement 
with the data from Table 1.1, which shows that NP proteins represent the most 
abundant component of a vRNP complex. Furthermore, as the number of nuclear NP 
proteins is coupled with the synthesis rate of vRNA molecules (NP proteins promote 
the replication of the viral genome, see section 1.6.4 and the terms 
nucPol
nucNPNP
nucNP
cv PPb
P
k ,
,
,
max, +−  in (2.4.1) and nucPolnucNPNP
nucNP
vc PPb
P
k ,
,
,
max, +−  in (2.4.2)), virus 
production is limited by both viral components involved. 
 
Based on the model it could be concluded that making NP proteins critical for virus 
production results in a situation when the number of produced virions represents an 
exponentially increasing function of time. Indeed, at the given set of model 
parameters the level of NP protein concentration kept in the nucleus is so low that 
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relation (4.3.1) is satisfied throughout the whole infection cycle. It means that both the 
number of produced vmRNA molecules and the number of produced polymerase 
complexes exponentially increase in time (see section 4.9). However, in the 
considered case the model does not allow predicting the exact dynamics of viral 
component production. As pointed out in sections 2.3 and 5.4, the behavior of viral 
components provided by the model is based on the assumption that the number of 
vRNA molecules exceeds the number of viral polymerase complexes, whereas 
throughout the whole process of the infection the inverse situation takes place. To 
obtain a realistic scenario of system behavior at the deficiency of NP proteins model 
equations might be modified to apply formulas (5.4.4) and (5.4.7) for the rates of 
genome replication and vmRNA production, respectively. 
 
 
5.8.2 Relation Between the Number of NS2 Proteins,  
         Polymerase Complexes, and vRNA Molecules 
 
Assume now that NP proteins, side by side with M1 proteins, are contained in the 
nucleus in such high amounts that they do not limit virus replication. It means that in 
addition to the modifications of the model described in section 5.8.1, the term 
 in (2.5.2) for NP proteins must be removed, and factors  
must be excluded from the terms mentioned in section 5.8.1. According to the results 
of such simulations, NS2 proteins become limiting for the formation of M1-vRNP 
complexes. The whole number of NS2 proteins is incorporated into newly produced 
M1-vRNP complexes, while vRNA molecules and viral polymerase complexes 
accumulate in the nucleus (see Appendix A1). 
∏
l
nuclvPun PCk nucNP ,, , nucNPP ,
 
Finally, consider the case when the nuclear concentration of NS2 proteins is also 
maintained to be higher than virions require for their replication. Simulation results 
show that in this case neither polymerase complexes nor vRNA molecules are 
completely consumed for the formation of new M1-vRNP complexes. Instead, both 
viral components involved accumulate in the nucleus. Such a scenario is reasoned by 
the reduced number of factors in the expression for the rate of packaging (the term 
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∏
l
nuclvCun PCk v ,,  in (2.4.2) and the corresponding term in (2.5.2)) resulting from 
model modifications involved. As follows from the numerical solution of the system 
of model equations, the order of the increase of the packaging rate remains lower than 
that of the synthesis rate throughout the whole process. At the same time, the numbers 
of both viral components (  (amino acids/cell) and  (nucleotides/cell)) 
represent slowly increasing
nucPolP , vC
12 functions of time (t, h):  
)()(, totP nucPol = , ; ∞→t
)()( totCv = ,  . ∞→t
This situation is similar to that described in Appendix A1 for the absence of the 
critical sort of system components (see relation (A1.6)). Additionally, as it can be 
seen from model equations (particularly, equation (2.4.2)), the numbers of polymerase 
complexes and vRNA molecules are coupled. It might be, consequently, concluded 
that the considered viral components are equivalent in respect to the incorporation to 
progeny virions. 
 
 
5.8.3 Viral Components at the Budding Site 
 
At the step of virus budding the process of virus production is limited by the number 
of newly produced M1-vRNP complexes. To determine, which of envelope proteins 
accumulating at the budding site (HA, NA, M2) is more critical for virus production, 
and which is, in contrast, redundant, let us, first, exclude factor  from the term 
 describing the assembly of progeny virus particles in (2.6.2) 
for all envelope proteins and remove the corresponding term from (2.7.2). Such a 
modification of the model corresponds to a scenario that the number of M1-vRNP 
complexes at the budding site does not limit virus production.  
budunS ,
∏
l
budlbudunPbud PSk budj ,,, ,
 
                                                 
12 By definition, attgotf →=   )),(()( , if at
tg
tf →→   ,0
)(
)(
. 
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Unlike NP proteins and viral polymerase complexes, viral envelope proteins do not 
seam to significantly influence the dynamics of the synthesis of other viral 
components, and functions representing their numbers are, hence, not coupled. 
Consequently, newly produced envelope protein, the number of which is the most 
critical for the formation of virus particles, represents the only limiting factor. 
Simulation results show that the viral component that limits virus production with a 
redundancy of M1-vRNP complexes is the number of HA proteins. 
 
Making now HA proteins redundant for virus production, it can be concluded that 
from the two remaining envelope proteins (M2, NA) NA proteins are more critical for 
virus production. However, the number of NA proteins does not decrease in time, 
tending to zero. Instead, it increases, approaching to a constant. Indeed, after model 
modifications made in this section the equation for the number of NA proteins 
(  (amino acids/cell)) has the form budNAP ,
(5.8.1)  budNArbudNAbudMbudNAPbudERNAbudERNA
budNA PkPPkPk
dt
dP
budNA ,deg,,2,,,,
,
, −− −−=  
The number of envelope proteins in the ER (particularly,  (amino acids/cell)) 
increases proportional to the first power of time (t, h): 
ERNAP ,
tkP ERNAERNA ,, = ,  
and the number of M2 proteins at the budding site (  (amino acids/cell)) also 
increases linearly: 
budMP ,2
tkP budMbudM ,2,2 =  
(Here,  (amino acids/h) and  (amino acids/h) are positive constants). 
Consequently, equation (5.8.1) at the late stages of the infection reduces to 
ERNAk , budMk ,2
(5.8.2)  budNArbudNAbudNAbudMPbudERNAbudERNA
budNA PktPkktkk
dt
dP
budNA ,deg,,,2,,,
,
, −− −−=  
As shown in Appendix A1, equation (5.8.2) corresponds to the situation, when the 
function  described by it tends to a positive constant. Furthermore, the value of 
the rate constant of packaging  )  is small enough for  to represent 
an increasing function of time. 
budNAP ,
budNAPbud
k
,,
( 1−h budNAP ,
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5.9 Are Their Any Other Possible Laws of Virus  
      Growth?  
 
As mentioned in section 4.3, the proportion between the numbers of viral proteins 
produced is kept throughout the whole process of the infection. Taking this into 
account, it can be seen from the term nucPol
nucNPNP
ivmv PPa
k ,
,
max,, 1
1
+−  in (2.3.1) that for 
any choice of model parameters there is a certain moment of time p.i., when the 
number of vmRNA molecules starts to grow linearly. The rate of vmRNA production 
is equal to prodvmv ,−µ , which is defined by the ratio of the number of polymerase 
complexes to the number of NP proteins (see section 4.10.1). It is also clear that at the 
latest stages of the infection the number of vmRNA invariably tends to constant.  
 
Thus, the polynomial stage of virus growth with its parabolic and linear phases is the 
property of any solution to the considered system of differential equations. It is 
evident that the initial exponential stage of virus growth also takes place 
independently of the set of initial conditions. Consequently, variations of model 
parameters, e.g., rate constants of degradation or transport, or switch parameters, can 
influence the time scale of the process, the character and the duration of the 
transitional stage, but the two major stages of progeny virus growth are always an 
exponential followed by a polynomial increase.  
 
 
5.9.1 Duration of the Exponential Stage 
 
The time interval, at which the number of released virions increases exponentially, 
depends on the ability of NP proteins to suppress vmRNA production, which is 
defined by . From the analysis of the system of model equations, particularly 
equations (2.4.2), (2.3.1) and (2.5.1) (the last two equations are considered for viral 
polymerase complexes) 
NPa
))(()()()()(
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,, tPotCtFtPtkdt
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v
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Discussion  188 
)()()()(
)(
,,,
,
,
tCtFtPtk
dt
tdC
nucPolCnucPolPolvmv
nucPol
nucPol
−= −  
)()(
)(
)(
)(
,
,
,
,
,
tPtF
d
tC
tk
dt
tdP
cytPolP
rib
cytPol
syntPol
cytPol
cytPol
−=  
( ,  )  are continuous nonnegative functions) it can be 
easily concluded that if the influence of NP proteins was neglected ( ), the 
exponential stage of virus growth would go on throughout the whole process of the 
infection.  
)(tFi },,{ ,, cytPolnucPolv PCCi∈ ( 1−h
0=NPa
 
It is remarkable that such a conclusion can be made independently on the assumed 
relation between the number of polymerase complexes and the number of vRNA 
molecules in the nucleus (see section 5.4). Indeed, if the rates of vRNA and vmRNA 
synthesis in (2.4.2) and in (2.3.1) are proportional rather to the number of vRNA 
molecules than to the number of polymerase complexes, 
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the solution to the system of model equations for the number of vmRNA molecules 
(and, hence, for the numbers of all newly produced viral components) will be, 
obviously, also represented by exponentially increasing functions of time. 
 
Based on the solution to the system of model equation, it could be assumed that the 
number of released virions could also exponentially increase in time, if the number of 
nuclear M1 proteins is maintained at such a high level that it does not limit the 
formation of new M1-vRNP complexes. Such a modification of the considered 
biological system would make the number of NP proteins critical for virus production, 
and, hence, insufficient to inhibit vmRNA synthesis. However, as NP proteins at the 
same time promote genomic vRNA synthesis, the level of vRNA molecules in the 
nucleus would be very low, and, therefore, the model does not allow adequately 
describing the system dynamics (see section 5.8.1). 
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Another reason for the transition from the exponential stage to the polynomial might 
be the observation that cRNA strands are produced only for a short period of time p.i. 
(Flint et al., 2000). Taking this into account would, evidently, result in a polynomial 
increase of the number of vRNA molecules, and, hence, in a polynomial increase of 
the number of virions released. However, since the mechanism for the inhibition of 
cRNA synthesis is still not yet understood, it is not considered in the model. 
 
 
5.10 Further Modifications of the Detailed Singe  
        Cell Model 
 
The model allows the simulation of the overall dynamics of virus replication, the 
analysis of the use of cellular resources and the testing of hypotheses concerning basic 
virus replication mechanisms, thus, essentially facilitating future studies of influenza 
viruses at a cellular level. The behavior of the number of newly produced viral 
components provided by simulations is in close agreement with results obtained by 
other models. A general rule states that every mathematical model should be as simple 
as possible and as complex as necessary. It is evident that any extension of the model 
scope and accuracy invariably leads to an increase of its complexity. However, if it is 
necessary, the structure of the model can be easily modified to consider additional 
features of the virus replication cycle.  
 
For example, several equations could be introduced to express the dynamics of 
splicing of M and NS vmRNA molecules and the effect of nuclear NS1 proteins on it 
(Nicholson et al., 1998; Juan, 1998). By modifying the rate coefficients of vmRNA 
synthesis, it is also possible to take into account that vmRNA molecules encoding 
different viral proteins are processed at different stages of the virus replication cycle 
(Watanabe et al., 2001). The possibility of such modifications of the model is, 
particularly, the reason why the numbers of vmRNA molecules of different sorts are 
kept represented by different functions. Furthermore, in the case when a reinfection is 
taken into account (or when virus internalization occurs slowly) the inhibitive effect 
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of M1 proteins accumulating in the cytoplasm on the nuclear import of genome 
segments released from the endosome (Martin and Helenius, 1991b) can be 
considered. Although the model does not consider in detail endocytotic and exocytotic 
pathways, it still can take into account (by incorporating several additional equations) 
certain events taking place during these pathways, e.g., virus binding to different 
number of cellular surface receptors (addressed, for example, in the study of Dee and 
Schuler (1997)) and coated pit formation.  
 
As shown in section 4.8, virus replication does not exhaust the pools of cellular 
resources. However, balance equations for the numbers of cellular precursor mRNA 
molecules, free nucleotides, and amino acids could be easily introduced into the 
model to investigate the change of cellular metabolism after infection. It would allow, 
for example, expressing mathematically the inhibitive effect of the NS1 protein on the 
splicing of precursor mRNA molecules (Lamb et. al., 1981), as well as the action of 
the NS1 protein as a translational enhancer for vmRNA molecules and its ability to 
retain cellular precursor mRNA molecules in the nucleus (Fortes et al., 1994; 
Nemeroff et al., 1998). Additionally, taking into account the balance of cellular 
resources would allow estimating more precisely the total capacity of the cell to 
produce virions. For this purpose the synthesis of amino acids and nucleotides after 
infection can also be considered. Finally, it would be possible to incorporate into the 
model a balance of energy and thus to observe the impact of virus replication on the 
cellular pools of ATP and NAD(P)H molecules.  
 
Other modifications and improvements of the model can be made as new details of 
the influenza virus replication cycle are revealed. 
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5.11 Methods to Increase the Number of Virions  
        Produced in a Cell 
 
According to simulation results, two parameters, the variations of which mainly 
increase virus production, are the speed of viral polymerase complexes and the 
elongation rate of polypeptide chains of viral proteins (see section 4.11.5). 
Consequently, the most effective ways to increase the virus yield are speeding up viral 
polymerase complexes (e.g., by using more efficient promoters) or the increasing of 
the translation efficiency of viral proteins (e.g. by virus mutants, which efficiently 
inhibit the processing of cellular mRNA molecules). What is more, the process of 
virus production can be effectively optimized by weakening the ability of NP proteins 
to bind to elongating RNA strands, which has a strong inhibitive effect on the 
transcription of virus genome (at low values of the switch parameter  the increase 
of the number of produced virions in time becomes close to exponential, see section 
4.11.1.2). As M1 proteins were shown to represent a bottleneck for virus replication 
(see section 4.9), their supply to the cellular nucleus would also result in an increase 
of the number of produced virions. Finally, the virus yield can be appreciably 
increased by increasing the efficiency of the transport of viral components into and 
out of the nucleus (e.g., by modifying the properties of signal sequences, see section 
4.11.3) or by increasing the lifetime of the cell (see section 5.3).  
NPa
 
While mentioned above modifications of the considered biological system have 
significant effects on the virus yield, to a lower extent an increase of the number of 
produced virions can also be achieved by a series of other variations of system 
parameters. Such variations are, for instance, the improvement of the impact of NP 
proteins on genomic vRNA production (see section 4.11.1.2), an increase of 
internalization and release rate coefficients (e.g., by the increasing of binding and 
fusion activities of HA proteins and cleavage activity of NA proteins, respectively, 
see section 4.11.2), as well as a decrease of the degradation rates of vmRNA 
molecules and cytoplasmic viral proteins (by the regulation of, correspondingly, 
cellular nuclease and protease activities, see section 4.11.8). Although based on the 
results of simulations the MOI optimal for virus production was found (see section 
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4.10), the increase of the virus yield reasoned by bringing the MOI to its optimal 
value is not very significant. 
 
 
5.12 Strategies for Antiviral Therapies and  
        Vaccine Production Optimization 
 
The detailed single cell model can be used to identify molecular targets for antiviral 
therapies. As shown in section 4.9, the number of M1 proteins in the nucleus limits 
the replication cycle of the virus at the assembly of M1-vRNP complexes. 
Consequently, virus production could be effectively suppressed by disabling nuclear 
M1 proteins. Furthermore, as pointed out in section 5.7.1, NP proteins internalized 
have a negative effect on the virus yield. The delivery of the high number of NP 
proteins into the nucleus of infected cells would block vmRNA synthesis and, hence, 
the production of progeny virions. An additional option to reduce the number of 
virions produced would be the shortening of the lifetime of infected cells (see section 
5.3). 
 
Several methods for the increase of the virus yield, discussed in section 5.11, could be 
applied in practice for the optimization of vaccine production. Such methods are the 
expansion of the lifetime of a cell, or the delivery of M1 proteins into the nucleus. 
Other ideas, however, would be difficult to realize. Indeed, vaccines are produced 
against a certain type of virus, which cannot be modified. One possible way out could 
be the creation of a reassortment virus, which has a desired property (e.g., improved 
polymerase complexes), and possesses the HA and NA proteins of the required virus 
strain.  
 
More hypotheses concerning the optimization of vaccine production in cell cultures 
can be derived based on the population model. As shown in section 4.15.2, the virus 
yield can be significantly improved by decreasing of the MOI. Besides that, the 
population model indicates that the number of produced virions increases if virus-
induced apoptosis (of either infected or uninfected cells) is inhibited, or the infection 
rate is decreased (see section 4.15.3). 
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5.13 Limits of Population Model Applicability 
 
At the given set of parameters the population model provides an upper estimate for 
the number of released virions. Indeed, the structure of the system of model equations 
implies that the synthesis of viral components, the number of which is taken for the 
calculation of the number of released virions, starts from the beginning of the primary 
infection. In reality, however, at the late stages of the process primarily infected cells 
often make up only a minor part of the total number of infected cells, most of the cells 
being infected by newly produced virions. Consequently, higher precisions of the 
results provided by the model (especially for low MOI values, see section 4.15.2) 
correspond to shorter lags between the beginning of the infection and the beginning of 
virus release. For the model to adequately predict the population dynamics the lag 
must be much shorter than the duration of the process of virus replication. 
 
According to simulation results, secondarily infected cells start to produce virions at 
about 10 h p.i. (Fig. 4.23), which is much less than 90 h (the duration of virus 
replication process). Besides that, little is known concerning the exact values of the 
rate coefficients of viral component transport. For example, as shown in section 
4.11.3.1 for the single cell model, increasing of the efficiency of viral component 
transport can result in approximately threefold decrease of the lag. Thus, at the given 
conditions the population model developed here seems to provide reasonable 
estimates for the virus yield and the size of cell populations. These estimates are to be 
further confirmed by experiments. 
 
 
5.14 Use of the Reduced Model 
 
As mentioned in section 2.9, the reduced model is mainly required as a starting point 
for the development of structured population balance models. A structured population 
balance model implies that the numbers of viral components in different 
compartments of the cell are considered as structure parameters of the cell population. 
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The number of cells Z  (cells/nL) represents a function of time and the number of 
vRNA molecules, viral proteins, etc. (parameters ): nii ,...,1
),...,,( 1 niitZZ = . 
The total number of virions in the extracellular medium is described by an 
independent state variable  (virions/nL), which accounts for the contribution of 
all cells in the population. 
)(tVex
 
Thus, the reduced model is aimed to provide the data concerning the dynamics of 
intracellular viral components. Accordingly, it is reasonable to consider all the 
functions describing the number of viral components, including the number of 
extranuclear virions and the number of assembled virions, related to the cell. For the 
same reason, it is not necessary to separate the number of extracellular virions from 
the total number of extranuclear virions and the number of released virions from the 
total number of virions assembled in the cell. 
 
On the other hand, the reduced model can be also used as a simplified version of the 
detailed model. In this case, two additional state variables describing the number of 
extracellular virions and the number of released virions could be introduced. Another 
option would be to consider the number of extranuclear virions and the number of 
assembled virions related to the volume of medium and to use them as 
approximations for the number of extracellular virions and the number of released 
virions, respectively. 
 
 
5.14.1 Is a Further Model Reduction Possible?  
 
All the steps of the infection cycle the reduced model represented by equations (2.9.1) 
– (2.9.7) takes into account (except the step of the packaging of viral components, see 
below in section 5.14.2) represent branch points of the process. 
 
It could be thought that the cytoplasmic and nuclear pools of vmRNA molecules can 
be lumped together. However, lumping these pools together would imply that the 
nuclear export of the viral genome and its translation are not separated anymore. As a 
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consequence, all the vmRNA molecules produced would be available for translation. 
Thus, after such a modification the model would not properly reflect the behavior of 
the biological system considered. Moreover, as the ribosome operation, defining the 
rate of viral protein production is fixed and cannot be changed, the lag between the 
beginning of the infection and the beginning of virus release would not be controlled 
by any model parameters (see section 4.12). Finally, omitting the step of vmRNA 
transport from the nucleus into the cytoplasm would deprive the model of the 
flexibility in respect to further possible modifications, e.g., taking into account the 
role of NS1 proteins in the nuclear export of cellular and viral mRNA molecules (see 
sections 1.6.3 and 1.6.5). 
 
For the nuclear and cytoplasmic pools of proteins the situation is similar. 
Nevertheless, lumping these pools together, i.e., considering together the nuclear 
import and packaging of viral proteins does make sense. Indeed, it seems that the 
virus does not have any mechanisms for the specific regulation of the transport of 
viral proteins from the cytoplasm into the nucleus, and, accordingly, at this step there 
is no need in model modifications. Additionally, the contribution of the delay of 
packaging concerned with the nuclear import of viral proteins to the lag of virus 
production can be taken into account by changing the rate coefficient of the nuclear 
export of vmRNA molecules.  
 
On the other hand, provided by certain restrictions of modeling purposes, a further 
reduction of the model still can be possible. For example, at certain sets of model 
parameters it can be possible to reduce the number of differential equations of the 
reduced model by one. Such a modification of the reduced model involved, which 
will be referred to as the “simplest model”, is considered in section 5.14.2. 
 
 
5.14.2 “Simplest Model” for Virus Production  
 
As shown in section 4.11.6, variations of the packaging rate constant , as well as 
variations of the rate constant , do not influence the number of released virions 
unk
budk
  
Discussion  196 
significantly. This is explained by the limitation of the formation of M1-vRNP 
complex by the number of newly produced M1 proteins. Consequently, it would be 
expected that the virus yield in the reduced model is not sensitive to variations of the 
rate constant  (shown in section 4.12.3); it is completely defined by the number of 
M1 proteins produced.  
pckk
 
In fact, if only the number of assembled virions is to be investigated, differential 
equation (2.9.7) describing virus release is not required. Instead, for the number of 
assembled virions it is possible to write an algebraic equation, expressing the 
proportionality of the number of released virions to the number of M1 proteins 
produced: 
(5.14.1) 1
,1
,
1
M
virM
redrel PP
V = . 
Thus, the “simplest model” is represented by as few as 9 ODEs. 
 
Besides that,  in (2.9.5) and the corresponding term in (2.9.6), 
describing the packaging of viral components are also can be excluded. These terms 
have no influence on the location of produced proteins. Indeed, the major part of the 
viral polymerase complexes and the NP proteins is accumulated in the nucleus, and 
only an insignificant number is required for progeny virus production. On the other 
hand, all the M1 proteins are incorporated into newly produced virions. Consequently, 
the two equations considered can be rewritten in the form 
∏
l
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Thus, the behavior of the number of assembled virions at different sets of model 
parameters can be investigated based on the “simplest model”, represented by 
equations (2.9.1)-(2.9.4), (5.14.1)-(5.14.3). However, the use of this model is limited 
by sets of model parameters, at which M1 proteins are limiting throughout the whole 
infection cycle. As discussed in section 4.11, this is not always the case; limiting 
  
Discussion  197 
factors at vRNP assembly, unlike those at virus budding, are sensitive to parameter 
changes. 
 
The reduced model presented by equations (2.9.1)-(2.9.7), in contrast, allows 
considering virus production independently of the bottlenecks. Additionally, it 
considers separately viral component assembly, thus making possible both to observe 
the changing of limiting factors during the infection cycle and to investigate their 
sensitivity to parameter changes (e.g., changes of the switch parameters  and 
). Thus, the reduced model (2.9.1)-(2.9.7), despite containing one extra 
differential equation, is more helpful to better understand the dynamics of viral 
component production than the “simplest model” (2.9.1)-(2.9.4), (5.14.1)-(5.14.3). 
NPa
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5.15 Possible Reasons for Cell Death  
 
According to experimental observations, cells infected with influenza virus die at 
about 10-12 h p.i. (Roy et al., 2000; J. Schulze-Horsel, Y. Genzel, personal 
communication). In the detailed single cell model the average lifetime of a cell is 
assumed to be 12 h. A more precise estimate can be derived based on the behavior of 
the number of living cells after infection (see Appendix A3). Particularly, the 
dynamics of the population of dead cells provided by the population model 
corresponds to the value of the average lifetime of an infected cell equal to 
approximately 10 h.  
 
The exact mechanisms, by which the virus induces cell damage, finally leading to cell 
death, are not fully understood. As shown in section 4.8, cellular resources consumed 
for virus replication, such as the number of free nucleotides and amino acids, make up 
only an insignificant part of the total number of the cellular resources. Therefore, cell 
death does not seem to be correlated with the exhaustion of the pools of these 
resources.  
 
The most likely reason for the early death of influenza virus-infected cells is virus-
induced apoptosis, an active process of cellular self-destruction (see section 1.5.5). 
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The positive role of apoptosis for virus replication was pointed out by Stray and 
Gillian (2000). It consists in the removal of the cells that have already been infected 
from those capable of producing more virions. Influenza virus-induced apoptosis is 
regulated by both cellular and viral factors, as well as by their interactions. Indeed, 
according to results of several studies, influenza virus, side by side with some other 
viruses (e.g., baculovirus; Zhou et al., 1998), interacts with the apoptotic response of 
the host cell by either promoting or inhibiting cell death.  
 
Olsen et al. (1996a) demonstrated that particularly in MDCK cells influenza virus-
induced apoptosis is inhibited by the expression of bcl-2, a human proto-onco-gene 
known to inhibit many forms of apoptosis. Other cellular factors commonly involved 
in apoptotic processes, such as calcium and reactive oxygen species, are, in contrast, 
involved in triggering the death of influenza virus-infected cells (Olsen et al., 1996b). 
Among viral factors, viral NS1 proteins were reported to be a major inducer of 
apoptosis (Schultz-Cherry et al., 2003). It was shown that the expression of NS1 
proteins in an inducible system was sufficient for the induction of apoptosis in MDCK 
cells. It was also shown that cell death was most likely induced by the binding of NS1 
proteins to specific cellular RNA molecules or by a complete inhibition of PKR, a 
double-stranded RNA-dependent kinase, which acts as an antiviral protein inhibiting 
both cellular and viral protein synthesis. On the other hand, M1 proteins were shown 
to inhibit viral apoptosis by the specific interaction with caspase-8 in chicken embryos 
(Zhirnov et al., 2002). A critical role of the activation of caspases in cells infected by 
equine influenza viruses was discussed by Lin et al. (2002). The impact of the 
interaction of cellular and viral factors on the process of programmed cell death was 
investigated, for example, in the study of Morris et al. (1999). It was shown that in 
MDCK cells NA proteins promoted apoptosis by the mechanism occurring at virus 
entry into the cell and based on the activation of the growth factor TGF-β, known as 
an inducer of apoptosis. 
 
Besides the direct interaction of the influenza virus with the apoptotic response of the 
cell, other scenarios of the induction of apoptosis might also be possible. As discussed 
in section 1.6.5, the synthesis of cellular proteins drastically slows down after 
infection (Park and Katze, 1995). Additionally, cellular functions can be 
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compromised by the consumption of nuclear precursor mRNA molecules, i.e., their 
cap fragments for vmRNA production. As discussed in section 4.8, the number of 
precursor mRNA molecules consumed for virus production seems to be negligible. 
However, as the cap snatching is a random process, it can exhaust some sorts of 
mRNA molecules present in low numbers of copies.  
 
Presumably, at the presence of influenza virus particles in cell cultures not only 
infected cells, but also uninfected cells can die due to virus-induced apoptosis (not 
shown). Apoptosis of uninfected cells is thought to be initiated by specific ligands, 
such as double-stranded RNA molecules (Ludwig et al., 2003), released by infected 
cells and binding to the receptor proteins of uninfected cells. To take this into account 
in the population model the term  in (2.12.1) was introduced. inununap ZZk ,
 
The detailed mechanisms of influenza virus-induced apoptosis still have to be 
experimentally elucidated. Based on such results, simulation time T in the detailed 
single cell model, which is now set as an initial condition (T=12 h), could be used as 
an additional parameter in simulations, and the influence of the apoptosis on virus 
yields could be investigated. 
 
 
5.16 Directions for Further Experimental Work 
 
The model still needs the experimental verification of its parameters, such as rate 
coefficients, parameters defining the dynamics of the switch from vmRNA production 
to genome replication, as well as the exact time scale of the individual steps. 
Experimental work to identify key model parameters and to test several options 
regarding the structure of the model is in progress. It focuses mainly on the infection 
of cells under conditions relevant for vaccine production processes, where MDCK 
cells are grown in static cultures and microcarrier systems (Genzel et al., 2001; 
Genzel et al., 2003). Having also available comprehensive experimental data on cell 
metabolism during infection and the analysis of virus propagation in cell populations, 
it might be possible to better understand basic laws of virus infection both in a single 
mammalian cell and in a population of cells. 
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6 Summary 
 
Presented in this study was a structured mathematical model of influenza A virus 
replication in mammalian cells, which is the first model covering all steps of the 
infection cycle from virus attachment and internalization to viral protein expression, 
genome synthesis, assembly of M1-vRNP complexes, and release of progeny virions 
to the extracellular medium. The major purposes of the present study are an 
investigation of the dynamics of virus growth and viral component production, a 
better understanding of the interaction of virions with their host cells, and the 
formulation of the ideas concerning the improvement of virus yields in vaccine 
production processes. 
 
Based on the detailed single cell model, it was found that the process of progeny virus 
release by a single cell consisted of two main stages, an initial exponential and a late 
polynomial, comprising parabolic and linear phases. Analysis of model equations 
clearly showed that the existence of the polynomial stage of virus growth was a 
consequence of the inhibitive effect of NP proteins on the transcription of the viral 
genome. The ability of NP proteins to suppress vmRNA synthesis is expressed by the 
parameter , which also defines the duration of the exponential stage. It was shown 
that certain viral components represented bottlenecks for virus production at different 
stages of the replication cycle. Namely, M1 proteins represent a limiting factor at the 
production of M1-vRNP complexes, whereas M1-vRNP complexes themselves are 
limiting during virus budding. Additionally, it was worked out, which of the 
remaining viral components were produced in redundant amounts, and which of them 
were, in contrast, more critical. The dynamics of viral components limiting the 
production of progeny virions was shown to be sensitive to variations of some model 
parameters, such as the rate coefficients of virus internalization and the rate constants 
of the degradation of viral proteins in the nucleus. Besides that, it was shown that the 
behavior of the system was strongly correlated with the switch from vmRNA 
NPa
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production to genome replication, which, in turn, depends on the values of switch 
parameters, as well as on the nuclear concentration of NP proteins. At last, analysis of 
limiting factors of virus replication allowed formulating an experimental method to 
identify if the incorporation of genome segments into a progeny virion is a purely 
random process, or some selective mechanisms take place. 
 
The interaction of virus particles with the host cell was mainly analyzed in respect to 
the consumption of cellular resources by virus replication. Simulations showed that 
the pools of cellular resources, such as the number of free cellular nucleotides and 
amino acids, as well as precursor mRNA molecules, are not significantly influenced 
by virus replication. It was determined that if the cell was able to produce virions until 
the complete exhaustion of its free amino acids (the most critical resource), even the 
initial pool of free amino acids would be sufficient to produce about 1.3⋅104 virions, 
which is approximately two times more than the number of virions released within 12 
h p.i. (average lifetime of the cell). It was also shown that transport events did not 
limit the process. Relying on these arguments, it was particularly concluded that the 
early death of cells infected by influenza virus was most likely reasoned by virus-
induced apoptosis. 
 
Finally, the model allowed revealing the methods to improve the number of virions 
produced in the cell and formulating the hypotheses concerning the optimization of 
vaccine production processes, as well as the strategies for antiviral therapies. Thus, all 
three major purposes of this study were achieved. Besides that, several model 
modifications, which can be helpful for solving different important tasks, were 
considered.  
 
From the investigation of the sensitivity of the system behavior to parameter changes 
it can be concluded that variations of model parameters such as, for example, rate 
constants of the dissociation of virions from the cellular surface or rate constants of 
the assembly of M1-vRNP complexes and progeny virus particles, have a negligible 
effect on both the virus yield and limiting factors of virus replication. Furthermore, 
several sequences of the steps of the infection cycle contain no branch points and can 
be, therefore, lumped together. These arguments provided the basis for the model 
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reduction. The reduced model of virus replication in a single cell has a rather simple 
structure, comprising as few as 10 differential equations. The dynamics of virus 
replication obtained from the reduced model resembles that obtained from the detailed 
model. Consequently, the model can be used for the development of structured 
population balance models considering the interactions of cells infected by different 
numbers of virus particles.  
 
Introduction of a reinfection to the model for a single cell shows that the number of 
produced virions differs only slightly from that in the model without reinfection. 
What is more, limiting factors of virus production, as well as the optimal value of the 
MOI in respect to the virus yield, are the same for both models. Thus, it can be 
concluded that for the single cell model the reinfection is not important.  
 
The model with a continuous infection allowed revealing the optimal way of the 
infection of cells. It was shown that the continuous supply of virions to the volume of 
medium surrounding the cell did not increase virus yield, and the optimal strategy of 
infection with respect to the maximization of the number of released virions seems to 
be the infection of the cell at the initial moment of time without further supply of 
virions. 
 
Taking into account the balances for the populations of uninfected, infected, and dead 
cells allowed simulating the dynamics of virus production in microcarrier systems and 
to obtain realistic scenarios of the process, which are in good agreement with 
experimental data. Particularly, relying on simulation results, the optimal time of virus 
harvesting was estimated. Based on the population model it is possible to predict the 
changes in the dynamics of cell and virus populations at different variations of model 
parameters, and to investigate the dependency of the population sizes both on the 
MOI and on the ability of individual cells to produce virions. The corresponding 
changes in the dynamics of intracellular viral components can also be investigated. 
Besides that, the model allowed obtaining estimates for the average lifetime of a cell 
after infection at different initial conditions; particularly, it was possible to estimate 
the average lifetime of an infected cell. It was noted that unlike the single cell model, 
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the population model did not reveal the value of the MOI optimal for virus 
production; instead, the total number of virions produced by the system represented a 
monotonously decreasing function of the MOI. Being based on the reasonable and 
convenient simplifying assumption concerning the number of cells involved in the 
process of virus production, the population model keeps the simple structure peculiar 
to the single cell model. It adequately describes the system behavior in the situations 
when the lag between the beginning of the infection and the beginning of virus release 
is short in comparison with the duration of virus replication stage in the fermentation 
process (about 90 h), which takes place for the given set of model parameters. Indeed, 
cells infected by a secondary infection start to produce virus particles at 
approximately 10 h p.i. For the cases when virus release starts late after infection the 
model can provide approximate data concerning the population dynamics, 
particularly, upper estimates of the virus yield. 
 
Providing the data concerning the overall dynamics of virus replication and making 
possible the testing of hypotheses concerning basic virus replication mechanisms, the 
model developed in this study essentially facilitates future studies of influenza viruses 
at a cellular level. Its structure can be easily modified to incorporate additional details 
of the virus replication cycle. Experimental work to test several options regarding the 
structure of the model and to identify key model parameters, such as those defining 
the time scale of individual steps and the switch from vmRNA production to genome 
replication is in progress. 
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Appendix 
 
A1. Dynamics of the Assembly of Simple  
       Components to Complex Particles 
 
While modeling the given process, it can be often noticed that the description of some 
of events making up the process involved is itself an independent problem that 
possibly has more general cases and can arise in different applications. One typical 
problem, arising during the mathematical modeling of the influenza virus life cycle, is 
the quantitative description of the production of complex particles from simple 
precursors. 
 
Consider a dynamic system consisting of N+1 types of particles, in which particles of 
N+1-th type (complex particles) consist of particles of first N types (simple particles). 
Let X1…XN designate the numbers of particles of types 1…N in the free state. The 
numbers of particles of types 1…N in one complex particle will be denoted, 
correspondingly, by Q1 … QN, and the number of complex particles will be, in turn, 
designated by X.  
 
Suppose that particles of types 1…N are produced from the external source at rates 
proportional to the m-th power of time with the rate coefficients ksynt,1…ksynt,N , 
respectively, and the particles of N+1-th type are synthesized from particles of types 
1…N at the rate proportional to X
)( 1−−mh
1 … XN  with the rate coefficient of packaging kpck 
. Besides that, particles of types 1…N will be supposed to undergo degradation 
with the rate coefficients k
)( 1−h
degr,1…kdegr,N ) . Then the dynamic system can be 
described by the following system of ODEs: 
( 1−h
(A1.1)  iir
N
l
lipck
m
isynt
i XkXktk
dt
dX
,deg
1
,, −−= ∏
=
, Ni ...1=  
  
 Appendix  219 
(A1.2)  ∏
=
=
N
l
lpck Xkdt
dX
1
 
Here, the rate coefficients kpck,i )  are connected with the rate coefficient k( 1−h pck  
via the relation 
)( 1−h
pckiipck kQk =, ,  Ni ...1=
 
Equations (A1.1)-(A1.2) can be used to describe, for example the dynamics of 
chemical reactions of synthesis 
AAAA N =+++ ...21 , 
provided that the substrates A1, A2, …, AN  are continuously synthesized. Furthermore, 
in the detailed mathematical model of influenza virus replication developed in the 
present study, systems of equations, similar to (A1.1)-(A1.2) represent the formation 
of more complex viral components from simpler ones, e.g., the assembly of vRNP 
complexes from vRNA molecules and capsid proteins or the formation of new virions 
from vRNP complexes and viral envelope proteins. Since at the late stages of the 
infection simple viral components (e.g., NP proteins and polymerase complexes) are 
synthesized with the rate proportional to the first degree of time, the model of virus 
replication refers to the case of m=1 in . Considered processes are, as a rule, 
accompanied by the complete consumption of particles of one type (i.e., particles of 
this type are limiting for the formation of complex particles) and the accumulation of 
particles of other types in the system. Nevertheless, the state of the system can also 
change according to other scenarios. In this section basic possible cases of the 
behavior of the system described by equations (A1.1)-(A1.2) will be discussed. 
m
isynt tk ,
 
To better understand the behavior of the dynamic system involved, consider the 
simple case, when a complex particle consists of simple particles of four different 
types, present in equal amounts:  
4=N ; 
4321 QQQQ === . 
It is obvious that the results obtained for this particular case can be easily extended to 
the general case. For simulations it will be additionally assumed that 
Q1 = Q2 = Q3 = Q4 =1;  
  
 Appendix  220 
kdegr,1 = kdegr,2= kdegr,3 = kdegr,4 =1.0 h-1;  
kpck =1.0 h-1. 
 
Evidently, at the late stages of the process the number of complex particles, similar to 
the numbers of simple particles produced, increases obeying a polynomial law. If a 
degradation of complex particles is not assumed, the increase of their number has the 
order equal to m+1 (integration of the m-th order law of the increase for the synthesis 
rate of simple particles): 
1~ +mtX . 
 
Suppose first that the rate coefficient of synthesis for particles of the 1st type is lower 
than that for particles of the 2nd, 3rd, and 4th types: 
(A1.3)  ,  isyntsynt kk ,1, < 4,3,2=i  
It is clear that newly produced particles of the 2nd, 3rd, and 4th types are redundant and 
accumulate in the system. Their numbers increase proportionally to the m-th power of 
time: 
m
i tX ~ , ,  ∞→t 4,3,2=i
The number of newly produced particles of the 1st type will be, in contrast, critical for 
the process. As follows from the numerical solution of system (A1.1)-(A1.2), after the 
initial increase due to a low rate of packaging their number in the system decreases, 
finally tending to zero (Fig. A1.1): 
01 →X ,  ∞→t
It means that the whole amount of particles of the 1st type is consumed for the 
production of complex particles. 
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Figure A1.1 Dynamics of simple particles in the case of three redundant types. It is 
assumed that m =1, ksynt,1 =0.1 h-2, ksynt,2 = ksynt,3 = ksynt,4 =1.0 h-2. Particles of the 1st type (X1, 
⎯) are completely consumed at the late stages of the process. The numbers of particles of 
the other types, e.g. the 4th type (X4, ---), in contrast, increase proportional to the 1st (m-th) 
power of time. 
 
Let the rate coefficient of synthesis for particles of the 1st type be equal to that for 
particles of the 2nd type and less than that for particles of the 3rd and 4th types:  
(A1.4)  ,  2,1, syntsynt kk = isyntsynt kk ,1, < ,  4,3=i  
Simple particles critical for the production of complex particles (in the considered 
case, particles of the 1st and the 2nd types) are, like in the previous case, completely 
consumed: 
0→iX , ,  ∞→t 2,1=i
However, the order of the decrease of their numbers is lower than that for the case 
considered before (the rate of packaging, expressed by  in (A1.1), contains 
only two increasing factors in comparison with three ones in the previous case) (Fig. 
A1.2). The numbers of redundant simple particles (those of the 3
∏
=
N
l
lipck Xk
1
,
rd and 4th types) in 
the system increase proportional to the m-th power of time: 
m
i tX ~ , ,  ∞→t 4,3=i
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Figure A1.2 Dynamics of simple particles in the case of two redundant types. It is 
assumed that m =1, ksynt,1 = ksynt,2 =0.1 h-2, ksynt,3 = ksynt,4 =1.0 h-2. The numbers of particles of 
the 1st (X1, ⎯) and 2nd types tend to zero, however, the order of the decrease is less by 1 (m) 
than it is in the case of one critical type. The numbers of particles of the 3rd and 4th (X4, ---) 
types increase proportional to the 1st (m-th) power of time. 
 
It is remarkable that the considered situation is similar to the case of three different 
types of simple particles (N=3) with one critical type. 
 
As shown above, for sufficiently high numbers of redundant types, simple particles of 
critical types are completely consumed for the assembly. However, according to the 
model it is not necessarily the case. Suppose now that simple particles of three types 
are critical for the production of complex particles, namely, that  
(A1.5)  ,  3,2,1, syntsyntsynt kkk == 4,1, syntsynt kk <  
According to the numerical solution of system (A1.1)-(A1.2), particles of the 1st, 2nd, 
and 3rd types, despite being critical, are not completely incorporated into newly 
produced complex particles. Instead, their numbers tend to positive constants Xi,o: 
0,ii XX → , ,  ∞→t 3,2,1=i
Such a solution results from the presence of only one increasing factor in the 
expression for the rate of packaging. At the constant numbers of critical components, 
the rates of their packaging have the same order as the rates of their synthesis 
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(correspondingly, the terms  and  in (A1.1)), which provides the 
equality of the right- and the left-hand sides of equation (A1.1). The behavior of the 
function representing the number of a critical simple component depends on the 
relation between the rate coefficient of the synthesis of this component and the rate 
coefficient of its packaging. At small rate coefficients of packaging (k
m
isynt tk , ∏
=
N
l
lipck Xk
1
,
pck), the number 
of a given component monotonously increases (Fig. A1.3), otherwise its initial 
increase due to the low rate of packaging is followed by the decrease (Fig. A1.4). 
However, as discussed above, in both cases the number of critical viral components 
tends to a positive constant. 
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Figure A1.3 Dynamics of simple particles in the case of one redundant type. It is 
assumed that m =1, ksynt,1 = ksynt,2= ksynt,3 =0.1 h-2, ksynt,4 =1.0 h-2. The numbers of particles of 
the 1st (X1, ⎯), 2nd, and 3rd types monotonously increase tending to constant. The number of 
particles of the 4th type (X4, ---) increases proportional to the 1st (m-th) power of time. 
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Figure A1.4 Dynamics of simple particles in the case of one redundant type (the rate 
coefficient of packaging is put to equal kpck =105 h-1). It is assumed that m =1, ksynt,1 = 
ksynt,2= ksynt,3 =0.1 h-2, ksynt,4 =1.0 h-2. The numbers of particles of the 1st (X1, ⎯), 2nd, and 3rd 
types, after initial increase, decrease tending to constant. The number of particles of the 4th 
type (X4, ---) increases proportional to the 1st (m-th) power of time. 
 
Consider the remaining possible scenario, when the rate coefficients of synthesis are 
equal for all simple particles: 
(A1.6)  4,3,2,1, syntsyntsyntsynt kkkk ===  
A numerical analysis of system (A1.1)-(A1.2) shows that in the considered case the 
numbers of simple components are represented by monotonous functions of time, 
increasing more slowly than the first order polynomial at the late stages of the 
process: 
)()( totX i = ,  , ∞→t 4...1=i  
It is also easy to see that in the general case the order of the increase of these 
functions is equal to m/N (at the given set of parameters it is 1/4) (Fig. A1.5). At the 
same time, the number of complex particles, as it does in the previous cases, increases 
proportional to tm+1. 
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Figure A1.5 Dynamics of simple particles in the case of equal synthesis rates. It is 
assumed that m =1, ksynt,1 = ksynt,2= ksynt,3 = ksynt,4 =1.0 h-2. The numbers of particles of all types 
(⎯) monotonously increase as o(t), t→∝. 
 
It is remarkable that although this situation is similar to the case of only one type of 
simple particles (N =1), the order of the increase of the number of simple particles in 
the case of N =1 (Fig. A1.6) differs from that in the cases of N =4 (four equal types of 
simple particles) (Fig. A1.5). It can be also seen from equations (A1.1) and (A1.2) for 
both cases. In the case of N =1 the equations are satisfied by linearly increasing 
functions representing the numbers of simple particles, whereas in case of N =4 the 
order of the increase must be 1/4. 
 
It is also worth mentioning the particular case when there are only two types of simple 
particles making up a complex particle (N=2). In this situation only two possible 
scenarios are possible: 
2,1, syntsynt kk <  
and 
2,1, syntsynt kk =  
It is obvious that all the conclusions made above for the case (A1.5) concerning the 
system containing four types of particles can be applied to the former scenario, 
whereas the letter scenario corresponds to the case (A1.6) for the system described 
above. It means that in the system containing two types of particles, provided by the 
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presence of the degradation of simple particles, particles of all types involved (both 
critical and redundant) accumulate in the system. If the rate coefficients of synthesis 
are different for two types of simple particles, the number of particles of the 
redundant type increases proportional to tm, whereas the number of particles of the 
critical type tends to constant. 
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Figure A1.6 Dynamics of simple particles in the case of one type of simple particles    
(N =1). The number of simple particles (⎯) is a linearly increasing function of time (m =1). 
 
Thus, at the late stages of the considered process, the number of complex particles 
invariably increases proportional to tm+1, whereas the numbers of simple particles of 
redundant types increase proportional to the m-th power of time. As for the simple 
particles of critical types, their dynamics is highly sensitive to the number of 
redundant types in the system. At the absence of redundant types the number of 
simple particles monotonously increases; in the case of one redundant type the 
numbers of simple particles of critical types tend to constant; and in the case of 
several (more than one) redundant types the particles of critical types are completely 
consumed by the production of complex particles.  
 
The model presented in this section can be easily modified to consider more complex 
expressions for synthesis rates of simple particles. For example, synthesis rates can be 
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assumed to be proportional to the number of simple particles of one of types (like 
polymerase complexes in the model for influenza virus replication, see section 2). 
 
 
A2. Infection Probability for Virus Particles  
      Containing Eight Genome Segments 
 
Let  designate the total number of nucleotides, making up the genome segments 
produced. Since all 8 segments are produced by viral polymerase with the same rate 
(measured in nucleotides per second), the number of nucleotides belonging to the i-th 
segment is equal to 
N
8
N  for any i. The number of produced i-th segments is then  
i
i N
NS 1
8
= ,  
where  is the number of nucleotides, making up one copy of the i-th segment. The 
total number of produced segments is, correspondingly,  
iN
∑
=
=
8
1
1
8 i iN
NS . 
 
Suppose that S and Si (i =1…8) are so big that taking away of several segments (less 
than eight) does not change them significantly. Then the number of all possible ways 
to choose 8 genome segments is  
8SM all = .  
However, only in  
∏
=
=
8
1
!8
i
idif SM  
cases 8 chosen segments will be different (∏  is the number of ordered selections, 
and 8! is the number of permutations). Taking the values for  from (Kneipe et al., 
2001), and calculating 
=
8
1i
iS
iN
iN
1  and 
S
Si  (Table A2.1), the probability to produce an 
infectious virion can be calculated as 
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10015.0
1
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1
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1
inf ≈==== ∏∑∏ =
=
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i
i
i
i
i
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N
N
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Table A2.1 Calculations of the probability of infection for a virus particle containing 8 genome 
segments 
 
iN
1
 
S
Si  
PB2 4.27⋅10-4 8.04⋅10-2
PB1 4.27⋅10-4 8.04⋅10-2
PA 4.48⋅10-4 8.44⋅10-2
HA 5.62⋅10-4 10.59⋅10-2
NP 6.39⋅10-4 12.04⋅10-2
NA 7.08⋅10-4 13.34⋅10-2
M 9.74⋅10-4 18.35⋅10-2
NS 11.24⋅10-4 21.17⋅10-2
∑ 53.09⋅10-4  
Π  3.60⋅10-8
 
 
A3. Method to Calculate the Average Lifetime of  
       a Cell 
 
Based on experimental data concerning the population of living cells after infection, 
the average lifetime of a cell can be calculated. Let  (cells/nL) designate the 
number of dead
)(tZ d
13 cells at the time point t  (h), which is the difference of the initial 
number of cells in the system (Z0 (cells/nL)) and the total number of living cells 
(uninfected and infected). Then the number of cells that die at time interval  
is , and the net lifetime of these cells at the considered interval is . 
];[ dttt +
)(tdZ d )(ttdZ d
 
                                                 
13 Like in the population model, function Zd represents the total number of dead and degraded cells. 
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If maxτ  (h) is the time point when all cells are dead, then the net lifetime of all cells in 
the system (  (h)) is ΣT
∫=Σ max
0
)(
τ
ttdZT d , 
and the initial number of living cells is, correspondingly, 
∫= max
0
0 )(
τ
tdZZ d . 
Consequently, for the average lifetime of a cell (T  (h)) the following formula can be 
written: 
(A3.1)  ∫== Σ max
000
)(1 τ dt
dt
tdZ
t
ZZ
TT d . 
This formula shows that required for the calculation of the average lifetime of a cell is 
the dependency of the number of dead cells on time. Such a dependency can be 
particularly obtained based on the population model (Fig. 4.23). Numerical 
integration in formula (A3.1) for the MOI=0.1 virions/cell provides the value of the 
average lifetime of a cell equal to approximately 22 h. 
 
For high values of the MOI, e.g., MOI=10.0 virions/cell (all the cells are immediately 
infected) formula (A3.1) gives T≈10 h, which corresponds to the average lifetime of 
an infected cell. 
 
 
A4. Estimation of Cellular Pools 
 
Calculations of the numbers of free cellular amino acids and nucleotides, as well as 
the number of precursor mRNA molecules, are summarized in Table A4.1. Among 
the components the wet weight of the cell consists of 0.4 % falls to free nucleotides 
and 0.4 % is made up by free amino acids (Alberts et al., 2002). Precursor mRNA 
molecules make up about 5 % of the total number of RNA molecules constituting the 
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biomass of the cell, and the fraction of RNA molecules of the wet weight of the cell 
is, in turn, 1.1 %.  
 
The percentage of the considered resources in the dry weight of the cell can be 
derived based on the data concerning the content of water: 70 % of the wet weight 
(Alberts et al., 2002). Cellular dry weight were taken equal to 5.41⋅10-10 g (MDCK 
cells; U. Reichl, personal communication) and the relation between the units of mass 
involved is 1 Da ≈ 1.66⋅10-24 g. The number of precursor mRNA molecules was 
calculated both in nucleotides and in molecules. In the latter case it was taken into 
account that the average length of the mRNA strand was approximately 6000 
nucleotides (Kaufman et al., 2000). 
 
Table A4.1 Calculations of the intracellular numbers of free nucleotides, amino acids, and 
precursor mRNA molecules 
 Amino acids Nucleotides mRNA 
% of cellular wet weight 
Source 
0.4 
1 
0.4 
1 
0.05⋅1.1 
1 
% of cellular dry weight 1.33 1.33 0.18 
Weight in the cell, g/cell 7.20⋅10-12 7.20⋅10-12 9.74⋅10-13
Average molecular weight, Da 
Source 
138 
2 
330 
3 
330 
3 
Number of molecules 3.14⋅1010 aa 1.31⋅1010 nt 1.78⋅109 nt 
2.97⋅105 mlc 
nt: Nucleotides 
aa: Amino acids 
mlc: Molecules 
1: Alberts et al., 2002 
2: Nelson et al., 2000 
3: Stryer et al., 2002 
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A5. Experimental Data for Virus Release and  
       Cell Detachment 
 
The virus yield and the number of cells in the supernatant were investigated for the 
infection of cells in roller bottles at different MOI (Y. Genzel). Experimental data is 
presented in Figures A5.1 and A5.2. 
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Figure A5.1 Virus yield (HA value) for different values of the MOI. 
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Figure A5.2 The number of cells in the supernatant (detached cells) for different values 
of the MOI. 
 
This data indicates that at the early stages of the process the HA value (which can be 
assumed to be proportional to the virus yield) increases faster at higher MOI (Fig 
A5.1). On the other hand, the maximal number of released virions does not depend 
significantly on the MOI.  
 
Figure A5.2 shows that within 48 h p.i. more than 90% of cells detach from 
microcarriers for all the MOI values considered. 
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